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Injection of tetanus toxin (TeNT), systemically or directly into the brain, has long been 
known to cause spastic paralysis or seizures respectively: thought to be due to 
disruption of inhibitory neurons and cleavage of vesicle associated membrane protein 
2 (VAMP2). Here we investigate mechanisms involved in TeNT-induced chronic 
epilepsy in the first 16 days following injections in vivo and focally onto organotypic 
hippocampal slice cultures. Immunohistochemical analysis identified a spatial and 
temporal cleavage of both VAMP1 and VAMP2 progressing from day 2 post injection 
through to days 8 and 16. This was concentration dependent in slice cultures. 
VAMP1 has been shown to co-localise predominantly with inhibitory and VAMP2 with 
excitatory neurons. Contradicting previous results we have shown cleavage of both 
VAMP1 and VAMP2, disruption of both inhibition and excitation and direct effects of 
the toxin in the contralateral hippocampus. This indicates that inhibitory neurons and 
VAMP2 are not specifically targeted by TeNT. This project benefits from the 
combination of electrophysiological and immunohistochemical techniques to uncover 
functional changes induced by TeNT. It is also the first study of focally injected TeNT 
onto slice cultures and offers benefits for future long term studies of the effects of the 
toxin and drug screening.  
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1.1 Epilepsy 
Epilepsy is a disease that affects approximately 1% of the population (Elger, 2002; 
Majores et al., 2007) and encompasses a large family of disorders (Fisher et al., 
2005). For the definition of epilepsy to be used, at least one epileptic seizure must 
have occurred; this being the clinical manifestation of a transient incidence of 
abnormal synchronous or excessive neuronal activity (Engel & Pedley, 1997; Blume 
et al., 2001; Fisher et al., 2005). The abnormal firing is often self-limiting and 
intermittent but the disease is characterised by a chronic predisposition to seizures 
occurring (Engel & Pedley, 1997; Fisher et al., 2005). There are also further 
consequences for the sufferer, including neurobiological, psychological, cognitive and 
social effects (Engel & Pedley, 1997; Fisher et al., 2005). This is a disease that can 
occur across all age groups and can be a result of various factors, including head 
injuries, tumours, febrile seizures, and even genetic predispositions (Engel, 2001; 
Gambardella et al., 2009; Ruban et al., 2009). Everyday-life can be severely affected 
for patients suffering from epilepsy and the ability to carry out normal activities can 
become constrained if seizures are not well managed. 
Epilepsy encompasses a broad variety of symptoms that arise due to disruptions and 
disorders of brain function that can result from pathologic processes. It is not itself a 
specific disease or a single syndrome. Epilepsies tend to be categorised by the type 
of seizure that manifest and also by other clinical features that are associated. 
Seizure types, recurrence patterns, age of onset, EEG recordings, familial 
occurrence or not, associated clinical or neurological signs and prognosis are all 
important in identifying certain epileptic syndromes (Engel, 2006). There are more 
- 3 - 
than 40 seizure types associated with humans and within these, some are familial 
(where genetic determinants are found) (Engel, 2006). The classification of 
epilepsies and seizure types is likely to be updated as further insights into the 
syndromes are made (Berg & Scheffer, 2011). The relief of seizures by treatments 
including medication or surgery is not always the end point to the disability. Lives can 
still be affected by the psychological effects that remain after the treatment of the 
medical factors. 
Of the multiple epilepsies, temporal lobe epilepsy (TLE) is the type that we 
investigate in this project. 
1.1.1 Temporal lobe epilepsy 
Temporal lobe epilepsy is the most common form of epilepsy (Engel, 2001; Choi et 
al., 2008), encompassing about 30% of people suffering from the disease. TLE can 
consist of simple partial seizures or complex partial seizures, where consciousness is 
maintained in the former but lost during the latter type. These seizures originate and 
can stay in one hemisphere of the brain, however they can progress to include both 
sides of the brain at which point secondary generalisation has occurred (Sharma et 
al., 2007). This form of epilepsy is often associated with morphological changes 
within the hippocampus know as hippocampal sclerosis, which affects approximately 
60% of TLE patients (Blumcke et al., 1999). For those who do not present with 
hippocampal sclerosis, the type of epilepsy is termed non-lesional TLE. 
For 20-40% of epilepsy sufferers, drug treatments are ineffective, categorising their 
epilepsy as medically intractable (Loscher, 1997; French, 2007; Loscher & Brandt, 
2010). This medically intractable epilepsy often involves numerous antiepileptics 
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being tried in mono- and combination therapies but to no avail (Loscher, 1997). 
Surgical resection is most commonly and most effectively used to treat TLE of all the 
epilepsies (Engel, 2001); however this is not a suitable option for all patients. In TLE 
compared to other epilepsies, patients have a much greater risk of being refractory 
with estimates in the range of 58-89% of cases, although variable worldwide 
(Loscher, 1997; Aull-Watschinger et al., 2008; Cascino, 2008). For patients that have 
to endure seizures which are not well controlled, the continued research into epilepsy 
to understand the mechanisms and variances is vitally important. This provides the 
first step to finding drugs or other means of treatment that may be able to help people 
with drug refractory epilepsy. To be able to do this, in vivo animal models and in vitro 
based techniques provide key research tools. 
Epilepsy is one of the main causes of neuropsychiatric disability, second to 
depression across the world (Engel & Pedley, 1997) and therefore deserves 
continuing research efforts. This project uses animal models of TLE to investigate the 
mechanisms of the disease further. 
1.2 Animal models of epilepsy 
Animal models are key tools for research into multiple diseases, including 
neurological diseases like epilepsy. An animal model is a representation of a 
disease, modelling different features or symptoms which allow an insight into the 
human disease. 
There are numerous models of epilepsy. These range from injections of substances 
acting on various biochemical pathways, either systemically or directly into the brain; 
for example kainic acid, picrotoxin or tetanus toxin (TeNT); to electrical stimulation of 
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parts of the brain, to hyperthermia and post-trauma models (Sharma et al., 2007). 
The different models are able to induce different types of seizures and can represent 
differing stages of the disease, for example length of time to onset, occurrence of a 
physical injury, frequency of seizures and morphological changes. We are yet to fully 
understand the underlying mechanisms in both human and animal models of 
epilepsy thus further research is required. There are animal models that model the 
lesional and non-lesional forms of TLE, and can represent acute or chronic 
spontaneous forms, dependent on the form of induction and time after administration 
(Vincent & Mulle, 2009).  
The existence of multiple models is of great use as the ability to model varying 
symptoms and causes of the disease is increased. Each model of course has 
advantages and disadvantages to be considered but they are tools that can provide 
many answers. 
1.2.1 Tetanus toxin-induced epilepsy 
It has been known for a long time that TeNT causes seizures in many animals, 
including rats, mice and rabbits (Roux & Borrel, 1898). Injection of a minute amount 
of TeNT into one hippocampus of an adult rat causes a chronic spontaneous model 
of TLE. The model does not involve a status epilepticus as in many of the other 
substance injection models (Raedt et al., 2009; Vermoesen et al., 2010). It also 
results in minimal cell death, with only about 10% of injected animals showing the 
hippocampal sclerosis morphology (Jefferys et al., 1992; Jefferys & Whittington, 
1996; Jiruska et al., 2010)(and unpublished data from our laboratory). This is 
compared with injections of pilocarpine (Turski et al., 1984; Cavalheiro et al., 1991) 
or kainic acid (Lothman & Collins, 1981) that cause severe pathology. The TeNT 
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model is therefore a useful tool for representing those patients that have seizures but 
without the associated hippocampal sclerosis. However, there still remain a number 
of unanswered questions about the epilepsy induced by intrahippocampal TeNT 
injection. The model produces spontaneous recurrent seizures in adult rats from 5-7 
days after injection and recovery from seizures occurs by 6-8 weeks (Mellanby et al., 
1977; Brace et al., 1985; Empson & Jefferys, 1993). Behavioural and learning 
impairments remain a feature after remission from the seizures (Brace et al., 1985; 
Jefferys & Williams, 1987). The aim of this study is to further understand the 
mechanism by which TeNT causes the epilepsy, focussing on the early stage – up to 
16 days after injection. Future experiments will address the later stages of this model 
in light of our findings. 
1.2.2 Actions of tetanus toxin 
To be able to understand the mechanisms involved in the epilepsy induced by 
injections of TeNT into the brain, we must first consider the actions of the toxin. The 
TeNT itself is an exotoxin from the bacterium Clostridium tetani with a molecular 
weight of ~150kDa (Helting & Zwisler, 1977; Chen et al., 2008a). The clinical feature 
most commonly associated with infection by TeNT is trismus, which is better known 
as ‘lockjaw’ (Smith & Drew, 1995; Farrar et al., 2000; Turillazzi et al., 2009). The 
TeNT is a zinc protease which consists of a heavy and a light chain, of which both 
are needed for the model. Both chains play important and different roles in the 
pathogenesis of the toxin. The heavy chain (~98kDa) is important for the binding, 
internalisation and transport of the toxin and is an atoxic component (Helting & 
Zwisler, 1977; Figueiredo et al., 1997; Jefferys & Walker, 2006; Chen et al., 2008a). 
The light chain (~52kDa) is responsible for the protease action of the toxin (Helting & 
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Zwisler, 1977; Jefferys & Walker, 2006; Chen et al., 2008a). The two chains are 
linked by a protease sensitive loop which tissue proteases cleave, leaving a 
disulphide bond between the two chains (Cook et al., 2001). This disulphide bond is 
reduced following internalisation of the toxin and this allows the light chain to become 
free (Cook et al., 2001; Yeh et al., 2010). The normal pathogenesis of the toxin 
involves entry through a break in the skin or a wound. The toxin is taken into 
motoneurons by endocytosis and then travels in endosomes by retrograde axonal 
transport along these motoneurons into the spinal cord (Figueiredo et al., 1997). 
Here the toxin is able to cross synapses between neurons and have its main action; 
the cleavage of vesicle associated membrane protein (VAMP; also known as 
synaptobrevin) in presynaptic terminals (Cook et al., 2001; Jefferys & Walker, 2006). 
The exact mechanism of entry into neurons of the central nervous system (CNS) 
remains uncertain. It is likely that there are different mechanisms involved in the entry 
into motoneurons and the subsequent entry into interneurons (Rossetto et al., 2001; 
Yeh et al., 2010; Blum et al., 2012). Whilst some show that entry into inhibitory 
neurons occurs through synaptic vesicle recycling and the binding of TeNT to 
synaptic vesicle protein 2 (SV2) (Yeh et al., 2010), others have shown that synaptic 
recycling may not be important and that binding to gangliosides is the suggested 
route (Chen et al., 2009; Blum et al., 2012). Disruption of SV2 isoforms (Yeh et al., 
2010) and gangliosides (Kitamura et al., 1999) have both shown some resistance to 
the cleavage effects of TeNT in comparison with control animals therefore the 
question as to TeNT entry into neurons still remains. If SV2 was to be the entry route, 
Yeh et al. (2010) have shown that inhibitory and excitatory neurons largely possess 
different SV2 isoforms in the cortex. Inhibitory neurons were found to mostly co-
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localise with SV2A, whereas SV2B was mostly present in excitatory neurons. This 
was the case in both spinal cord and cortical neurons however they also show that 
this differential expression does not correspond with a preference of the target to one 
population or the other. The hippocampus has been shown to express both SV2A 
and SV2B although their co-localisations with specific neuron populations has not 
been studied (Janz & Sudhof, 1999), but a lack of SV2B staining in the stratum 
lucidum (str. lucidum) and hilus would suggest that perhaps SV2B is not expressed in 
excitatory granule or mossy cells of the hippocampus. 
1.2.3 Vesicle Associated Membrane Protein (VAMP) as the target for TeNT 
The VAMPs belong to the group of soluble N-ethylmaleimide sensitive factor 
attachment protein receptors (SNARE) which are required for neurotransmitter 
release following vesicle fusion with the presynaptic membrane (Chen et al., 2008a). 
A single hydrophobic C-terminal segment anchors the VAMP to the synaptic vesicle 
and the rest of the protein remains in the cytoplasm (Sollner et al., 1993; Yamasaki et 
al., 1994). For vesicle fusion to occur, a SNARE complex must be formed. This is 
through the interaction of a v-SNARE; those that sit within the vesicle membrane e.g. 
VAMP, and two t-SNAREs; those that reside in the target membrane, e.g. syntaxin1 
and synaptosomal-associated protein 25 (SNAP-25) (Figure 1.1). 
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Figure 1.1. Schematic of vesicle fusion by formation of the SNARE complex. 
Panel A shows VAMP/synaptobrevin (v-SNARE) associated with synaptic vesicles 
and syntaxin and SNAP25 (t-SNAREs) associated with the target membrane 
(synaptic cleft). Panel B shows the formation of a SNARE complex and the resulting 
fusion of the vesicle membrane with that of the target membrane, allowing for 
neurotransmitter release. The SNARE complex is formed when the SNARE motifs of 
each of VAMP/synaptobrevin, syntaxin and SNAP25 are combined. Figure adapted 
from Sudhof (2004). 
 
Botulinum toxins (BoNTs) and TeNT have specific cleavage sites on VAMP, syntaxin 
and/or SNAP25. These are represented in Figure 1.2. Interestingly, Hayashi et al. 
(1994) showed that the cleaved fragment of VAMP2 (cleaved by TeNT) was still able 
to form the stable complex with syntaxin and SNAP25 but if the complex had already 
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been formed, then the TeNT could not have its action. This showed that vesicles that 
had already docked and fused with the presynaptic membrane were unaffected by 
the protease action of the toxin. Humeau et al. (2000) also showed that there was a 
very tight window during the docking process of vesicles at the active zone in which 
the TeNT could have its action. Over time, the TeNT will continue to cleave the 
VAMP isoforms when they become available within the ‘physiological window’ 
(Humeau et al., 2000). 
 
                    
Figure 1.2. Sites of cleavage by TeNT and BoNTs. Representation of the cleavage 
sites of the seven different BoNTs and TeNT. These cleave VAMP/synpatobrevin, 
syntaxin and SNAP25 at distinct sites. BoNT/B and TeNT cleave at the same site on 
VAMP/synaptobrevin. Adapted from Humeau et al. (2000). 
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The use of toxins like tetanus and botulinum allowed for the discovery of the function 
of proteins involved in neurotransmitter release e.g. VAMP, and to further understand 
the mechanisms used (Schiavo et al., 1992; Yamasaki et al., 1994; Hussain & 
Davanger, 2011). New techniques have also allowed for TeNT light chain to be 
targeted to specific neurons in drosophila and rat brain to elucidate the function of 
subpopulations of neurons. These include use of the GAL4/UAS system in drosophila 
that has shown roles of specific neurons in circadian rhythm, visual fixation and 
locomotion (Xiong et al., 2010; Chow et al., 2011; Umezaki et al., 2011; Alekseyenko 
et al., 2013). Recombinant proteins have also been used to specifically target 
subpopulations of neurons in rats to show the neurons involved in rotational 
behaviour (Kobayashi et al., 2008) and virally targeted TeNT in CA1 parvalbumin 
neurons has shown their importance in spatial reference memory (Murray et al., 
2011). Whilst intrahippocampal injections of TeNT have been predominantly carried 
out in rats, a recent study has shown epileptiform activity after TeNT into the visual 
cortex of mice (Mainardi et al., 2012). Our laboratory is also currently undertaking 
intrahippocampal injections into mice for comparative studies to those in rats. These 
experiments emphasise the importance of TeNT as a tool to look at neuronal function 
and the resulting dysfunction of the network,  
In the TeNT model of chronic recurrent epilepsy, the disruption of neurotransmission 
through the disruption of the formation of SNARE complexes after cleavage of VAMP 
accounts for changes in neuronal activity. This is thought to be through disturbances 
in the inhibition-excitation ratio. The literature regarding TeNT includes some 
discrepancies as to the target of the exotoxin. Most claim that VAMP2 alone is the 
target based on work by Schiavo et al. (1992), whereas others only state that 
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inhibitory neurons are preferentially targeted (Humeau et al., 2000; Doheny et al., 
2002) due to the spastic paralysis caused after peripheral infection. Part of this 
project looks to resolve this discrepancy by looking at the distribution of the VAMP1 
and VAMP2 isoforms at different time points throughout the in vivo and in vitro model 
and to further understand their roles in the induction of epilepsy. 
1.2.4 Summary of TeNT model 
This TeNT model has been shown to be complex and discrepancies exist between 
different theories as to the actions of the toxin. The aim of this project is to study, in 
detail, the changes that occur during the first 16 days of the model with a focus on 
the cleavage effects of the toxin using immunohistochemistry and the coupling of 
these results with functional electrophysiological recordings. This study focuses on 
three specific time points within the course of the TeNT-induced epileptic syndrome. 
Two days post injection was chosen as the first time point as it represents a stage 
before epileptic seizures have been witnessed and within in vitro slices, no epileptic 
activity could be stimulated (Jefferys, 1989). The 8 day post injection group were 
chosen as this is at a time when seizures have begun in most animals and the 
threshold for burst firing was at its lowest in acute ex vivo slices (Whittington & 
Jefferys, 1994). The day 16 group represents the time point when epileptic activity is 
at its peak in ex vivo slices (Whittington & Jefferys, 1994). The use of the 
hippocampus, an area which has a laminar structure allows for detailed analysis of 
the effects of the toxin. 
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1.3 The Hippocampus 
The hippocampus contains a unique and specialised organisation and is the main 
focus of this study. It forms part of the temporal lobe and is a structure that is 
important in learning and memory. The hippocampal formation is made up of the 
cornu ammonis (CA) regions of which there are three; CA1-3; the hilus and the 
dentate gyrus (DG). The tri-synaptic pathway, in brief, carries information from 
external brain regions to the dentate gyrus, which in turn passes this information on 
to the CA3 which finally innervates the CA1. The innervations within the 
hippocampus are organised and complicated. The two hippocampi of the brain are 
connected via commissural projections. The projections of the CA3 make contact 
with both the ipsilateral and the contralateral CA1 and CA3 (Laurberg & Sorensen, 
1981; Amaral & Lavenex, 2007). There are also commissural projections from the 
hilus to the contralateral inner molecular layer of the dentate gyrus (Laurberg & 
Sorensen, 1981) and weak projections between the CA1 on both sides of the brain 
(van Groen & Wyss, 1990; Gulyas et al., 1998; Amaral & Lavenex, 2007). 
The hippocampus consists of both inhibitory and excitatory neurons, of which the 
percentages are 10% and 90 % respectively (Freund & Buzsaki, 1996). Balance 
between the excitatory and inhibitory neurons is important when such interconnected 
networks exist between the different areas of individual hippocampi and between the 
two hippocampi. It is thought that an imbalance between the excitation-inhibition ratio 
could explain part of the mechanism of epilepsy. The principal excitatory cells in the 
hippocampal formation are the pyramidal cells of the CA1 and CA3, the granule cells 
of the dentate gyrus and the mossy cells of the hilus. There are multiple types of 
inhibitory neurons, which can be classed using multiple criteria, for example 
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neurochemical markers, firing properties and morphology (Freund & Buzsaki, 1996; 
Sugino et al., 2006). Given that there are so many types and subclasses of neuron, 
the potential for disruption of the regulatory balance by a dysfunction or interruption 
of part of the neurotransmission mechanism is high. 
1.3.1 Use of the hippocampus for investigation into the mechanisms involved in 
epilepsy 
The hippocampus provides a useful research tool in that the cell layers are clearly 
defined and accessible in slices. In vitro techniques including using brain slices allow 
for an insight into the physiology and morphology of different brain structures in 
control and disease situations. For the purposes of modelling epilepsy, slices can be 
used that were obtained from an animal that had epilepsy induced in vivo or that had 
received a treatment in the in vitro setting to induce an epilepsy-like condition. 
Electrophysiology and immunohistochemical analyses can be carried out on these 
slices to gain an insight into the changes that occur during the course of the epilepsy 
model. 
1.3.1.1 Acute ex vivo slices 
Acute ex vivo slices are commonly used for studying the electrophysiological 
properties of the hippocampus following in vivo injection with either TeNT or control 
solutions (Jefferys, 1989; Empson & Jefferys, 1993; Vreugdenhil et al., 2002). These 
slices allow application of drugs to isolate different features of the slices’ properties 
as well as electrophysiological recordings from various regions and layers within the 
structure. However, a disadvantage of these slices is that they can only be used for 
electrophysiological recordings for about 24 hours after isolation from the animal. 
Following this the slices can be fixed and utilised for immunohistochemistry. The 
- 15 - 
slicing process causes a substantial degree of damage through deinnervation. The 
24 hour time limit does not allow for any reorganisation or reinnervation of these 
denervated axons therefore recordings may not be as accurate a representation of 
the in vivo condition as would be preferable. Recordings and immunohistochemical 
analysis of ex vivo slices are used for part of this project however a technique that 
may go some way to overcoming the disadvantages associated with acute slices is 
that of organotypic hippocampal slice cultures, which are used for the remaining part 
of the project. 
1.3.1.2 Organotypic hippocampal slice cultures 
Organotypic hippocampal slice cultures are an in vitro technique that has been 
around for a number of decades (Gahwiler, 1981). A popular method involves a roller 
tube containing a hippocampal slice maintained in a plasma clot which goes through 
rotations in an incubator to alternate between being submerged in the clot and being 
in contact with the air. A second technique published in 1991 by Stoppini et al. (1991) 
had slices resting on a semi-permeable membrane at an interface between culture 
medium below the membrane and the humidified atmosphere of the incubator air 
above. No expensive rotating devices for the incubator were required with this 
method and no plasma clot was involved. New born animals are used for slice 
cultures with a greater success rate than with adult slices (Gahwiler et al., 2001; 
Fuller & Dailey, 2007). This interface method is the method that we have used for the 
project. 
Organotypic hippocampal slice cultures retain their organisation and viability for a 
number of weeks following isolation. From just one animal, up to 20 slices (400µm) 
can be cultured, with some being treated with control solution, and others with the 
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TeNT. This means that the animal acts as its own control. The cytoarchitecture of the 
hippocampus is preserved within slice cultures which provides a useful platform for 
manipulations of different areas. Kamada et al. (2004) show that the organisation of 
the pyramidal layers and granule cell layer within the slice are reorganised slightly 
but remain in the position that would be expected. The pyramidal cell layer of the 
CA1 reorganises to spread out into a flatter layer rather than the cells remaining piled 
on top of each other as is seen in the CA3 (Stoppini et al., 1991; Buchs et al., 1993), 
but this reorganisation is minimal. Another advantage of the organotypic slices is that 
they can be recorded from on multiple days. This allows for following changes within 
a slice at multiple time points. These slice cultures provide a way of refining and 
reducing the number of animals used in research and therefore acts as good 
practice. This technique has the potential to act as a medium throughput screen for 
antiepileptic drugs before they are used in live animals. 
Organotypic hippocampal slice cultures are becoming commonly used to model a 
number of different disease states, including post trauma, oxygen and glucose 
deprivation and epilepsy. Most of these models induce the disease activity by 
exposing the whole slice to an agent, whether it be chemical such as kainic acid 
(Bausch & McNamara, 2004; Reid et al., 2008) or glutamate (Ziobro et al., 2011) put 
into the culture medium to induce epilepsy, perfusion with an epileptogenic agent 
(Albus et al., 2008) or solution e.g. low-Mg2+ (Gutierrez et al., 1999; Kovacs et al., 
1999; Wahab et al., 2009), or depriving the whole slice of oxygen (Jung et al., 2012). 
Either way, it is generally the entire slice that has been ‘treated’ with something.  
Part of this project involved establishing a treatment method that can apply the TeNT 
in a focal manner to the organotypic slice, to mimic that of the injections of TeNT that 
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are carried out in vivo. As far as we are aware, this has not been done in slice 
cultures to date. A handful of groups have used TeNT with slice cultures for various 
experiments (Mitchell, 1998; Scheuber et al., 2006) but none have applied it focally 
for an epilepsy model. The advantage of focal injections is that the activity of different 
areas of the hippocampus can be assessed following injection into a remote area. 
This will allow investigation into the spread of the effects of the toxin throughout the 
hippocampus from the injection site of the CA3. We will be able to follow this spread 
across the time course of the model and compare and contrast to results from ex vivo 
slices from animals that had received in vivo intrahippocampal TeNT injections. 
There are a number of advantages to using organotypic slice cultures over acute 
slices and thus was the reason for attempting to establish a slice culture model of 
TeNT-induced epilepsy. Firstly they are a good representation of the connectivity that 
is present in vivo (Kim et al., 2013) as the first week in culture allows the slice to 
recover from the isolation procedure and a degree of reorganisation occurs, unlike in 
acute slices. Admittedly recurrent connections are formed but De Simoni & Edwards 
(2006) have shown that cut axons do not sprout randomly but show some selectivity. 
Connections between the dentate gyrus and CA1 have however also been shown to 
form in slices that do not contain the entorhinal cortex (Gutierrez & Heinemann, 
1999). This is thought to be because the afferent inputs to the dentate gyrus which 
arise from places like the entorhinal cortex have been cut and so new connections 
are formed within the remaining areas. In our slices, the entorhinal cortex remains 
attached to the hippocampus. 
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Overall, these slice cultures offer the possibility to study the effects of focal TeNT 
injections and to compare the results with the wealth of information that already 
exists from in vivo experiments and ex vivo slices. 
1.4 Aims 
The main aims of this project are to investigate the effects of TeNT on VAMP1 and 
VAMP2 within the hippocampus and therefore to further understand the mechanisms 
of epilepsy in the early stages of this model, up to 16 days post injection. Part of the 
work looks at these effects following in vivo intrahippocampal injections that induce 
chronic, spontaneous, recurrent epilepsy. Whilst there is a wealth of literature 
focussed on in vivo intrahippocampal TeNT injections, this is the first study to look at 
the spatiotemporal effects of the toxin on VAMP1 and VAMP2 expression in slices ex 
vivo. This was done over a timescale up to 16 days post injection. The next aim was 
to investigate VAMP immunopositive boutons around cells that had been recorded 
from at 8-16 days post injection. This was to correlate electrophysiology with 
immunohistochemistry to give a more detailed view of the changes within the first 16 
days of the epileptic syndrome. The final stage of the project was to establish an in 
vitro model of the TeNT injections in organotypic hippocampal slice cultures. These 
are good representations of the in vivo situation with regards to organisation of the 
slices and connections, and offer advantages over the acutely prepared slices that 
are so commonly used where synaptic reorganisation is not possible in the time 
frame of experiments. Focal injections of an epileptogenic agent have not been 
characterised in organotypic hippocampal slice cultures to date and so information as 
to whether the effects of the TeNT can be replicated in vitro will offer important 
observations towards the uses of TeNT. Electrophysiological recordings were 
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compared to immunohistochemical analysis following injections, again to understand 
the spatiotemporal effects of the toxin. 
1.4.1 Hypotheses 
• VAMP2 will be cleaved within the first two weeks following in vivo 
intrahippocampal TeNT injection, the stage at which seizure onset occurs. 
VAMP1 will remain unaffected by the toxin given that Schiavo et al. (1992) 
have shown the TeNT cleavage site is not present in this isoform. 
• Functional electrophysiological changes will be associated with local changes 
in VAMP expression 
• Focal TeNT application onto organotypic hippocampal slice cultures in vitro 
will show comparable changes in electrophysiology and immunohistochemistry 
to that observed after in vivo injections. 





2 MATERIALS AND METHODS
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2.1 In vivo intrahippocampal TeNT injections for the investigation of the 
effects on VAMP1 and VAMP2 
This section of the study aims to understand the spatiotemporal effects of TeNT 
injections on VAMP1 and VAMP2 within the early stages of the epileptic syndrome 
induced by these injections. This will consider the changes up to 16 days post 
injection and will look at both ipsilateral and contralateral hippocampi. 
2.1.1 Surgery 
Three experimental groups were used for this part of the study. The number of 
animals in each of the control experimental groups was 2. For the animals injected 
with TeNT: 6 were killed at 2 days post injection, 4 at 8 days post injection and 6 at 
16 days post injection. The three experimental groups represented three different 
time points after surgery at which the rats were killed and their brains prepared for 
immunohistochemistry. All procedures were carried out under the Animals (Scientific 
Procedures) Act 1986. 
Surgery was carried out by Dr Alex Ferecsko and Dr Premysl Jiruska. Adult male 
Sprague-Dawley rats were anaesthetised by inhalation of Isofluorane adjusted to 
block the pedal reflex while sustaining regular breathing. An intramuscular injection of 
the analgesic Buprenorphine (1ml/kg) was given to all rats. Rats were positioned in a 
stereotaxic frame and the skull exposed to drill a small burr hole at stereotaxic 
coordinates: -4.1mm anterior-posterior (AP) and -3.9mm lateral (Paxinos & Watson, 
1998). A 1µl Hamilton syringe was positioned over the burr hole and lowered to a 
depth of -3.8mm below the cortical surface into the stratum radiatum (str. radiatum) of 
the dorsal CA3 area of the hippocampus (Figure 2.1). A 1µl injection of vehicle 
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solution, 0.05M phosphate buffered saline (PBS; Sigma-Aldrich, Dorset, UK) and 2% 
bovine serum albumin (BSA, Sigma-Aldrich), or TeNT-containing solution (25ng/µl 
(Sigma-Aldrich #B5002) in the PBS and BSA solution) was made at 200µl/min. The 
needle was left in place for 5mins following the injection to prevent backflow of the 
solution up the needle tract and allow for diffusion away from the injection site. The 
Hamilton syringe was removed and the skin above the midline sutured. Rats were 
housed individually for recovery and video monitoring. 
 
Figure 2.1. Injection site into rat brain. Coronal section at anterior-posterior co-
ordinate –4.16mm within rat brain. Dotted line shows the targeted position of the 
injection: –3.9mm lateral and -3.8mm deep, corresponding to the right hand CA3 str. 
radiatum. Figure adapted from Paxinos & Watson (1998). 
 
2.1.2 Video monitoring 
Rats that had received the TeNT injection and were in the 8 and 16 day groups were 
video monitored individually from 5 days post injection. Those animals that were in 
the day 2 group were not video monitored as behavioural seizures have not been 
shown to occur at this early stage (Jiruska et al., 2013). The monitoring equipment 
was infrared digital cameras (MSI 380i) coupled with Spike 2 software (CED, 
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Cambridge, UK). The video monitoring allowed for confirmation of the seizure 
syndrome using the Racine scale of seizure severity (Racine, 1972). 
2.1.3 Histology 
2.1.3.1 Perfusion, fixation and slicing 
At the given time points of 2, 8 and 16 days post injection, the animals received an 
overdose of Euthatal (Merial Animal Health Limited, Essex, UK) and were perfused 
with saline at a speed of 1ml/min followed by 4% paraformaldehyde (Sigma-Aldrich) 
in 0.1M phosphate buffer (PB; Sigma-Aldrich). The brain was removed and post-fixed 
in 4% paraformaldehyde with gentle agitation for a further hour before storing in 0.1M 
PB at 4˚C. 
The most anterior and posterior parts of the brain were removed and the central part 
glued to the block of the Vibratome Series 1000 (Technical Products International, St. 
Louis, MO, USA) for sectioning. Coronal sections of 80µm thickness were collected 
into 0.1M PB in 24 well plates. Only sections containing the hippocampus were 
collected. Slices were stored in 0.1M PB containing thimerosal (0.01%; Sigma-
Aldrich) to avoid fungal infections.  
2.1.3.2 Immunohistochemistry 
Sections were washed 3 x 10 minutes in 0.1M PB followed by 2 x 15 minute washes 
in tris buffered saline (TBS; Sigma-Aldrich) + Triton X-100 (0.5%; Sigma-Aldrich) 
(TBST) for permeabilisation. The blocking solution of TBST and 5% normal goat 
serum (NGS; Burlingame, CA, USA) was added to the slices for 45 minutes at room 
temperature before incubating the respective slices in the primary antibody solution 
containing TBST, 2% NGS, 0.01% thimerosal and antibodies against either VAMP1 
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(rabbit, 1:500; Abcam, Cambridge, UK) or VAMP2 (rabbit, 1:1000; Synaptic Systems, 
Goettingen, Germany). The sections were incubated for three days at 4˚C. Sections 
were then washed 2 x 10 minutes in TBST and the secondary antibody solution 
added. This consisted of TBST, 0.01% thimerosal and Alexa 488 goat anti-rabbit IgG 
(1:1000; Molecular Probes, Paisley, UK). Sections were incubated overnight at 4˚C in 
the dark. 
Finally, sections were washed 3 x 15min 0.1M PB and mounted on glass slides with 
glass coverslips using the home made anti-fade medium, Mowiol (Sigma-Aldrich). 
Immunofluorescent microscopy (Olympus BX61 microscope (Olympus, Essex, UK)) 
equipped with an EXi Blue digital camera (QImaging, Surrey, Canada) was used to 
reveal the labelling and tiled images at low magnification were taken to give a basic 
overview of the slice. An exposure time of two seconds and a light intensity of 75% 
were used to image all slices. 
2.1.4 Analysis 
2.1.4.1 Grey level analysis of VAMP1 and VAMP2 immunosignal 
A grey level analysis was carried out on the low magnification images from the 
VAMP1 and VAMP2 immunostained slices using Image-Pro Plus software 
(MediaCybernetics, Maryland, USA). The Area of Interest (AOI) tool was used to 
outline the dentate gyrus (DG), CA2/3 and CA1 separately (Figure 2.2, Panel A). It 
should be noted that for VAMP1 the outer molecular layer of the dentate gyrus was 
not included as it had very low intensity immunostaining. The individual AOIs allowed 
for each area to be analysed separately. A further square AOI, placed in the 
contralateral subiculum was used as a marker for the brightest pixel intensity. This 
area was used as it is considered as part of the hippocampal formation yet does not 
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receive commissural projections from the ipsilateral hippocampal areas. CA1a 
neurons project to the subiculum just across the border from the CA1, whereas CA1c 
neurons project to the distal portions of the subiculum, e.g. further from the CA1, but 
only within the same side of the brain (Amaral et al., 1991). It was hypothesised that 
this area would therefore be least affected, if at all, by the TeNT. The darkest 
intensity of pixels was considered as the threshold where all pixels in all areas were 
included (see Panel D in Figure 2.2). Both hippocampi (ipsilateral and contralateral) 
received identical staining conditions as the two sides of the brain were attached 
during immunostaining. 
 
Figure 2.2. Grey level analysis. Panel A shows the outline made of each of the DG, 
CA2/3 and CA1. Panel B shows the pixels included in grey level 3 to be counted 
within the active AOI: the CA1 (outlined in green). Panel C shows the pixels included 
in grey level 5 and it can be seen that more pixels are present in this brighter 
intensity grey level than in grey level 3. Panel D shows the pixels included within the 
range of minimum and maximum pixel intensities for that slice. 
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The range between the highest and lowest pixel intensities (contralateral subiculum 
and all pixels included, respectively) for each individual slice was divided into 8 
different grey levels. The Count/Size dialogue box within Image-Pro Plus was used 
and the Select Ranges tool allowed thresholds to be set for a particular count. The 
output for the count was set to give the sum of the area of the pixels in the selected 
intensity range for example grey level 3 (as shown in Panel B of Figure 2.2). The 
upper and lower limits for each grey level were set in the Select Ranges box and the 
area covered by the pixels in that range was collected. Once this had been done for 
each grey level, the AOI was converted to an object to measure the total area. This 
allowed the pixel intensities in each grey level to be represented as a percentage of 
the total area of the AOI. This was done for all three regions (CA1, CA2/3 and DG) in 
both the ipsilateral and contralateral hippocampi. The outputs allowed graphs to be 
made that show the distribution of the pixel intensities in the different regions of the 
hippocampus in control and TeNT injected animals. Any changes in the individual 
areas at different time points in the model and in different parts of the hippocampus 
(e.g. mid and posterior levels, dorsal and ventral) can also be determined. 
2.1.4.2 First moment analysis 
To allow for ease of comparisons of the distributions of pixel intensities in the 
different treatment groups (ipsilateral TeNT, contralateral TeNT, ipsilateral control 
and contralateral control) a form of analysis that gives a weighted average of the 
distribution was used. This is first moment analysis. Using a weighted average for 
each of the grey level spectrums allows an overall comparison of the treatment 
conditions to be made regarding the pixel intensities. Rather than having to compare 
each treatment within each grey level, the first moment looks at the distribution within 
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each treatment as a whole and can show if there has been a statistically significant 
shift towards darker or lighter intensity grey levels. If there has been a shift of the 
trace towards the darker grey levels, for example following cleavage of one of the 
VAMP isoforms, then the first moment will reflect this as a lower value. 
The equation for calculating the first moment is as shown below where f is the grey 





The first moment for the individual hippocampal areas of each slice was calculated. 
2.1.4.3 Reliability of measurements 
The measurements from the grey level analysis would have benefitted from a 
number of steps to check reliability and repeatability. Resources did not allow for 
experiments to be carried out under blind conditions but a number of steps were 
included in the analysis to try and overcome this and remove human bias where 
possible, for example, the automation of the measurements. This included the 
thresholding tool to determine the upper and lower limits of the grey level analysis in 
specific and consistently chosen regions of the hippocampus. The contralateral 
hippocampus acting as an internal control was also important. Slices were incubated 
in antibody solutions with the ipsilateral and contralateral sides attached thus being 
exposed to the same conditions. 
The boundaries of the different regions of the hippocampus were outlined by hand 
and thus there may be some margin of error regarding the exact regions but given 
that the regions are so large then this should not have too much of an implication on 
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the overall results. Ideally, to check the reliability of the results, duplication of the 
measurements could be carried out by a second person. This would include the 
duplication of the tracing of the areas of interest and the measurements of the grey 
levels. 
2.1.4.4 Statistical analysis 
Control values from each of the time points were compared within the individual 
hippocampal regions (one way ANOVA). No significant differences were found (see 
Appendix Section 7.1) and therefore the controls from all time points were pooled 
together within the individual regions. This was done separately for ipsilateral and 
contralateral controls. The low number of control slices at each time point was 
therefore no longer a problem. 
Two way ANOVAs were used to compare the side (ipsilateral or contralateral) with 
the treatment (control or TeNT) within a hippocampal region, for example CA1, and 
within individual time points. SigmaPlot (Systat Software Inc., London, UK) was used 
to carry out all statistical analysis and a significance criterion of 0.05 was used unless 
otherwise stated, for example after correction for multiple comparisons. The 
Bonferroni correction for multiple comparisons was used when three tests 
representing days 2, 8 and 16 were carried out within an individual region, for 
example the comparisons within the CA1 mentioned above. This corrected the 
significance criterion to 0.0167 and reduced the chance of obtaining one or more 
false positives to 0.05. Whilst the data within the three individual time points was not 
used in more than one of the two-way ANOVAs within this grouping, the correction 
for multiple comparisons was still used to reduce the chance of Type I errors as the 
data was treated as a whole cohort rather than individually. For clarity within the 
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analysis, multiple univariate tests were used. This consisted of data from within 
individual time points being compared initially; two way ANOVAs of side versus 
treatment. This allowed for observations of the effects of the treatment at the specific 
time points and to identify the changes, if any, that occurred in the two sides of the 
brain during the duration of the epileptic syndrome. Following this, the three different 
time points were compared, but only within TeNT treated slices, as the controls had 
been grouped across the three different time points. Data is presented as mean ± 
standard error of the mean (SEM) unless indicated. 
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2.2 In vivo injections for functional analysis of TeNT effects 
This section of the project aimed to look at VAMP1 and 2 immunohistochemistry in 
slices that had already been used to look at the electrophysiological effects of the 
toxin injected animals in comparison to controls. VAMP1 and 2 immunopositive 
boutons were counted to relate to the synaptic physiology. This was in order to test 
whether the changes in physiology that are seen in the TeNT model of epilepsy can 
be explained by the direct action of the toxin on VAMP1 and/or VAMP2. 
2.2.1 Surgery 
Two batches of animals were used, the first to investigate the ipsilateral 
hippocampus, the second to look at the contralateral side. Adult male Sprague-
Dawley rats received a unilateral intrahippocampal injection of 1µl vehicle (0.05M 
PBS + 2% BSA) (6 rats for ipsilateral study and 8 for the contralateral) or TeNT-
containing solution (2.5ng/µl toxin (Quadratech Diagnostics Ltd., Surrey, UK) in 
0.05M PBS + 2% BSA) (5 rats for ipsilateral study and 6 for the contralateral group). 
Surgery was carried out by Dr Wei-Chih Chang and Dr Atif Saghir following the same 
protocol as described in Section 2.1.1. Animals were housed individually and allowed 
to recover. Spontaneous recurrent seizures began after a latent period of 5-7 days. 
Animals were killed and perfused with ~100ml cold sucrose ACSF (in mM: 204.8 
sucrose, 2.5 KCl, 26 NaHCO3, 1.2 NaH2PO4H2O, 10 glucose, 5 MgCl2, 0.1 CaCl2) (by 
Dr Wei-Chih Chang) at 8-16 days post injection. Brains were then quickly removed 
and sectioned to 300µm along the coronal plane using a Vibrating Microtome 
7000smz-2 (Campden Instruments, Loughborough, UK) with a cooling system and a 
specimen bath cooler at temperature of ~1°C. Individual slices were then transferred 
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to a gassed ACSF-filled holding chamber. Whole-cell patch clamp recordings were 
carried out from cells within the CA1, either at the subiculum end (CA1a) or the CA3 
end (CA1c) (Dr Wei-Chih Chang and Dr Andrew Powell). Patched cells were filled 
with an internal solution containing Alexa 488 and neurobiotin. Each slice was fixed 
in 4% paraformaldehyde for 1 hour and then washed once with 0.1M PB before 
storage in 0.1M PB plus thimerosal (0.01%). 
2.2.2 Histology 
2.2.2.1 Re-sectioning 300µm slices to 80µm 
A thickness of 300µm was not suitable for the staining protocols so the slices needed 
to be re-sectioned to a thickness of 80µm using a Vibratome Series 1000. A square 
of wax was first sectioned using the vibratome to ensure a completely flat surface, 
large enough for the section (containing just cortex and hippocampus) to be glued 
onto. The section was then superglued to the flat wax and submerged in 0.1M PB. 
The blade was carefully lowered in 10-20µm steps until it began to cut the surface of 
the slice. At this point 80µm thick sections were collected into 0.1M PB in a 24 well 
plate. Generally three 80µm and one 40µm thick sections were collected from a 
single 300µm slice. Sections were stored in fresh 0.1M PB with thimerosal (0.01%) at 
4˚C in the fridge before immunohistochemistry. 
2.2.2.2 Immunohistochemistry 
The immunostaining procedure for these sections was very similar to that carried out 
on the slices used for grey level analysis, but with some slight modifications. Sections 
that were to be stained with the VAMP2 antibody were ready for the 
immunohistochemistry straight away following re-sectioning and storage, however 
tests with the VAMP1 antibody indicated that the slices needed to be fixed in 4% 
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paraformaldehyde for a further 5 hours to achieve ideal staining conditions. Aside 
from this, the initial part of the protocol was the same for both antibodies with initial 
washes in 0.1M PB and then TBST followed by 45 minutes in the blocking solution 
and a three day incubation in the primary antibody solution at 4˚C. The sections were 
incubated with either VAMP1 (1:800, Abcam) or VAMP2 (1:1000, Synaptic Systems).  
The secondary antibody solution differed slightly to the previous experiments. For 
slices that did not contain recorded cells, the secondary antibody solution consisted 
of TBST, 0.01% thimerosal and Alexa 488 goat anti-rabbit IgG (1:1000; Molecular 
Probes) as previously. However, for sections that contained cells labelled with 
neurobiotin, Alexa 546 conjugated streptavidin (Molecular Probes) was added to the 
secondary antibody solution at a concentration of 1:200 to visualise filled cells. The 
sections were incubated overnight at 4˚C in the dark and then mounted onto glass 
slides with glass coverslips and Mowiol. 
2.2.2.3 Microscopy 
Immunofluorescent microscopy was carried out to reveal streptavidin labelled cells 
and the VAMP immunostaining. Images were taken at low magnification (4x and 10x 
objectives) with a light output of 25% and a 1 second exposure time. High 
magnification (oil immersion 100x objective) images were taken with a light output of 
10% and an exposure time of 0.2 seconds. 
High magnification images were taken in the strata pyramidale and radiatum of both 
the CA1 and the CA3. Only the CA1 contained cells that had been recorded from. 
These cells provided the position for the image to be taken and corresponded to 
either the CA1a or CA1c. If the cell body of the patched cell was present then this 
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was positioned in the centre of the field of vision. If it was not visible then the position 
was estimated by the dendrites that were visible or the position of the cell body in 
adjacent slices. Images of the str. pyramidale were taken with this layer running 
horizontally through the middle of the field of vision, with the strata oriens and 
radiatum present above and below respectively. For the str. radiatum images, the 
field of view was positioned so that the cell body layer was just out of view. A Z-stack 
with a total depth of 2µm made up of 10 images from the surface was taken using the 
fluorescein isothiocyanate (FITC) filter to look at the VAMP1 or 2 immunostaining. 
The Z-stacks in the CA3 were taken in the CA3b region in the same way as in CA1, 
but without the marker of the Alexa 546 conjugated streptavidin stained cell. Z-stacks 
were taken from the ipsilateral and contralateral sides of the first batch of animals, 
with the contralateral image positions being estimated and trying to match to the 
ipsilateral halves. Only the contralateral side of the second batch was used. 
2.2.3 Analysis  
2.2.3.1 Str. radiatum 
Figure 2.3 shows a flow diagram with an overview of the image processing that was 
required before analysis. The purpose of these Z-stacks was to be able to count 
boutons that contain the vesicles that have been immunostained to reveal either 
VAMP1 or VAMP2. It is the vesicles within the boutons that are being visualised but 
we shall refer to these groups of vesicles as boutons from here onwards. The Z-
stacks underwent 3D deconvolution using AutoQuant (MediaCybernetics, Maryland, 
USA) to reduce the distortion and produce a clearer image. Image-Pro Plus was then 
used to flatten the Z-stacks to one image using the Extended Depth of Field option, 
and the Max. Intensity Output without normalisation. Filters were applied to enhance 
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the image and aid the automatic counting of the boutons. The Median filter was 
applied first with a kernel size of 3x3 and 20 passes. Next the Flatten filter with the 
dark background setting and 7 pixels feature width was applied before the Despeckle 
filter, again with a kernel size of 3x3 and 20 passes with sensitivity of 1. A region of 
interest (sized 10x10µm) was placed in four different areas across the image. The 
software automatically counted the bright objects in the area followed by a watershed 
split giving an output of all the different areas of the counted objects. Only those 
objects that were within the size range of 0.1-<0.7µm2 were included in the analysis 
as boutons. This range was chosen as it included objects that were deemed to be 
consistently sized and present and thus hypothesised to be boutons containing the 
vesicles. This was considered across a number of images before making the 
decision. 
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Figure 2.3. Image processing for the quantification of VAMP1 and VAMP2 
immunopositive boutons. Flow diagram showing an overview of the image 
processing required to quantify boutons in the strata radiatum and pyramidale within 
high magnification ex vivo images. 
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2.2.3.2 Str. pyramidale 
Counting of the boutons in the str. pyramidale had to be carried out in a slightly 
different way to that of the str. radiatum as shown in Figure 2.3. This was because 
the area contained a lot of dark space where the cell bodies were spread throughout 
the str. pyramidale layer, thus giving a less homogeneous layer. After the filters were 
applied, the boutons that were in the range of 0.1-<0.7µm2 were counted using the 
bright objects counting system in Image-Pro Plus. These bright objects were then 
saved as a mask so that the background was black and the boutons white. This 
stage was an addition, different to the str. radiatum. In the case of the str. pyramidale 
images, randomly placing the AOI would not suffice (as was done in the str. 
radiatum) as there was a high chance that it could be placed in the centre of a dark 
cell body or out of the layer entirely. A large AOI, 15x60µm was placed within the str. 
pyramidale layer. This was of a size that covered about half the length of the image 
and was small enough to fit within the width of the str. pyramidale. 
For the majority of images, it was very clear where the boutons were and they could 
be seen surrounding cell bodies. However, with some images where there were not 
very many boutons, some noise from the background was picked up as bright 
objects. Boutons needed to be counted, but in a way that excluded the background 
noise. Filtering based on Roundness was tried, where the value was calculated using 
the perimeter and the area. Here, a perfect circle was equal to 1, and anything else 
was >1. The problem here was that even background noise was sometimes being 
considered a perfect circle, or very close, when it was clearly not. This was because 
the perimeter and area could have been such that they satisfied the equation even 
when the image showed that the noise wasn’t actually round. Instead, Radius Ratio 
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was chosen to filter the objects. This gave another indication of roundness but 
considered just the maximum and minimum radii. A perfect circle would again give a 
Radius Ratio equal to 1 (maximum radius divided by minimum radius). The cut-off for 
Radius Ratio was set at 2 to give some leeway to objects that weren’t fully round. 
This did exclude a number of boutons, both in control and TeNT slices but it certainly 
made sure that the background noise was not included in the counts. This form of 
analysis was carried out in the CA1 and CA3 images, making sure in the CA3 
images, that the AOI was put in the str. pyramidale and not in the adjacent str. 
lucidum. 
Results from the bouton counts were compared with results from the 
electrophysiological recordings based on the positions of the cells (CA1a and CA1c), 
the side of the brain in which they were present and the treatment to which the 
animals had been exposed. 
2.2.3.3 Statistical analysis 
SigmaPlot was used for statistical analysis of the bouton counts within CA1a, CA1c 
and CA3. The t-test or Mann Whitney Rank Sum test was used with a significance 
criterion of 0.05. If a correction for multiple comparisons was needed then the 
Bonferroni correction was used (as in Section 2.1.4.4) and the adjusted significance 
criterion will be stated within the Results. Two way ANOVAs were not used in the 
analysis of the bouton counts as the data from some groups did not satisfy the 
conditions of normal distribution and equal variance. Thus multiple t-tests (for 
normally distributed data) or Mann Whitney Rank Sum tests (for non-normally 
distributed data) were required for comparison of the data. 
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2.3 Organotypic hippocampal slice cultures for the analysis of TeNT in vitro 
This final set of experiments investigates whether injections of TeNT onto 
organotypic hippocampal slice cultures in vitro can reproduce the results seen 
following in vivo injections. Both electrophysiological and immunohistochemical 
experiments are undertaken. 
2.3.1 Preparation of organotypic hippocampal slice cultures 
2.3.1.1 Animals 
The animals used for the setup of newborn organotypic hippocampal slice cultures 
were 5-6 day old Balb/C mice. All procedures were carried out under the Animals 
(Scientific Procedures) Act 1986. 
Initially new born Balb/C mice aged between 5 and 10 days were used. The yield of 
slices that were suitable for use usually ranged from about 40-60% per animal. This 
meant that a number of slices from each animal showed degradation of quality 
throughout the days in culture and therefore could not be used for the experiments. 
Slices were classed as viable if the hippocampal structure could be clearly identified 
and showed an intact appearance under low magnification. Poor slices tended to 
have holes in the CA3 area, which seemed to be the most vulnerable, or show very 
dark patches, indicating dead cells. In preliminary recordings from untreated slices, it 
was rare to achieve recordings from these darkened areas suggesting that the cells 
were no longer living. Sometimes the cell layer of the CA3 became very close to the 
edge showing that there had been a recession of the tissue at the edge of the slice. 
Slices that displayed these characteristics were not treated as the circuitry could not 
be guaranteed and could vary from intact slices. The results of each set up were 
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variable between early batches. Best results were achieved from animals that were 
aged between 5 and 6 days, consistent with that in other studies (Gahwiler et al., 
2001; Fuller & Dailey, 2007). This age range of mice was used for collection of the 
results presented in this study. The yield of these slices was much better, with 60-
80% of slices being usable. 
Slices could be maintained with a change of medium twice a week if not out of the 
incubator for more than a couple of minutes. Slices had been maintained up to 50+ 
days in culture, which following immunohistochemistry, still showed the hippocampal 
architecture. 
2.3.1.2 Chemicals and reagents 
Culture medium consisted of: Minimum Essential Medium (MEM – with Earle’s salts, 
without glutamine, 50%; GIBCO, Paisley, UK), Heat-Inactivated Horse Serum (25%; 
GIBCO), Hank’s Balanced Salt Solution (HBSS, 25%; GIBCO), 45% D-glucose (~1%; 
Sigma-Aldrich), GlutaMAX (~1%; Sigma-Aldrich) and Penicillin-Streptomycin (~1%; 
Sigma-Aldrich). Dissection medium consisted of Gey’s Balanced Salt Solution 
(GBSS; Sigma-Aldrich) and 45% D-glucose (1%; Sigma-Aldrich). 
2.3.1.3 Culturing equipment 
Two Millicell Cell Culture Inserts (30mm diameter, 0.4µm pore width; Millipore, Co. 
Cork, Ireland) were positioned on top of 1.2ml of culture medium in two wells of a 6 
well plate for each brain that was dissected. The plate was put into the humidified 
atmosphere incubator (5% CO2 and 37˚C) for at least 30 minutes before dissection 
began to allow the medium to equilibrate. 
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2.3.1.4 Dissection 
The method used for the organotypic hippocampal slice cultures was based on that 
of Stoppini et al. (1991), with slight modifications. A 5-6 day old Balb/C mouse pup 
was killed using an approved Schedule 1 procedure: cervical dislocation followed by 
decapitation. An incision was made down the midline to expose the skull which was 
then opened to allow access to the brain. The brain was removed and placed into a 
sterile petri dish containing the dissection medium and hemisected under a Leica 
GZ6 dissection microscope. The midbrain was carefully removed to provide access 
to the hippocampus and using a pair of fine tweezers and a paddle pastette, the 
hippocampi from both hemispheres of the brain were gently eased away from the 
surrounding tissue. The hippocampi were then transferred straight to the platform of 
a McIlwain tissue chopper (The Mickle Laboratory Engineering Co. Ltd., Surrey, UK) 
and sliced to 400µm, with the long axis perpendicular to the blade. Slices were then 
transferred into another sterile petri dish containing dissection medium. Fine 
tweezers were used to separate the slices. Each Millicell insert received 8-10 slices 
which were positioned to avoid contact between the slices. Any excess liquid was 
removed and the plate returned to the incubator. The orientation of each of the slices 
was noted later on the day of dissection. 
2.3.1.5 Maintenance of slice cultures 
The medium in each well supporting the Millicell inserts was replaced every 3-4 days 
following 30 minutes of pre-warming in the incubator. Cultures were maintained for 
10-14 days before any treatments were carried out. 
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2.3.2 Treatment solutions 
The treatments consisted of an injection of either a vehicle solution for control slices 
(0.05M PBS and 2% BSA) or the TeNT solution at concentrations of 5, 25 or 50ng/µl 
toxin (Quadratech Diagnostics Ltd.) within the vehicle solution. 
2.3.3 Optimisation of a focal treatment method 
Having established that the culturing procedure produced viable slices, the next 
stage was to investigate how to carry out focal injections to the str. radiatum of the 
CA3. Organotypic hippocampal slice cultures have been used in other studies to look 
at epileptic activity following treatment with substances, for example kainic acid, but 
in these cases the entire slice was exposed to the treatment, with the substance 
being added to the culture medium. Other non-epilepsy based protocols employed a 
chamber to expose the entire well, for example, to a high oxygen environment. 
Again, here the entire slice is exposed. The aim of this project was to carry out focal 
injections like those in the in vivo model of TeNT induced epilepsy. 
A number of factors were to be considered to establish this focal injection method; 
apparatus for delivering the injection, injection volume, controlled and consistent 
delivery of injection and maintaining the viability of slices during the injection process. 
The following sections will describe the different procedures that were tested to 
address these factors and how the final method was decided upon. 
2.3.3.1 Methylene blue injections using hand held glass pipette 
The first factor to be addressed was the volume of the injection and the apparatus for 
delivery. In vivo, 1µl of control or TeNT solution was injected into one hippocampus 
of an adult rat. Here, in vitro we were dealing with a single slice with thickness 100-
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150µm from a new born mouse so the volume needed to be scaled down 
substantially. Testing started with injections of control solution containing methylene 
blue onto some fixed slices. Here a glass pipette (Wiretrol II, 10µl; Drummond 
Scientific Company, PA, USA) that had calibration marks at every 1µl was used. A 
plunger inserted into the end and pushed very gently was used to try to inject 0.25µl 
of the solution onto the slices. This produced a large amount of spread across the 
small slice and was therefore not suitable. Not only was the size of the injection a 
problem but also the accuracy at delivering a consistent volume with only judgement 
by eye. 
2.3.3.2 Filter paper as a means of focal treatment 
Next, it was thought that perhaps a small piece of filter paper soaked in the 
substance for treatment could provide a means of focal injection. The considerations 
here however included having a regular sized piece of filter paper and maintaining 
sterility of the slice. Would putting filter paper onto the slice cause any damage, for 
example introducing a barrier between the slice and the surrounding atmosphere? To 
fit onto just the str. radiatum of the CA3 it would have to be a very small piece of filter 
paper. It was tried a few times but was not taken any further. 
2.3.3.3 Positioning a glass pipette in a holder to give better control. 
The filter paper idea was dropped and we reverted back to using a glass pipette with 
a small tip size. To gain better control over the positioning of the glass pipette it was 
put in an electrode holder which was held in place on a clamp stand. This allowed for 
positioning of the pipette tip over the slice and then pushing on the plunger to eject 
the liquid. The tip was left in place on the slice for 5 minutes to mimic that of the 
injections that are carried out in vivo. 
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With tip sizes of around 20µm it was very difficult to withdraw the solution into the 
pipette. Tip sizes had to be increased to a minimum of 30µm to allow solution to 
enter. If it was difficult to get the solution in then it would be hard to be certain that it 
was coming out of the tip when it came to the injections. With tip sizes of 30-50µm, 
the injections could be made using the plunger but again it was difficult to control the 
volume. Even with a Vaseline coating around the plunger, it was not always a smooth 
movement. We needed to find a way to inject a smaller volume than 0.25µl and in a 
controlled manner. 
2.3.3.4 Microinjections using a motorised pump 
A microinjection pump is used with a Hamilton syringe in the in vivo injections so a 
variation of this idea was tried. The tip of the Hamilton syringe itself is very large in 
comparison to the str. radiatum of slice cultures and therefore would inject too large 
an area. We wanted to keep using a glass pipette to make sure that the tip size could 
be small enough. A Hamilton syringe was heat sealed to some rubber tubing which 
was in turn attached to the glass pipette supported by the electrode holder. However, 
liquid failed to be ejected from within the glass pipette. With such an elaborate setup 
it was likely that air was escaping somewhere or just being compressed. The end of 
the rubber tubing was put into a beaker of water to see if bubbles were released 
when the pump was set to inject but there weren’t any, implying that the air was 
indeed being compressed rather than moved. 
This setup needed simplifying. A paper was found Shao & Feldman (2007) that used 
a microinjection pump with a glass pipette and plunger clamped in place instead of 
the Hamilton syringe. In their study they were removing liquid rather than injecting it 
but the principal of the setup seemed consistent with what was required. This set up 
- 44 - 
 
was tried and immediately the injections proved easier to control. User defined 
settings were inputted into the MicroSyringe Pump Controller, relating to the length 
and volume of the glass pipette to work out the volume per step. Differing volumes 
were tested to see the spread of the injection solution across the slices. Volumes 
started at 150nl working downwards and with speeds ranging from 50nl/sec to 
2nl/sec. Once we had established that 3nl was an injection volume that didn’t 
disperse too much across fixed slices, the apparatus was set up to test on living slice 
cultures. To be able to control the pipette positioning on the slice, a USB camera was 
put in one of the eye pieces of a dissection microscope and connected to a 
computer. The software ScopePhoto (Scopetek, Zhejiang Province, China) was used 
to view and record the injections. It was difficult to manipulate the focus and lower the 
glass pipette whilst watching the computer screen at first but this got a little easier 
with practice. Injections of 3nl of control solution were made onto slice cultures with 
the tip left in place for 5 minutes on each slice. With the culture insert containing up 
to 10 slices and a 5 minute wait following injections, the plates were out of the 
incubator too long. The medium was going very pink with exposure to the low 
concentrations of carbon dioxide in the air. Instead, the plates were put back into the 
incubator between each injection to try and keep the slices in their ideal environment 
for as much time as possible. Later this was adapted by removing the 5 minute wait 
which seemed unnecessary due to the thin tissue and so any backflow of the TeNT 
would not occur (as was the reason for leaving it there in vivo). 
To double check that consistent injections were occurring, fluorescent DiI was 
included in the injection solution (control) to see the spread of the solution across the 
slices. Volumes ranged from 3nl to 30nl. It was clear that the higher volume injections 
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produced larger diffusion areas when viewed under fluorescent microscopy. It was 
decided that the 16nl injection was not spreading too far and seemed better than 3nl 
which were not always clear as to whether the solution had come out the pipette. 
Injections were therefore carried out at a volume of 16nl and injection speed of 
2nl/sec onto the slices. Slices were returned to the incubator between injections. 
Having tried carrying out the injections in the hood using ScopePhoto to visualise the 
positioning of the pipette tip, it was clear that this was adding a level of unnecessary 
difficulty and extra time. The setup was therefore moved to a different flow hood to be 
able to view the slices directly down the dissection microscope rather than through 
ScopePhoto and the computer. This gave greater control and greatly sped up the 
process which meant that the slice cultures remained viable. 
A final amendment to the method included cutting around the individual slices and 
placing these (and their attached membrane) on a new Millicell culture insert before 
carrying out the treatments. This meant that individual slices could easily be removed 
for electrophysiology or immunohistochemistry without disturbing the surrounding 
slices. Previously slices had been cut around when needed but this could have 
disturbed the toxin if the slices had been treated. 
2.3.3.5 Final treatment procedure 
Four hours prior to treatment, the membrane of the Millicell inserts was cut out from 
the surrounding plastic ring. Each individual slice and a small amount of the 
surrounding membrane were then cut out and all were positioned onto a new 
membrane. This meant that following treatment, each slice could be manipulated 
individually without disturbing the surrounding slices. This was important if the TeNT 
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was still present on the slice to avoid loss of toxicity. The medium was also changed 
at this point. Glass pipettes (Wiretrol II, 10µl; Drummond Scientific Company, PA, 
USA) were pulled on a Narishige PN-3 pipette puller (Narishige, Tokyo, Japan) and 
broken back to give a tip size of 30-40µm. A pipette was held in place by an 
electrode holder which was secured between the clamps of a MicroSyringe Pump 
(World Precision Instruments, FL, USA) which was in turn secured in a 
micromanipulator (Figure 2.4). A wire plunger was inserted into the top of the pipette 
with a Vaseline coat to aid the movement. The vehicle or TeNT solution was slowly 
withdrawn into the pipette. The MicroSyringe Pump was controlled by the Micro4™ 
MicroSyringe Pump Controller (World Precision Instruments, FL. USA) and user 
settings manually inputted. 
 
Figure 2.4. MicroSyringe Pump and Controller. These images show the glass pipette 
with inserted wire plunger held in place by an electrode holder which is clamped into 
place in the MicroSyringe Pump. This is all controlled by the Micro4™ MicroSyringe 
Pump Controller shown in the right hand panel. 
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The slice cultures were positioned under the dissecting microscope and viewed at 
the highest possible magnification so the cell layers of the slice could be visualised 
(the cell layers were darker than the surrounding areas). The tip of the pipette was 
positioned over the str. radiatum of the CA3 and lowered to touch the slice. An 
injection of 16nl of treatment solution at 2nl/sec was made and the pipette gently 
raised away from the slice. Injections onto all the slices on the membrane were 
carried out in one session and returned to the incubator as soon as possible. Plates 
were handled very gently to prevent too much movement which can cause loss of 
toxicity of the toxin. Each individual treatment was restricted to slices on the same 
membrane. 
The slices were then left for a minimum of 2 days before the first recordings were 
carried out. Medium was changed 3 days after treatment and then again every 3-4 
days (alternating). Having established the most appropriate treatment method, the 
investigation of the effects of TeNT on the slice cultures could now begin. 
2.3.4  Electrophysiology 
2.3.4.1 Field recordings 
At 2, 8 and/or 16 days post treatment (±2 days), field recordings on the vehicle and 
toxin-injected slices were carried out. These recordings were carried out in an 
Olympus FV1000 confocal microscope with an attached incubation box (Solent 
Scientific, Segensworth, UK). The temperature of this box was maintained at 30°C 
and was useful to keep the relative sterility of the slices whilst they were being 
recorded from. Very few infections were caused as a result of removing slices from 
the culture inserts and using them for about 45 minutes in this chamber once or 
multiple times. The stage area consisted of an inflow and outflow of ACSF (in mM: 10 
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glucose, 125 NaCl, 26 NaHCO3, 3 KCl, 1.25 NaH2PO4H2O, 1 MgCl2 and 2 CaCl2) 
bubbled with 95% O2-5%CO2, heated to 30°C with an inline heater (Scientifica, 
Uckfield, UK) and flowing at 3ml/min. A temperature probe and ground electrode 
were also present within the stage area. Slices were positioned on the glass 
coverslip and weighed down to prevent movement during the recordings. The 
stimulus electrode was a twisted nichrome wire (50µm diameter; Advent, Oxford, 
UK). Recording electrodes were borosilicate glass electrodes (1.2mm O.D, 0.69mm 
I.D.; Harvard Apparatus, Kent, UK) pulled on a P-97 horizontal puller (Sutter 
Instruments, Novato, CA, USA) with resistances of 5-7MΩ. An NPI SEC-10L amplifier 
(Scientifica), low-pass Bessel filter set at 1kHz (NL-125, Digitimer Ltd., Welwyn 
Garden City, UK) and Power 1401 (CED) for digitization at 10kHz were all used for 
recordings. The stimulus electrode was placed in the str. radiatum of the CA3 (Figure 
2.5). A recording electrode was then placed in the CA1 str. pyramidale (Figure 2.5). 
Signal (CED) was used to deliver a square pulse at 0.1 seconds with a length of 
0.001 seconds. A stimulus response curve was created with stimuli ranging from 0-
70V and a frame length of 30 seconds. The order of the stimuli was random each 
time and differed from one slice to the next. Stimulus response curves were then 
repeated in the str. radiatum of the CA1 and the strata pyramidale and radiatum of 
CA3 (Figure 2.5). 
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Figure 2.5. Positions of stimulus and recording electrodes for field recordings in 
organotypic hippocampal slice cultures. Stimulations were made at Position S 
(marked with asterisk). Recording positions were CA1 str. pyramidale (A), CA1 str. 
radiatum (B), CA3 str. pyramidale (C) and CA3 str. radiatum (D). 
 
In three cases, particularly robust and regular spontaneous seizure-like activity was 
seen in the hippocampal slice cultures treated with 50ng/µl TeNT. To confirm this as 
biological activity, tetrodotoxin (TTX; Alomone Labs, Jerusalem, Israel) was added at 
a concentration of 1:1000 to the circulating ACSF. Recordings were continued with a 
40V stimulus every 30 seconds. When all activity was blocked, the TTX was washed 
out with fresh ACSF and recordings continued, to look for the return of responses. 
A low magnification image was taken after each stimulus response curve to record 
the position of both the stimulation and recording electrodes. This meant that when 
recording from a slice on multiple days, the electrodes could be placed in as similar a 
position to the previous recordings as possible. This would give an indication of the 
changes, if any, which could occur across the time points of the model within the 
different treatments. 
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Following recordings, slices were either fixed (see Section 2.3.5.1) or returned to the 
Millipore inserts for further recordings on a later day. 
2.3.4.2 Analysis of field recordings 
Analysis of str. pyramidale field recordings used cursors within Signal (CED) to give 
an indication of the size of the response. The first cursor was placed at the beginning 
of the excitatory post synaptic potential (EPSP) and the second cursor at the peak of 
the population spike. The trough output measures the amplitude of the response, 
halfway along a tangent that is formed between the start of the EPSP and the peak of 
the population spike. This gave a value of the size of the population spike in mV. For 
the str. radiatum recordings, the two cursors were placed on the EPSP within the 
middle 60% and the slope measurement used, giving a value of mV/ms. This was 
carried out for all frames within the stimulus response curve and the data plotted in 
SigmaPlot. For CA1 these measurements were used without problems. However, 
within the CA3, the largely interconnected network gave rise to both antidromic and 
orthodromic responses. These multiple components of the response made the 
measurement of the slope and trough difficult. These different components are not 
easily differentiated without the use of pharmacological blockers of synaptic activity. 
Therefore the analysis of CA3 strata pyramidale and radiatum was changed to take 
into account the difficulty of separation without the use of drugs. A crude 
measurement of the peak amplitude in relation to baseline was used; positive 
amplitude for str. pyramidale and negative amplitude for str. radiatum. This took into 
account the difference between treatment groups in the production of an antidromic 
response alone or an antidromic and orthodromic response combined, if a difference 
exists. The presence of an orthodromic response, that produced by synaptic 
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transmission, is likely to produce a larger positivity and negativity than an antidromic 
response alone. The proximity of the recording electrode to the stimulating electrode 
also played a part in the differences between CA1 and CA3 responses and analysis. 
Epileptic like activity was seen in a number of slices, across the different treatments. 
These consisted of evoked afterdischarges that occurred after the stimulation or 
spontaneous activity not related to the stimulus. Measurements of the durations of 
these events were taken as well as the stimulation voltage that caused the evoked 
afterdischarges. An afterdischarge was considered to have occurred if there was 
activity remaining after the peak of the population spike and continuing to occur more 
than 0.02 seconds after the stimulation pulse was given. 
2.3.4.3 Statistical analysis 
A 3 parameter sigmoid curve was fitted to the data, from both types of analysis, to 
give a read-out of the maximal response size (Vmax) and the voltage required to 
produce half this maximal response (V50). Statistical analyses of these values were 
carried out using t-tests or Mann Whitney Rank Sum tests within SigmaPlot. The 
choice of these tests was due to the data from some conditions not following a 
normal distribution or showing equal variances with other groups. The significance 
criterion was 0.05 and the Bonferroni correction was used in cases of multiple 
comparisons, where stated. This will include comparisons of the four different 
treatment conditions which results in six different tests, thus requiring a correction of 
the significance criterion to 0.0083. Comparisons of the three different time points 
within individual treatment conditions requires three different tests and thus a 
Bonferroni correction to 0.0167 is made. 




Slices were fixed following electrophysiological recordings or at time points up to 16 
days post injection. Originally, the method used for the fixation of the ex vivo slices 
was also used for the hippocampal slice cultures (1 hour 15 minutes in 4% 
paraformaldehyde). However the quality of the staining seemed to deteriorate. A 
number of possible issues were addressed. The fixation time was altered, the 
concentrations of antibodies changed and antibodies to test for a glial layer across 
the slice that could prevent penetration of the antibodies were all tested. None of 
these remedied the problem or provided answers to the problems with 
immunostaining. Microwave fixation was tried and alleviated the problems. 
2.3.5.2 Microwave fixation 
The microwave fixation method was as follows. A water-load of 250ml was placed in 
the centre of the microwave in a glass bottle. The shape of the membrane containing 
the slices was noted and 3-4 slices placed into a vial of 4ml 4% paraformaldehyde (at 
4°C). Two of these vials without the lid on were then placed in each of two small 
beakers containing 40mls water (room temperature). These were placed on either 
side of the water-load in the microwave. The slices were then microwaved for 30 
seconds, turned off for 15 seconds and finally microwaved again for 15 seconds. 
Slices were then promptly removed from the paraformaldehyde with a paint brush 
and put into 0.1M PB in 24 well plates for a 10 minute wash. Slices were then stored 
in 0.1M PB and thimerosal (0.01%) at 4°C before immunohistochemistry. 
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2.3.5.3 Immunohistochemistry 
The initial washes, blocking solution, primary antibody solution and secondary 
antibody solution stages were mostly the same as stated in the previous sections 
however with some slight modifications. Sections were removed from the fridge and 
washed 3 x 10 minutes in 0.1M PB followed by 2 x 15 min TBST (0.5%) to 
permeabilise the cells. Blocking solution consisting of 5% NGS in TBST was this time 
supplemented by 1% BSA to decrease the background staining that was sometimes 
occurring with these slices. The blocking solution was put on the slices for 45 
minutes at room temperature. The primary antibody solution consisting of TBST, 2% 
NGS, 0.01% thimerosal and the primary antibody of either VAMP1 (1:800 Abcam) or 
VAMP2 (1:1500; Synaptic Systems) was put on the slices and incubated for three 
days at 4˚C. 
Following the three day incubation, the primary antibody solution was removed and 
the sections washed 2 x 10 minutes TBST before overnight incubation in the 
secondary antibody solution; TBST, 0.01% thimerosal and Alexa 488 goat anti-rabbit 
IgG (1:1000; Molecular Probes). The only difference following incubation with the 
secondary antibody was that sections were washed 2 x 15 minutes 0.1M PB before 
incubation in 4’,6-Diamidino-2-Phenylindole (DAPI; 1:333) for 10 minutes at room 
temperature in the dark. A final wash in 0.1M PB and the sections were mounted on 
glass slides with Mowiol and glass coverslips. Nail varnish was used to seal the 
slides. 
2.3.5.4 Microscopy 
The low magnification microscopy protocol was the same as in Section 2.2.2.3. The 
high magnification microscopy was carried out using a similar protocol to that in 
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Section 2.2.2.3 but with some differences. Firstly, the exposure time was 0.05 
seconds for the organotypic slice cultures. Also, there were no filled cells to use for 
the positioning of the Z-stacks, unlike the slices used in the ex vivo experiments. 
Instead, the images were taken from CA3b and CA1b consistently throughout all 
slices to correspond with the positioning of the electrodes in the field recordings. 
2.3.6 Analysis 
2.3.6.1 Analysis of high magnification images 
As with the bouton counts in the ex vivo batch (Section 2.2.3), boutons within the 
CA1 and CA3 strata pyramidale and radiatum were analysed. Unfortunately, the 
analysis method used in the ex vivo slices was not suitable for use with the 
organotypic slice cultures. The automatic bright object count was counting areas of 
the image that were clearly not boutons but background noise, predominantly within 
TeNT treated slices. This resulted in the analysis method having to be altered for the 
purpose of quantitating changes, if any occurred, following treatments with control 
and the TeNT at different concentrations. As the automatic bright object count in 
Image-Pro was not successful, the Thresholding tool had to be used. This is the 
same tool that was used in the grey level analysis. The thresholding level was 
adjusted to include only objects that appeared to be boutons. There was a clear 
distinction between boutons and background noise in the way that the pixels 
appeared. Boutons were clearly groups of pixels in a relatively round formation that 
appeared at similar brightnesses. The background noise was seen as individual 
pixels or very small groups of pixels that had no clearly defined shape. Once the 
threshold had been set to include only those objects that were boutons, the AOI(s) 
was positioned. These AOIs were the same as used in the analysis of ex vivo slices 
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and positioned in the same way. A count was then conducted which measured the 
area occupied by the VAMP1 or 2 immunopositive objects within the threshold range 
already set. 
2.3.6.2 Statistical analysis 
Statistical analysis used for the bouton areas of the organotypic hippocampal slice 
cultures were the same as used in Section 2.2.3.3. 
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2.4 Methodological limitations and considerations 
This section will address the limitations that presented themselves throughout the 
study in regards to methodology and analysis. As with all experiments, there remain 
limitations of the techniques used and the conclusions that can be drawn from the 
observed results. 
2.4.1 Histology 
Throughout the study there were a small number of issues encountered regarding 
histology, particularly when it came to quantification of TeNT cleavage. 
2.4.1.1 Grey level analysis 
The grey level analysis included multiple layers from each region of the 
hippocampus. If some layers were affected by the toxin and others were not then 
there is the possibility that the TeNT induced cleavage would be diluted by the 
unaffected layers. Distance from the injection site may also have a similar dilution 
effect. This was part of the rationale behind the later bouton analyses within 
individual layers of the hippocampus and also investigating CA1a and CA1c 
separately whilst correlating with electrophysiological recordings. Overall however the 
grey level analysis provided an initial insight into the spatiotemporal changes in 
VAMP isoform expression following treatment with TeNT. 
2.4.1.2 Injection position 
It is important to remember that within the grey level analysis and the bouton counts, 
there is likely to be variation between animals. Even though the in vivo injections 
were made using stereotaxic co-ordinates, the injection itself may not always 
perfectly align within the str. radiatum of the CA3. The same applies for injections 
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onto the slice cultures. Here, the highest magnification was used with the dissection 
microscope but there will be some variation because of the judgment of the 
positioning by eye. Minute differences could result in the effects of the toxin initially 
targeting different neuronal populations and the position of the injections cannot be 
confirmed in all animals. The injection track within animals of the day 2 group (ex 
vivo) can mostly be identified, although the exact end point of the injection is not 
always clear. For those animals within the day 8 and 16 groups, the injection track is 
not usually still visible and thus there is no confirmation of the correct positioning of 
the injection. All animals injected in vivo and used between 8 and 16 days showed 
seizures following treatment with the toxin. There is variation between animals 
relating to the frequency of seizures and the day of onset, similar to previous reports 
(Mellanby et al., 1977; Jefferys & Whittington, 1996). This further shows that there is 
variation, whether it is biological variation or as a result of the injection position. 
Therefore the differences between the grey level distributions and the bouton counts 
would be expected to vary somewhat, even when all conditions are attempted to be 
kept consistent. 
2.4.1.3 Slice fixation 
Unfortunately, the fixation method used within the ex vivo slice experiments was not 
suitable for fixation of the slice cultures due to inconsistent and patchy staining. The 
microwave protocol used resolved the difficulties and resulted in successful staining. 
We believe it is unlikely that the fixation method was responsible for the need to 
change the bouton quantification method in slice cultures as visually the slice 
cultures appeared very similar to the ex vivo slices, and it was only the TeNT treated 
slices that caused the problem with the automatic bright objects count. 
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2.4.2 Use of multiple slices from the same animal 
Multiple slices from the same animals were used within the same analysis groups, 
from injections in vivo and in vitro. This was used to reduce numbers of animals 
where possible. For recordings and bouton analysis of ex vivo slices, more than one 
area within the animal, e.g. CA1a and CA1c, were used, but from separate slices. It 
may be suggested that using multiple slices from the same animal would produce 
more variability because the extent of the toxin’s effects may not be included within 
all slices. However, from the grey scale analysis, it was clear that there was already 
variation between animals and that the spread of the lesion was quite wide at 8-16 
days post injection. Using multiple slices from the same animal for the culturing 
experiments would produce less variation in the extent of the lesion because each 
slice was treated individually.  





3 INVESTIGATION OF THE SPATIOTEMPORAL EFFECTS OF 
TETANUS TOXIN FOLLOWING UNILATERAL INTRAHIPPOCAMPAL 
INJECTION
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3.1 Spatiotemporal analysis of the distribution of VAMP1 and VAMP2 in 
control and TeNT-treated rats 
In this section, the distribution of the VAMP1 and VAMP2 immunostaining in 
ipsilateral and contralateral hippocampal slices will be discussed. This will look at 
both the control and TeNT injected animals at 2, 8 and 16 days post injection. We will 
consider the distribution of staining by looking at low magnification images taken at 
each of the time points and then will move onto discussing the grey level analysis of 
these sections, looking at the individual areas of the hippocampus; dentate gyrus, 
CA2/3 and CA1. This will elucidate the changes, if any, which occur in these different 
regions over the early part of this model. First moment analysis will be used to look at 
the grey level graphs and analyse each trace as a single number to make 
comparisons between the changes in overall intensity distribution. Slices that have 
had the antibody for VAMP1 applied will be looked at first, followed by VAMP2. 
3.1.1 Distribution of VAMP1 immunopositivity 
In this section we will first establish the distribution of VAMP1 immunopositive areas 
within the hippocampus in control treated rats. Following this, the effects of TeNT 
injections will be shown at 2, 8 and 16 days post injection in the ipsilateral and 
contralateral hippocampi, at both mid and posterior levels within coronal brain 
sections. 
3.1.1.1 Control hippocampus 
The immunostaining distribution of VAMP1 in control sections is layer specific 
throughout the hippocampus (Figure 3.1 upper panels). This staining was consistent 
with that seen by Raptis et al. (2005) who looked at VAMP distribution across the 
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entire brain. The dentate gyrus shows the highest intensity immunosignal following 
fluorescent microscopy in the hilus and a lower intensity in the granule cell layer, 
indicating that the most VAMP1 is present in the hilus. The inner and outer molecular 
layers show differential immunostaining. The inner layer displays a brighter intensity 
immunosignal than the very dark outer molecular layer. The str. lacunosum 
moleculare is also seen as a dark area, similar to that of the outer molecular layer, 
suggesting a very low level of VAMP1 present. 
The CA1 and CA2/3 show the highest immunosignal in the strata radiatum and 
oriens with a lower intensity in the str. pyramidale. This is consistent along the length 
of each area. The str. lucidum in the CA3 shows a brighter intensity than the 
pyramidal layer and is of similar intensity to the adjacent str. radiatum. 
This layer specific distribution is consistent at 2, 8 and 16 days post injection (Figure 
3.1 upper panels) and is not disrupted by the needle tract (Figure 3.1 marked with 
asterisks). Around this tract the tissue is of course damaged but the individual layers 
retain their low or high intensity immunosignal. 
The contralateral control slices (Figure 3.2 upper panels) show the same layer 
specificity as that of the ipsilateral hippocampus and the staining is consistent across 
the three time points. The distribution of VAMP1 in the posterior sections remains the 
same as in the mid level sections, both ipsilateral (Figure 3.3 upper panels) and 
contralateral (Figure 3.4 upper panels). Even though the orientation of parts of the 
hippocampus has changed, the layer specificity remains. This shows that the spread 
of the control solution, if there is any spread, has no effect on the VAMP1 synaptic 
protein.




Figure 3.1. Distribution of VAMP1 immunopositivity in mid level ipsilateral hippocampus of rats injected with control or TeNT 
solutions. Low magnification fluorescent images of ipsilateral (injected) mid level hippocampi stained with antibody against 
VAMP1 and revealed using an Alexa 488 secondary antibody. Slices from control (upper panels) and TeNT (lower panels) 
injected animals killed at 2, 8 and 16 days post injection are shown. Asterisks in the day 2 images show the remains of the 
injection tract caused by the needle. Consistent differential immunostaining is seen across the hippocampi from control 
animals but there are increasing effects of the toxin seen in the TeNT treated slices, where a focal cleavage of VAMP1 is seen 
at 2 days post injection which spreads to include a larger area by day 8 and into day 16. Scale bar represents 500µm. 
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Figure 3.2. Distribution of VAMP1 immunopositivity in mid level contralateral hippocampus of rats injected with control or TeNT 
solutions. Low magnification fluorescent images of contralateral (uninjected) mid level hippocampi stained for VAMP1. The 
upper panels show control injected animals and the lower panels show TeNT injected animals at 2, 8 and 16 days post 
injection. The immunostaining distribution of VAMP1 is layer specific and consistent across the time points in control injected 
animals. Effects of the TeNT begin to be seen at day 8. Scale bar represents 500µm. 
Day 2 Day 8 Day 16 




Figure 3.3. Distribution of VAMP1 immunopositivity in posterior level ipsilateral 
hippocampus of rats injected with control or TeNT solutions. Low magnification 
fluorescent images of ipsilateral posterior hippocampi immunostained for VAMP1. 
The secondary antibody used was Alexa 488. Animals were injected with either 
control (upper panels) or TeNT (lower panels) solutions. Three different groups of 
animals were used; those killed at 2, 8 and 16 days post injection. The control slices 
shows consistent differential immunostaining throughout the different layers and 
areas of the hippocampus. The TeNT slices show cleavage of VAMP1 most 
prominently at days 8 and 16. Arrowheads in TeNT images indicate that above, 
within dorsal regions, there is cleavage of VAMP1, particularly in the inner molecular 
layer, shown by loss of the bright immunosignal. Scale bar represents 500µm. 
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Figure 3.4. Distribution of VAMP1 immunopositivity in posterior level contralateral 
hippocampus of rats injected with control or TeNT solutions. Low magnification 
fluorescent images of contralateral posterior hippocampi stained for VAMP1. The 
upper panels show slices from control injected animals killed at 2, 8 and 16 days post 
injection respectively. The lower panels show slices from animals injected with TeNT. 
The controls show consistent staining across the three time points and the TeNT 
slices show only minimal disruption of staining in the dorsal inner molecular layer at 
day 16. Scale bar represents 500µm. 
Day 2 Day 8 Day 16 
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3.1.1.2 Mid level ipsilateral hippocampus in TeNT injected rats  
Figure 3.1 (lower panels) shows representative mid level ipsilateral sections from 
TeNT injected animals at 2, 8 and 16 days post injection. Here it is clear that there 
are changes in pixel intensity in many layers surrounding the needle tract (marked by 
asterisks), from a focal cleavage at day 2 to a more widespread effect at later stages. 
At day 2, there is a slight darkening of the inner molecular layer closest to the 
injection site, in comparison to the more medial area of this layer. There is also a 
decrease in the intensity of the immunosignal in the str. radiatum of the CA3, 
indicated by the stark difference in pixel intensity between the hilus and the str. 
radiatum. The difference between the two layers is less pronounced in control 
injected slices. The immunosignal has also decreased in the CA1c region which is in 
line with the injection tract. Both the strata radiatum and oriens around this area, both 
sides of the needle tract, are darker than the CA1a end of the hippocampus which is 
further from the injection site. This could imply that after removal of the needle, some 
toxin rose up the tract. The darkening of the str. radiatum in the CA3, and to some 
extent in the CA1, is emphasised by the str. pyramidale immunosignal appearing 
brighter. The darkening in CA3 and CA1c is not seen around the needle tract in 
control injected slices indicating that the injection of a solution itself is not causing 
changes in VAMP1 expression. The CA1a end shows immunostaining that is very 
similar to the control slices, with the str. pyramidale having a darker immunosignal 
than the surrounding strata radiatum and oriens. The str. lucidum appears normal in 
these 2 day slices, with relatively bright fluorescence, particularly in the CA3c. Some 
decrease in signal intensity may be seen in the str. lucidum of CA3b. These changes 
are seen in slices that have the needle tract present (n=3) but not to such an extreme 
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extent in slices without the tract (n=3). Of the 3 animals where slices showed the 
needle tract, two had corresponding anterior sections (1920µm more caudal) which 
showed minimal or no changes in the VAMP1 immunosignal. These slices were not 
included in the analysis as were too anterior. This shows in itself that the focal 
decrease in immunosignal intensity is localised around the area which received the 
injection at this early stage of the model. These focal changes in pixel intensity 
around the injection site are represented further in Figure 3.5.  
Figure 3.5 shows slices from control and TeNT injected animals at day 2. The line 
histograms demonstrate that whilst there is a disruption of the pixel intensities due to 
the damage of the tissue by the needle tract, the control images show relatively 
consistent pixel intensities within the str. radiatum, from CA1 continuing into CA3. 
Within the TeNT slice however, there is a clear decrease in the pixel intensities 
shown by very dark areas in the image and also by the change in intensities within 
the graph. It also highlights that whilst the CA3 and CA1c are clearly affected by the 
toxin; the majority of the CA1 is not, representing the focal nature of the cleavage. 
Figure 3.1 also shows a slice from a TeNT injected animal that was killed 8 days post 
injection. Here, the decrease in the immunosignal that was limited to the area 
surrounding the needle at day 2 has expanded to include more of the hippocampus. 
The decrease in the intensity of the immunosignal within the inner molecular layer 
has spread, although the crest of the dentate gyrus appears to have an 
immunosignal comparable to controls. The CA3 strata radiatum and oriens as a 
whole have become much darker than in control sections and this is emphasised by 
the apparent brightening of the hilus in comparison. The pyramidal layer appears 
brighter than the surrounding areas. In the CA3, the str. lucidum is also affected by 
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the toxin, shown by its lack of differential staining compared with the decreased 
immunosignal in the str. radiatum. More of the CA1 is affected at this time point with 
the spread of the cleavage extending from CA1c towards CA1a. 
The animals in the day 16 group (Figure 3.1, lower right panel) show varying degrees 
of staining disruption across the hippocampus. This group shows a continued 
decrease in the brightness of the immunosignal in the inner molecular layer but to 
differing degrees between the slices. In the majority of cases (4 of 6) the whole layer 
looks darker but in others it is just the part nearest the CA3 that is affected. The most 
pronounced effects continue to be seen in the CA3 as a whole, and most of CA1b 
and c. Consistent with the changes seen at earlier time points of the model, the strata 
radiatum shows a darkening which makes the str. pyramidale and hilus appear 
brighter than in the control equivalents.















































Figure 3.5. Analysis of pixel intensities around the site of control or TeNT injection 
within VAMP1 immunopositive slices. The images show VAMP1 immunopositive slices 
from 2 days after injection of control or TeNT solution. The analysis of pixel intensities starts 
within the CA1 str. radiatum (indicated by the asterisk; VAMP1 Control panel) and 
corresponds to Pixel 1 in the x axis of the graphs. Note that the sudden deflections (marked 
by a star) in the pixel intensity relate to the disruption of the tissue by the injection tract. 
Overall it can be seen that in VAMP1 immunopositive slices, the injection of TeNT causes a 
dramatic shift towards darker pixel intensities around the injection site, including CA1c and 
CA3. Scale bar represents 500µm. 
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3.1.1.3 Mid level contralateral hippocampus in TeNT injected rats 
In contrast to the ipsilateral slices, there is no disruption of the staining in the 
contralateral side at 2 days post injection. The layer specific distribution remains well 
defined (Figure 3.2, lower panels). This lack of change in the immunosignal is likely 
to be because the cleavage of the toxin is only seen in a tight area around the 
injection site at day 2 and has had little time to spread to more remote areas for 
example the contralateral hippocampus. 
By day 8 there are some very slight changes in the contralateral hippocampus but 
they are not as clear as those seen in the ipsilateral side. As seen in the ipsilateral 
dentate gyrus, there is a very slight decrease in the immunosignal of the inner 
molecular layer at the tip of the buried blade. The hilus and part of the str. lucidum 
appear brighter in comparison to a slight decrease in the immunosignal of the str. 
radiatum. There is also some darkening in the CA1 strata radiatum and oriens. The 
grey level analysis later in this chapter will show the changes that occur in the 
contralateral side in a quantitative manner rather than qualitatively. 
Within the day 16 group there is some variation. Whilst there are no dramatic 
decreases in immunosignal seen, there are some subtle changes particularly within 
the str. radiatum of CA1 where there is a decrease in the signal (5 of 6 animals). 
These animals also show decreases in the immunosignal of the inner molecular layer 
across the majority of the layer rather than just focussed at the tips of the blades. 
3.1.1.4 Posterior level ipsilateral hippocampus in TeNT injected rats 
Much of the staining in the poster level sections of the day 2 TeNT treated group is 
very similar to that of the controls (Figure 3.3). The only difference occurs in 2 slices 
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where the very top of the slice shows a small degree of change. Here the crest of the 
dentate gyrus shows a darkening of the immunosignal in the inner molecular layer, 
shown above the arrow heads in the day 2 TeNT slice in Figure 3.3. This shows that 
the spread of the toxin varies from one animal to another and most likely depends on 
the exact position of the injection. 
In the day 8 group the effects of the toxin on the inner molecular layer begin to 
spread to a wider area (Figure 3.3). There is a decrease of the immunosignal from 
this layer for about 2/3rds the length of the dentate gyrus. In two cases the CA3 
strata radiatum and oriens is also darkened. The spread of the cleavage in the strata 
radiatum and oriens in the CA1 is more pronounced in some slices than others. Most 
of the effects are focused around the dentate gyrus and the CA3 . 
The day 16 group, similar to the day 8 group, shows a decrease in the immunosignal 
from the inner molecular layer (Figure 3.3). Five of 6 slices show a darkening of the 
strata radiatum and oriens in the CA3 region. Within the CA1, the decrease in 
immunosignal across the most dorsal regions of the strata radiatum and oriens 
results in a brighter str. pyramidale. 
3.1.1.5 Posterior level contralateral hippocampus in TeNT injected rats 
The changes in the posterior contralateral hippocampus are minimal at all time points 
but when they do occur they are in specific layers of the hippocampus. The day 2 
slices show staining that is comparable to that of the control slices (Figure 3.4, lower 
left panel). At day 8 there is a specific decrease of the immunosignal in the dorsal 
CA1 strata radiatum and oriens compared with the ventral part of this region. Other 
than this the TeNT appears not to have affected the other regions at this time point. 
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By day 16 there is a slight reduction in the immunosignal of the inner molecular layer 
at the crest of the dorsal dentate gyrus in all slices. In 3 of 6 slices there is also a 
reduction in the immunosignal in a small area of the dorsal CA1. Other than this, the 
staining in the CA1 and CA3 remains undisturbed. This all shows that there are 
minimal changes in the contralateral side but they are localised in the dorsal 
hippocampus.  
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3.1.2 Grey level analysis of VAMP1 immunosignal in control and TeNT treated rats 
The low magnification fluorescent images from the previous sections (Figures 3.1-
3.4) have shown an overview of the staining distributions in control slices and the 
effects of the TeNT treatment at the different time points. In this following section we 
will quantify the changes seen. As described in the Materials and Methods section, 
the grey level analysis looks at the pixel intensities within the individual areas of the 
hippocampus. The pixel intensities for each slice and each region are divided into 8 
different grey levels and the distributions plotted. The graphs in the following sections 
show the distributions of the immunosignal intensities as an average of all the slices 
from the same treatment condition and time point (Figures 3.6-3.8). The dentate 
gyrus, CA2/3 and CA1 are considered as separate regions of the hippocampus and 
therefore we shall be looking at these areas individually and comparing the 
treatments and sides within each of these areas, and also considering the middle and 
posterior sections. The first moment graphs give a representation of the changes at 
the different time points and between the treatments using a weighted average. 
At each survival time, only two rats were injected with the control solution. The 
rationale behind this was to minimise the numbers of animals used and we had 
hypothesised that there would be no differences between the controls. This however 
meant that the number of slices for each time point was low, particularly as one of the 
day 8 control animals had a very large ventricle which affected the hippocampus and 
was thus excluded. Statistical analysis (ANOVA) confirmed that there were no 
differences between the control slices at the different time points. The control data 
(ipsilateral and contralateral separately) are made up of slices from days 2, 8 and 16 
pooled together. Thus, when referring to the control data in the following sections, 
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looking at the individual areas, the values will be the same at 2, 8 and 16 days post 
injection. 
Each graph contains the data from ipsilateral TeNT, contralateral TeNT and 
ipsilateral control injected animals. The contralateral control traces are not shown in 
these graphs as they are very similar to the ipsilateral control traces. The data 
however is used within statistical analyses. 
Due to the number of tests that are used for the comparisons of the different 
treatments at the three time points, the significance criterion for each individual area, 
for example mid level dentate gyrus, will be lowered to 0.0167 to be more stringent 
(using the Bonferroni correction). This reduces the chance of obtaining one or more 
false positive results to 0.05 after multiple tests. This will be used because within 
each individual area, three two-way ANOVAs were used, one for each of 2, 8 and 16 
days post injection. A single two-way ANOVA was used to look at whether there were 
any differences between the three time points within the slices from TeNT treated 
animals, looking at ipsilateral and contralateral sides separately. As only one ANOVA 
was used for each area, the significance criterion will remain at 0.05. Two-way 
ANOVAs were used for the comparisons unless otherwise stated. 
3.1.2.1 Mid level dentate gyrus 
Figure 3.6 (upper panels) shows the grey level graphs for the mid level dentate gyrus 
at 2, 8 and 16 days post injection, along with the first moment analysis that allows for 
a direct comparison between the treatment groups and sides of the hippocampus. 
The distribution of staining intensity across the controls (pooled data from 2, 8 and 16 
days) shows that in the dentate gyrus, the highest percentage of pixels are present in 
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grey levels 3 and 4. The first moment for ipsilateral control is 3.57±0.08 which shows 
that the weighted average for the trace rests in grey level 3. This is in the mid to low 
intensity range and would be expected due to the low immunosignal of the granule 
cell layer where less VAMP1 is expressed. There is a decrease in the percentage of 
pixels as you go to the lighter grey levels. This is a trend consistent with the 
contralateral TeNT treated slices at all three time points. The ipsilateral TeNT trace 
however shows changes across the time points. At day 2 there is a slight shift to the 
left, indicating some decrease in the immunosignal (first moment 3.21±0.27). By day 
8 there is a further dramatic shift to the left and the first moment has decreased to 
2.58±0.18. At this point, the majority of pixels are in grey level 1 and the change is 
likely due to the cleavage of VAMP1 within the inner molecular layer. At 16 days post 
injection the trace remains with the majority of pixels at the darkest grey levels and 
the first moment remains low at 2.70±0.41. 
The comparisons graph in Figure 3.6 (upper row, right hand panel) shows the first 
moments at each of the time points for ipsilateral TeNT (solid line), contralateral 
TeNT (dotted line) and ipsilateral control (dashed line). Statistical analysis was 
carried out within each of the time points to compare the treatments and the sides of 
the hippocampus. This showed that there are significant differences between the 
ipsilateral control and TeNT slices at 8 days post injection (p=<0.001). Controls show 
significantly higher first moments, and thus have an average weighting in a lighter 
grey level than that of ipsilateral TeNT slices. There are also significantly higher first 
moments in contralateral TeNT slices versus ipsilateral TeNT at all three time points; 
p=0.014, p=<0.001 and p=0.006 as the days increase.  
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A comparison of the TeNT slices at the different time points (but within the individual 
sides) showed no significant differences.
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Grey level






























































































































































































Figure 3.6. Grey level distributions within dentate gyrus of VAMP1 immunopositive slices.                     
Grey level graphs for the middle (top row) and posterior (bottom row) dentate gyrus at 2, 8 and 16 days post injection from VAMP1 
immunostained slices. The distribution of the pixels across the 8 grey levels (1-8; dark-light) is shown for TeNT ipsilateral (solid), TeNT 
contralateral (dotted) and Control ipsilateral (dashed) conditions. Data presented as mean ± SEM. The right hand panels (Comparisons) 
shows the first moments for each of the time points and treatment conditions. Control traces contain 6 or 7 slices in both middle and 
posterior slices (ipsilateral and contralateral). Middle TeNT traces contain 6 slices, except for day 8 TeNT groups which each contain 4 
slices. Posterior TeNT groups contain 3, 4 and 6 slices for days 2, 8 and 16 respectively.
Day 2 Day 8 Day 16 Comparisons 
Day 2 Day 8 Day 16 Comparisons 
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3.1.2.2 Posterior level dentate gyrus 
The pooled controls for the posterior dentate gyrus shows the highest percentage of 
pixels in grey level 3 which is towards the darker end (first moment 4.05±0.24) 
(Figure 3.6, lower panels). As with the middle sections, this will be due to the low 
immunosignal from the granule cell layer which makes up a large proportion of the 
dentate gyrus. In the day 2 graphs, the highest percentage of pixels for the 
contralateral TeNT slices is in grey level 4 and for the ipsilateral TeNT slices is grey 
level 5. Overall the traces are very similar. These are similar to that seen in the mid 
level sections, if not a little lighter. By day 8 and continuing into day 16, there is a 
shift towards the darkest grey level for the ipsilateral TeNT trace (first moments 
2.89±0.25 and 2.88±0.31 respectively) whilst the contralateral TeNT (first moments 
4.19±0.16 and 4.08±0.12 respectively) remains similar to the control trace. 
The comparisons graph (Figure 3.6, lower right panel) shows that within the posterior 
hippocampus, the effects of the toxin do not begin until day 8. There are no 
significant differences between the treatment conditions at 2 days post injection, 
shown by very closely associated first moments in the graph. At days 8 and 16, there 
are significantly higher first moments in ipsilateral control in comparison to ipsilateral 
TeNT (p=0.003 and p=0.002 respectively) and also higher in contralateral TeNT 
versus ipsilateral TeNT (p=0.003 and p=0.002 respectively). 
Comparisons of the ipsilateral TeNT slices at the different time points shows that 
within the posterior slices, there are significant differences when comparing day 2 to 
day 8 (p=0.010) and day 2 to day 16 (P=0.009), where in both cases the day 2 
showed the higher first moment indicating a brighter overall immunosignal. The 
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decrease in brightness of pixel distribution at the later time points is due to the 
widespread decrease in immunosignal of the inner molecular layer. In the 
contralateral side there are no differences between the different time points in toxin 
treated slices. 
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3.1.2.3 Mid level CA2/3 
The data from the pooled controls in the CA2/3 show the peak of the curve in grey 
level 5 and the first moment is 5.14±0.14 (Figure 3.7, upper panels). This will be due 
to the bright immunosignal from the strata radiatum and oriens which makes up the 
largest percentage of the CA2/3 region. At all three time points, the contralateral 
TeNT trace remains similar to the controls, with the first moment remaining in grey 
level 5. The ipsilateral TeNT however starts to show a shift towards the darker grey 
levels at the earliest time point (first moment 3.95±0.29). By day 8 this shift has 
dramatically increased with the majority of pixels in the darkest two grey levels, 
similar to that seen in the dentate gyrus (first moment 2.69±0.39). This is due to the 
increased area of the toxin’s cleavage affects. The trace at day 16 however shows a 
similar distribution to day 2, indicating that the very intense decrease in 
immunosignal seen at day 8 has subsided somewhat by day 16 (first moment 
4.22±0.50). This is further emphasised in the comparisons graph (Figure 3.7, upper 
right panel). 
There are clear differences between the ipsilateral control and TeNT slices, where 
the control slices show significantly higher first moments: p=0.004, p=<0.001 at 2 and 
8 days post injection respectively. There is then a recovery towards control levels at 
day 16, indicated by no significant differences between the treatments in the 
ipsilateral side. There are significantly higher contralateral TeNT first moments than 
in the ipsilateral TeNT at all three time points; p=<0.001, p=<0.001 and p=0.004 at 
days 2, 8 and 16 respectively. Interestingly, the contralateral TeNT trace in the 
comparisons graph shows a trend similar to that of the ipsilateral TeNT slices, 
although to a less dramatic extent. It can be seen that at day 8, there is a subtle 
- 81 - 
 
reduction in the first moment compared to days 2 and 16. This suggests that the 
TeNT may have some cleavage effect within the contralateral side, but not to the 
extent seen within the ipsilateral side, hence no significant differences compared with 
control slices.  
A comparison of the different time points in the ipsilateral TeNT slices showed that 
there was a significant difference between the first moments of 8 and 16 days post 
injection (p=0.044). There were no significant differences between the time points in 
the contralateral side.
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Figure 3.7. Grey level distributions within CA2/3 of VAMP1 immunopositive slices.                               
Grey level graphs for the middle (top row) and posterior (bottom row) CA2/3 at days 2, 8 and 16 in VAMP1 immunostained 
slices. The distribution of the pixels in the TeNT ipsilateral (solid), TeNT contralateral (dotted) and Control ipsilateral (dashed) 
slices are shown across the 8 grey levels (1-8; dark-light). Data presented as mean ± SEM. The Comparisons panels show the 
first moments for each of the time points and treatment conditions. Control traces contain 6 or 7 slices in both middle and 
posterior slices (ipsilateral and contralateral). Middle TeNT traces contain 6 slices, except for day 8 TeNT groups which each 
contain 4 slices. Posterior TeNT groups contain 3, 4 and 6 slices for days 2, 8 and 16 respectively.
Day 2 Day 8 Day 16 Comparisons 
Day 2 Day 8 Day 16 Comparisons 
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3.1.2.4 Posterior level CA2/3 
The control slices pooled together for posterior CA2/3 show a peak in the 6th grey 
level, one of the lighter grey levels (Figure 3.7, lower panels). The first moment for 
the ipsilateral control slices is 5.88±0.22. The graphs also show that the staining 
across the CA2/3 is consistent at 2 days post injection in the posterior sections, 
whether treated with control or TeNT and whether on the ipsilateral or contralateral 
side. By day 8, the ipsilateral TeNT line has shifted towards the darker grey levels 
with the peak shown in grey level 4 (first moment 4.39±0.15). The contralateral TeNT 
and control lines remains focused in the brighter grey levels. At day 16, the peak of 
the ipsilateral TeNT slices remains in grey level 4 (first moment 4.45±0.35). 
There are significantly higher first moments in the ipsilateral control versus TeNT at 
days 8 and 16 (p=<0.001 in both instances). There are also significantly higher 
contralateral than ipsilateral TeNT first moments at these time points (p=<0.001 in 
both cases). 
A comparison of the time points within the TeNT slices shows that in the ipsilateral 
side, there is a significant difference between days 2 and 8 (p=0.010) with day 8 
showing a lower first moment value and thus a darkening of the overall area. Day 16 
also shows a significantly lower first moment than day 2 (p=0.011) indicating a 
sustained darkening, rather than a recovery as seen in the mid level CA2/3. In the 
contralateral side there are no differences between the different time points. 
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3.1.2.5 Mid level CA1 
The grouped control slices for CA1 show the highest percentage of pixels in the 
middle range grey levels (4 and 5) with a first moment of 4.69±0.20 (Figure 3.8, 
upper panels). The day 2 graphs show the peaks for all three conditions in grey 
levels 4 or 5. This is similar to the CA3 which would be expected as the layer 
distribution of the VAMP1 protein is similar throughout the CA3 and CA1, apart from 
the presence of the str. lucidum in the CA3. Similar to the dentate gyrus and CA2/3, 
the biggest shift in pixel intensity distribution happens in the ipsilateral TeNT injected 
animals at day 8. The peak for these slices is in grey level 2 (first moment 2.26±0.09) 
showing that most pixels are at the darkest end of the spectrum. By day 16, the 
distribution of pixels in the ipsilateral TeNT slices is less biased towards the darker 
grey levels than at day 8 and may be recovering towards control values ( ipsilateral 
TeNT first moment 3.65±0.53). 
The first moment comparisons graph shows that there are changes in the ipsilateral 
TeNT from day 2. There are significant differences between the ipsilateral control and 
TeNT slices at day 8 (p=<0.001) however not at days 2 or 16. Contralateral TeNT 
slices show significantly higher first moments than ipsilateral TeNT slices at all three 
time points (p=0.008, p=<0.001 and p=0.002 for days 2, 8 and 16 respectively). The 
day 8 contralateral CA1 shows a significantly higher first moment in the control slices 
in comparison to TeNT slices (p=0.001) suggesting that the TeNT has travelled to the 
contralateral CA1 and has had its cleavage effect on VAMP1. This trend of a 
decrease in the first moments of day 8 contralateral TeNT slices was also seen in the 
CA2/3, although was not significant. It is interesting that this occurs at the peak time 
of the effect in the ipsilateral side as well. As with the CA2/3, the day 8 shows the 
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greatest darkening and then some recovery by day 16 in mid level ipsilateral 
sections. 
Comparing the different time points within the TeNT slices shows that there is a 
significant difference between the first moments at 2 and 8 days post injection 
(p=0.025) in the ipsilateral side. In the contralateral side however, there is a 
significant difference between the 8 and 16 day slices (p=0.029) where the day 16 
shows a higher first moment than the day 8 slices, further indicating a cleavage 
within contralateral CA1 at day 8.
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Figure 3.8. Grey level distributions within CA1 of VAMP1 immunopositive slices.                                        
Grey level graphs for VAMP1 immunostained slices from the middle (top row) and posterior (bottom row) CA1. Graphs are 
shown for 2, 8 and 16 days post injection. The distribution of the pixels across the 8 grey levels (1-8; dark-light) is shown for 
TeNT ipsilateral (solid), TeNT contralateral (dotted) and Control ipsilateral (dashed) conditions. Data presented as mean ± 
SEM. Comparisons of the first moments at each of the time points and between the treatment conditions are shown in the right 
hand panels. Control traces contain 6 or 7 slices in both middle and posterior slices (ipsilateral and contralateral). Middle TeNT 
traces contain 6 slices, except for day 8 TeNT groups which each contain 4 slices. Posterior TeNT groups contain 3, 4 and 6 
slices for days 2, 8 and 16 respectively. 
Day 2 Day 8 Day 16 Comparisons 
Day 2 Day 8 Day 16 Comparisons 
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3.1.2.6 Posterior level CA1 
The pooled controls show a peak in grey level 5 and a first moment of 5.33±0.16 
(Figure 3.8, lower panels). At day 2, the ipsilateral and contralateral TeNT slices have 
peaks in grey level 6 (first moments 5.74±0.66 and 5.33±0.46 respectively). The day 
8 graphs show that the peak pixel intensities of the ipsilateral TeNT slices have 
shifted towards grey level 4, which remains by day 16 (3.79±0.11 and 3.84±0.32 
respectively). The contralateral TeNT trace at day 8 also shows a shift of the peak to 
grey level 4 but the majority of the pixels remain in the brighter grey levels (first 
moment 4.89±0.27). 
The posterior first moment analysis shows that there are no significant differences 
between the treatment conditions at 2 days post injection. At days 8 and 16, there 
are significantly higher first moments in ipsilateral control versus TeNT (p=<0.001 at 
both time points). There are also higher first moments in contralateral versus 
ipsilateral TeNT at these two time points (p=<0.001 in both cases). At day 8, there is 
a higher first moment in contralateral control in comparison to contralateral TeNT 
(p=0.014). This was also shown in the mid level CA1 and further supports the travel 
of the toxin to the contralateral hippocampus at a time when the peak cleavage effect 
is seen in the ipsilateral side. 
A comparison of the ipsilateral TeNT slices shows that there is a significant difference 
between day 2 and day 16 (p=0.021 t-test) but not between day 2 and day 8. Day 2 
shows the highest first moment and day 16 the lowest, demonstrating that the effect 
on the posterior hippocampus remains at day 16, whereas in middle sections it 
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begins to recover. There are no differences between the time points in the 
contralateral side. 
3.1.2.7 Summary of the effects of TeNT on the VAMP1 immunosignal in the 
ipsilateral and contralateral hippocampi 
Overall the low magnification images and grey level analysis have shown that the 
earliest effect of the toxin on VAMP1 is at 2 days post injection in the mid level CA2/3 
of the injected hippocampus. By day 8, the toxin has affected all areas in the mid 
level ipsilateral hippocampus, however there seems to be some recovery towards 
control levels by day 16. This is in contrast with the posterior sections, where the 
initial effect of the toxin is seen at day 8 in ipsilateral sections and remains at day 16, 
with no recovery seen. This suggests that the spread of the toxin’s effects moves 
away from the initial site of injection between days 2 and 8. Interestingly, at day 8, in 
both mid level and posterior slices, there are significantly higher first moments in CA1 
of contralateral controls than contralateral TeNT slices. This suggests that the toxin’s 
effect has spread to include the contralateral CA1.  
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3.1.3 Distribution of VAMP2 immunopositivity 
In this section we will be considering the distribution of VAMP2 across the different 
regions of the hippocampus, both ipsilateral and contralateral, at mid and posterior 
levels within slices from 2, 8 and 16 days post injection. 
3.1.3.1 Control hippocampus 
The distribution of VAMP2, as with VAMP1, shows layer specificity across the 
hippocampus (Figure 3.9). However there are differences in the distribution in 
comparison to VAMP1. The dentate gyrus shows a hilus full of VAMP2 (intense 
immunosignal) surrounded by a dark granule cell layer indicating a lower presence of 
the protein. The inner molecular layer has a slightly brighter immunosignal than the 
granule cell layer and the outer molecular layer is brighter still, showing that VAMP2 
rather than VAMP1 is the protein abundant in this area. This corresponds with the 
results shown by Raptis et al. (2005). The str. lacunosum moleculare is of similar 
immunosignal intensity to the outer molecular layer representative of a high level of 
VAMP2 also residing here. It is slightly brighter in immunosignal intensity than the str. 
radiatum in the CA3 and CA1. In these areas, the strata radiatum and oriens are 
similar in fluorescent intensity to each other across their length. The str. pyramidale 
that runs through the centre of these areas is darker which shows less VAMP2 
present. The str. lucidum is the brightest area of the CA3 indicating an abundance of 
VAMP2. 
These staining distributions are present in all mid level ipsilateral slices across the 2, 
8 and 16 day groups (Figure 3.9). This staining is also the same in the mid level 
control contralateral hippocampus (Figure 3.10) and the control posterior sections; 
both ipsilateral and contralateral (Figures 3.11 and 3.12 respectively).




Figure 3.9. Distribution of VAMP2 immunopositivity in mid level ipsilateral hippocampus of rats injected with control or TeNT 
solutions. Low magnification fluorescent images of ipsilateral (injected) mid level hippocampi immunostained with antibody 
against VAMP2. The upper panels show control injected and the lower panels TeNT injected animals. Slices were taken from 
animals killed at 2, 8 and 16 days post injection. The control images show consistent distribution of the VAMP2 in the different 
layers of the hippocampus across the three time points. A focal cleavage of VAMP2 is seen to start at day 2 and spread to 
include a wider area by days 8 and 16. Scale bar represents 500µm.  
Day 2 Day 8 Day 16 




Figure 3.10. Distribution of VAMP2 immunopositivity in mid level contralateral hippocampus of rats injected with control or 
TeNT solutions. Low magnification fluorescent images of VAMP2 immunostaining from contralateral (uninjected) mid level 
hippocampi. The upper panels show slices from control injected animals killed at 2, 8 and 16 days post injection. The lower 
panels show slices from TeNT injected animals. The staining distribution of the TeNT slices is mostly comparable to that of 
controls, although with subtle differences at day 16. Scale bar represents 500µm. 
Day 2 Day 8 Day 16 




Figure 3.11. Distribution of VAMP2 immunopositivity in posterior level ipsilateral 
hippocampus of rats injected with control or TeNT solutions. Low magnification 
fluorescent images from ipsilateral posterior hippocampi. Slices have been 
immunostained with antibody against VAMP2 and revealed using an Alexa 488 
secondary antibody. Images in the upper panels show slices from control injected 
animals killed 2, 8 and 16 days post injection respectively. Slices from TeNT injected 
animals at the same time points are shown in the lower panels. The effects of the 
toxin are seen focally at day 2, predominantly within the inner and outer molecular 
layers of the dentate gyrus and spread to include a wider area at days 8 and 16. 
Scale bar represents 500µm.  
Day 2 Day 8 Day 16 




Figure 3.12. Distribution of VAMP2 immunopositivity in posterior level contralateral 
hippocampus of rats injected with control or TeNT solutions. Low magnification 
fluorescent images of contralateral posterior hippocampi from control (upper panels) 
and TeNT (lower panels) injected animals. Animals were killed at three different time 
points; 2, 8 and 16 days post injection. No effects of the toxin are seen at any of the 
time points studied. Scale bar represents 500µm. 
Day 2 Day 8 Day 16 
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3.1.3.2 Mid level ipsilateral hippocampus in TeNT injected rats 
The day 2 group of animals that were injected with the TeNT and immunostained 
with antibody against VAMP2 (Figure 3.9 lower panels) show very faint traces of a 
cleavage but nothing as stark as in the VAMP1 immunostained slices. This is also 
shown in Figure 3.13 where a line histogram for slices from the control and TeNT 
injected animals in the day 2 group are compared. This shows the very consistent 
staining throughout the str. radiatum in control slices and only a minimal decrease in 
pixel intensity in the TeNT slice, corresponding to area CA3a/b. Here there is a slight 
decrease in the immunosignal from the str. radiatum. In two slices there is a possible 
brightening of the str. lucidum (Figure 3.9 lower panels). This coincides with a str. 
pyramidale which is less clearly differentiated from the str. lucidum, especially when 
compared to control slices. Overall however, the effects are very small and therefore 
we will consider the results of the grey level analysis to give a quantitative result in 
the next sections. 
The day 8 group decreases in fluorescent staining intensity around the injection site 
and to a wider area. The crest of the dentate gyrus remains with the differentiation 
apparent between each of the layers. In contrast, in the centre part of the 
hippocampus, the outer and inner molecular layers of the buried blade of the dentate 
gyrus have decreased in intensity to a level similar to the granule cell layer, thus 
showing cleavage of VAMP2. The overall brightness of the immunosignal in the CA3 
has decreased in all layers. Whilst the str. lucidum remains the brightest region in 2 
of 4 slices, its intensity is not as vibrant as in controls. In the other 2 slices, no 
distinction can be made between the str. lucidum and the adjacent str. radiatum. In 
the CA1c the str. pyramidale is particularly bright and is the brightest part of this 
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region, corresponding with the darkening of the strata radiatum and oriens. In all 
cases, the CA1a region remains undisturbed by the toxin. The differences between 
the two ends of the CA1 shall be addressed later in this chapter, where high 
magnification microscopy is used to look with more sensitivity at smaller areas. 
By day 16, the effects of the toxin are still visible in the mid level hippocampal slices. 
The hilus appears bright in contrast with the lower immunosignal of the adjacent 
granule cell layer and CA3 str. radiatum in all slices. The outer and inner molecular 
layers show some decrease in immunosignal within the buried blade of the dentate 
gyrus but this is not apparent at the crest, away from the original injection position. In 
3 out of 4 slices in the CA3, the immunosignal from the str. lucidum has decreased in 
brightness (in CA3a/b) and the str. pyramidale has returned to being the darkest 
layer of the CA3, although it may show less immunosignal than in controls. The strata 
radiatum and oriens remain darker than in comparison to controls. The str. 
pyramidale of the CA1 is dark throughout. In CA1c the strata radiatum and oriens 
have lower intensity immunosignals than in the CA1a showing that the effects of the 
toxin are still present around the original injection site but that they are not reaching 
to the furthest, more medial, parts of the hippocampus.















































Figure 3.13. Analysis of pixel intensities around the site of control or TeNT injection 
within VAMP2 immunopositive slices. The images show VAMP2 immunopositive slices 
from 2 days after injection of control or TeNT solution. Pixel 1 in the x axis of the graph 
corresponds to the start of the line trace in the CA1 str. radiatum (indicated by the asterisk; 
VAMP2 Control panel). Only a very subtle decrease in pixel intensity is seen corresponding 
to the CA3a/b of VAMP2 immunopositive slices following exposure to TeNT. Scale bar 
represents 500µm. 
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3.1.3.3 Mid level contralateral hippocampus in TeNT injected rats 
The immunosignal of the contralateral hippocampi from the three time points show 
minimal deviations from controls (Figure 3.10). The only subtle differences are within 
the str. radiatum of the CA3 and the inner and outer molecular layers of the dentate 
gyrus in day 16 animals where there appears to be some darkening (3 of 5 animals). 
3.1.3.4 Posterior level ipsilateral hippocampus in TeNT injected rats 
The day 2 TeNT injected group show posterior slices that have slight changes 
(Figure 3.11, lower panels). The inner and outer molecular layers at the crest of the 
dentate gyrus decrease in immunosignal intensity to a level that is similar to the 
granule cell layer. This effect is focused in the most dorsal parts of the dentate gyrus. 
A small portion of the str. radiatum in the CA1 also shows some very slight darkening 
in 2 of 4 slices. 
The day 8 posterior slices continue to show a cleavage of the VAMP2 protein in the 
inner and outer molecular layers at the crest of the dentate gyrus. Here, the outer 
molecular layer is much darker than the str. lacunosum moleculare whereas they are 
normally similar in intensity, as seen in the more ventral parts of the slice. The effects 
have spread to include a larger area of the dorsal part of the hippocampus than in the 
day 2 group. In the CA3, the strata radiatum and oriens have darker immunosignals 
than the contained str. lucidum and surrounding hilus, showing a contrast that is 
much clearer than in control slices. The CA1 area shows mostly homogenous 
staining throughout the strata radiatum and oriens apart from in the dorsal region 
where there is some darkening in comparison to the ventral portion. 
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The day 16 group of slices show similar effects to that seen in the day 8 group. The 
inner and outer molecular layers at the dorsal crest of the dentate gyrus show a 
decrease in the immunosignal intensity as the predominant feature along with a 
darkening of the str. radiatum and oriens in the dorsal CA3 and CA1 (3 of 4 slices).  
3.1.3.5 Posterior level contralateral hippocampus in TeNT injected rats 
The contralateral posterior VAMP2 immunopositive slices show staining that is 
unaffected by the TeNT at all time points studied (Figure 3.12). The inner and outer 
molecular layers that were affected in the ipsilateral posterior slices show no 
decrease in immunosignal on the contralateral side. This is indicated by an 
immunosignal that is brighter than the granule cell layer and of comparable 
brightness to the str. lacunosum moleculare in the case of the outer molecular layer. 
There is also no cleavage identified in the CA3 or CA1. 
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3.1.4 Grey level analysis of VAMP2 immunosignal in control and TeNT treated rats 
As with the VAMP1 sections, the distribution of VAMP2 across eight different grey 
levels within the different areas of the hippocampus will be investigated. This allows 
for a first moment analysis to be carried out giving a weighted average of the staining 
within the different treatment conditions to determine if there are quantitative 
differences at the different time points and within the different regions and sides of 
the hippocampus. 
The grey level and first moment analyses for the controls at the three different time 
points have been pooled together, having tested that there are no significant 
differences between them (as undertaken in VAMP1 immunopositive slices). The 
significance criterion remains set at 0.0167, corrected for multiple comparisons, for 
analysis of the effects of the different treatments within individual time points as 
before. The significance criterion for the comparison of the three time points within 
the TeNT treated animals remains at 0.05. As with the VAMP1 grey level analysis, 
the statistical tests used were two-way ANOVAs unless otherwise stated. 
3.1.4.1 Mid level dentate gyrus 
The pooled controls show a relatively even distribution across the 8 different grey 
levels (Figure 3.14 upper panels). The first moment for the control slices is 
4.12±0.19. All three conditions included in the graphs for the day 2 slices show very 
similar pixel distributions across the different grey levels. By day 8, the peak of the 
graph for the ipsilateral TeNT slices shifts all the way to grey level 1 which is the 
darkest (first moment 3.29±0.50). This is in comparison to the contralateral TeNT 
where first moment is 5.27±0.23, thus remaining in the brighter grey levels. The day 
16 group also shows the peak of the ipsilateral TeNT in the darkest grey level, but 
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here the percentage of pixels is even higher than in the day 8 group (first moment 
2.44±0.51), suggesting a further darkening in the area which corresponds to the 
spread of the TeNT effect in the inner and outer molecular layers. Interestingly, the 
contralateral TeNT line has also shifted to the left, showing the peak in grey level 2 
(first moment 3.75±0.52). 
The first moment comparisons graph in Figure 3.14 (upper right panel) shows that 
there are clear differences between the treatment conditions in the dentate gyrus. At 
2 and 8 days post injection there are no differences between the treatments in the 
ipsilateral or contralateral sides. At day 16, there is a difference between the 
treatments in the ipsilateral side (p=0.002) where the controls show a higher first 
moment. At day 8, there is a significantly higher first moment in the contralateral 
TeNT compared with the ipsilateral TeNT (p=<0.001).  
A comparison of the ipsilateral TeNT slices at the three different time points shows 
that day 2 has a significantly higher first moment, and thus brighter overall staining, 
than day 16 (p=0.005). In the contralateral TeNT slices, there are significant 
differences between days 2 and 16 (p=0.037) and between days 8 and 16 (p=0.028) 
with day 16 showing the lowest first moment in both cases. This data, coupled with 
the lack of difference between the ipsilateral and contralateral TeNT first moments 
shows that there is some effect of the toxin in the contralateral dentate gyrus by day 
16.
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Figure 3.14. Grey level distributions within dentate gyrus of VAMP2 immunopositive slices.                  
Grey level graphs for the middle and posterior dentate gyrus (upper and lower rows respectively) at days 2, 8 and 16 in 
VAMP2 immunostained slices. The distribution of the pixels across the 8 grey levels (1-8; dark-light) is shown for TeNT 
ipsilateral (solid), TeNT contralateral (dotted) and Control ipsilateral (dashed) slices. Data presented as mean ± SEM. The 
right hand panels show comparisons of the first moments for each of the time points and treatment conditions. Control traces 
contain 7 slices at each time point, within middle and posterior slices, whilst TeNT traces contain 4 slices.
Day 2 Day 8 Day 16 Comparisons 
Day 2 Day 8 Day 16 Comparisons 
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3.1.4.2 Posterior level dentate gyrus 
Pooled controls show a peak in the 5th grey level (Figure 3.14 lower panels) and a 
first moment of 4.81±0.21. At 2 days post injection the distributions are similar for all 
treatments. By day 8, as was the trend in the mid level slices, the peak for the 
ipsilateral TeNT has shifted to the darkest grey level and shows a more equal spread 
of percentage of pixels across the different intensity grey levels (first moment 
3.83±0.38). This shift has increased by day 16 (first moment 3.47±0.16). 
The comparisons of the first moments within the different time points shows that in 
the posterior sections there are significant differences between the treatments in the 
ipsilateral side at days 8 and 16 (p=0.010 and p=<0.001 respectively), where the 
controls show higher first moments. When comparing the ipsilateral and contralateral 
TeNT slices, there are higher first moments in the contralateral side at 8 and 16 days 
post injection (p=0.004 and p=0.007 respectively). 
There are no significant differences between the first moments at any of the time 
points within the ipsilateral TeNT, however there is a significant difference between 
the day 2 and day 16 first moments in the contralateral side (p=0.024). This suggests 
subtle changes within the dentate gyrus at this latest time point. No changes were 
observed from the low magnification images. 
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3.1.4.3 Mid level CA2/3 
The pooled controls for CA2/3 show the peak of the distribution in the 4th grey level 
(Figure 3.15 upper panels) with a first moment of 4.37±0.33. The peak is much higher 
than in the dentate gyrus and there are fewer pixels in other grey levels whereas in 
the dentate gyrus the distribution was more evenly spread. This is because of the 
difference in staining across the two different regions. At 2 days post injection, all 
three conditions show a relatively similar trend in the distribution of the pixel 
intensities. The ipsilateral TeNT trace at day 8 shows a shift towards the darker grey 
levels with the peak in grey level 2 (first moment 2.32±0.36) and intensifying by day 
16 (first moment 2.18±0.33). Very few pixels are in grey levels 6-8 showing that there 
are very few bright areas within the CA3 following the toxin treatment at these time 
points. 
Comparing the treatments within the different time points shows that at day 2 there 
are no differences between the different sides of the hippocampus or the treatments. 
At days 8 and 16, there are significantly higher first moments in the ipsilateral control 
versus ipsilateral TeNT (p=0.002 in both cases) and in the contralateral TeNT versus 
ipsilateral TeNT (p=<0.001 in both cases). 
A comparison of the three different time points in the TeNT slices shows that in the 
ipsilateral side there are significant differences between days 2 and 8 (p=0.004) and 
between days 2 and 16 (p=0.004). There are no differences between any of the time 
points in the contralateral side however, overall showing that the TeNT has had no 
effect there.
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Figure 3.15. Grey level distributions within CA2/3 of VAMP2 immunopositive slices.                          
Grey level graphs for the middle (upper row) and posterior (lower row) CA2/3 of VAMP2 immunostained slices at 2, 8 and 16 
days post injection. The distribution of the pixels across the 8 grey levels (1-8; dark-light) is shown for the different treatment 
conditions; TeNT ipsilateral (solid), TeNT contralateral (dotted) and Control ipsilateral (dashed). Data presented as mean ± 
SEM. The Comparisons panels show the first moments for each of the time points and treatment conditions. Control traces 
contain 7 slices at each time point, within middle and posterior slices, whilst TeNT traces contain 4 slices.
Day 2 Day 8 Day 16 Comparisons 
Day 2 Day 8 Day 16 Comparisons 
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3.1.4.4 Posterior level CA2/3 
The pooled control slices in the CA2/3 region show a peak in grey level 5, one of the 
mid-to-light grey levels (first moment is 4.87±0.25) (Figure 3.15 lower panels). The 
distribution of pixels across the different grey levels is similar for all three conditions 
at day 2, with the peak in grey level 5 in all cases. By day 8 there has been a shift of 
the ipsilateral TeNT slices to include the majority of pixels in the darker grey levels 
(first moment 3.86±0.28). Again, by day 16, ipsilateral TeNT slices show a further 
increase in the percentage of pixels in the darkest grey levels: first moment 
decreasing further to 3.02±0.19, showing that here as well as in the mid level slices 
there is an increased affect by this latest time point. 
The lower right panel of Figure 3.15, comparing the first moments, shows that there 
are no differences between the treatments or sides at 2 days post injection in the 
posterior sections, as with the middle sections in the CA2/3. At 8 and 16 days post 
injection, the control first moment is significantly higher than the TeNT in the 
ipsilateral side (p=0.006 (ANOVA) and p=0.006 (Mann Whitney Rank Sum) 
respectively). The day 16 first moment is the lowest. The ipsilateral slices show 
significantly lower first moments than the contralateral slices in the TeNT treatments 
at day 8 (p=0.014). 
Comparing the time points within the TeNT slices show that there is a difference 
between days 2 and 16 in the ipsilateral (p=0.013) and contralateral sides (p=0.025) 
suggesting a cleavage of VAMP2 in the CA2/3 of both sides of the brain. 
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3.1.4.5 Mid level CA1 
Pooled controls in the CA1 show a peak in grey level 4 with a first moment of 
4.49±0.34 (Figure 3.16 upper panels). The peaks for all three lines are within grey 
levels 4 and 5 at 2 days post injection. The distribution of the pixels either side of 
these peaks decreases in a steady manner. At day 8 in the CA1, as was seen in the 
dentate gyrus and CA2/3, there is a shift towards the darker grey levels for the 
ipsilateral TeNT (first moment reducing to 3.17±0.32). The peaks for the control and 
contralateral TeNT slices remain in grey levels 4 and 5 respectively. The day 16 
group also shows that the shift towards the darker grey levels has remained for the 
ipsilateral TeNT slices (first moment of 2.77±0.65), and has further increased the 
percentage of pixels in the darkest two grey levels. 
A comparison of the first moments within the middle CA1 shows that there are no 
differences between the treatments or the sides of the brain at any of the time points 
studied. This suggests that the effect of the TeNT within CA1c is not great enough to 
cause a significant shift in the distribution of pixels within the CA1 region as a whole. 
The differences between the CA1a and CA1c regions may account for the larger 
variations between the data within the day 16 ipsilateral TeNT group and thus is 
responsible for the lack of difference compared with control slices. 
Comparing the days within the TeNT slices shows no differences between the time 
points in the ipsilateral or contralateral sides. This is interesting as it is the only mid 
level area within VAMP2 immunopositive slices where this is true and is likely to do 
with the larger variation within the day 16 ipsilateral TeNT data.
- 107 - 
 
Grey level































































































































































































Figure 3.16. Grey level distributions within CA1 of VAMP2 immunopositive slices.                              
Grey level graphs for the middle and posterior CA1 (upper and lower rows respectively) at days 2, 8 and 16 in VAMP2 
immunostained slices. The distribution of the pixels across the 8 grey levels (1-8; dark-light) are shown for TeNT ipsilateral 
(solid), TeNT contralateral (dotted) and Control ipsilateral (dashed) slices. Data presented as mean ± SEM. The right hand 
panels compare the first moments for each of the time points and treatment conditions. Control traces contain 7 slices at each 
time point, within middle and posterior slices, whilst TeNT traces contain 4 slices. 
Day 2 Day 8 Day 16 Comparisons 
Day 2 Day 8 Day 16 Comparisons 
- 108 - 
 
3.1.4.6 Posterior level CA1 
The pooled controls for the posterior CA1 region show a peak in grey level 4 and a 
first moment of 4.17±0.25 (Figure 3.16 lower panels). At day 2 the spread of the 
percentage of pixels in each grey level is similar across the three traces. At day 8 
there is no shift to the left in the CA1 of the ipsilateral TeNT slices (first moment 
4.12±0.19) showing that the posterior CA1 is not affected at this time point. By day 
16, a slight shift can be seen for the ipsilateral TeNT (first moment decreasing to 
3.21±0.17), however not as dramatic as in the CA2/3. 
In the posterior sections of the CA1, there are no significant differences between the 
sides or the treatments at 2 and 8 days post injection. In all the other posterior areas, 
there have been differences between the treatments in the ipsilateral side and 
between the sides in the TeNT slices at day 8, but here there are not. At day 16 
however, the ipsilateral TeNT shows the lowest first moment in comparison to 
ipsilateral control (p=0.015) and contralateral TeNT slices (p=0.004). 
A comparison of the different time points within the TeNT slices show that there are 
no significant differences in either the ipsilateral or contralateral slices. 
3.1.4.7 Summary of the effects of TeNT on the VAMP2 immunosignal in the 
ipsilateral and contralateral hippocampi 
Overall, this section has shown that the VAMP2 is cleaved by TeNT and as with the 
VAMP1, the cleavage is layer specific. The inner and outer molecular layers are the 
most affected regions of the dentate gyrus, and the strata radiatum and oriens of the 
CA2/3 and CA1. The str. lucidum shows a greater susceptibility in VAMP2 positive 
slices compared with the VAMP1 equivalents, likely due to the higher abundance of 
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the VAMP2 protein in this layer. The grey level analysis has shown that the toxin has 
no significant effect in any of the hippocampal areas at 2 days post injection. In mid 
level hippocampus, by day 8, changes are seen in the CA2/3 where ipsilateral control 
first moments are significantly higher than those of ipsilateral TeNT slices. By day 16 
this has spread to include the dentate gyrus as well. Both the dentate gyrus and the 
CA2/3 show that the day 16 first moments are significantly lower than those of day 2, 
which shows that in VAMP2, the peak effect of the toxin is seen at 16 days post 
injection (compared with day 8 for VAMP1). In the posterior hippocampus, ipsilateral 
control values are significantly higher than ipsilateral TeNT in the dentate gyrus and 
CA2/3 at 8 and 16 days, and this spreads to include CA1 by 16 days. Contralateral 
cleavage of VAMP2 is suggested to occur in both the mid and posterior level dentate 
gyrus and the posterior CA2/3 at 16 days post injection. Interestingly, these changes 
were observed only in a small number of low magnification images, if at all, which 
suggest that the grey level analysis is suitable for uncovering more subtle changes. 
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3.2 Differential expression of VAMP isoforms in inhibitory and excitatory 
neurons 
We have seen in the previous sections that both the VAMP1 and VAMP2 proteins 
have been affected by TeNT, albeit at different time points. Considering that much of 
the literature refers to TeNT having an affinity for inhibitory neurons and that VAMP2 
is the substrate for the toxin, our group chose to look at whether the VAMP1 and 
VAMP2 were localised in specific subsets of neurons. The initial work was carried out 
by Dr Alex Ferecsko and he found that inhibitory neurons (GAD65 expressing) most 
predominantly expressed VAMP1, whereas the VAMP2 was mostly co-localised with 
VGLUT1 (excitatory marker) immunopositive neurons (unpublished data). These 
results were interesting in that they contradict what is stated in much of the literature. 
We have shown that both the VAMP proteins are cleaved by the TeNT and thus both 
inhibitory and excitatory neurons are affected, however perhaps to varying degrees 
and on a differing time scale. These findings led us to investigate the functional 
effects of the toxin on neurons within the CA1 at 8-16 days post injection. 
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3.3 Functional effects of intrahippocampal TeNT injection and 
corresponding bouton analysis 
Having shown that both VAMP1 and VAMP2 are cleaved by the injection of TeNT 
into the hippocampus, and that these two proteins are differentially expressed and 
co-localised with VGLUT1 and GAD, it leads to the hypothesis that both inhibition 
and excitation are affected by the TeNT injections. Previous data and clinical 
evidence has suggested that the toxin has an affinity for inhibitory neurons (Mellanby 
& Green, 1981; Farrar et al., 2000; Turillazzi et al., 2009). To further investigate this 
we undertook a group of experiments to look at the functional consequences of these 
injections. Here we couple electrophysiological recordings with 
immunohistochemistry for VAMP1 and VAMP2. This will give a further insight into the 
functional changes that occur and how these relate to the changes in the expression 
of the two proteins. 
3.3.1 Electrophysiological recordings from CA1 of control and TeNT injected rats 
Dr Andrew Powell and Dr Wei-Chih Chang carried out the electrophysiology on the 
acute ex vivo hippocampal slices from 8-16 day post injection rats. These slices were 
then processed for immunohistochemistry. For technical reasons, neurons from 
CA1a and CA1c were whole-cell patch clamped, but not from CA3 because in adult 
rats this area proves very difficult for patch clamp recordings. The electrophysiology 
results shall be briefly summarised below. 
3.3.1.1 Ipsilateral hippocampus 
Whole-cell patch clamp recordings were carried out in CA1a (away from injection 
site) and CA1c (adjacent to injection site). The results of the electrophysiology show 
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that evoked inhibitory post synaptic currents (IPSCs) were completely abolished 
(amplitude was zero), whilst the evoked excitatory post synaptic current (EPSC) 
maximal amplitude fell to 22% of controls in CA1c. There were no effects of the toxin 
in CA1a, where evoked responses were similar to controls. Spontaneous IPSCs 
(sIPSC) and EPSCs (sEPSC) were also recorded and showed that although the 
amplitude remained at levels comparable to controls, the frequency was severely 
reduced in the CA1c area for both sEPSCs and sIPSCs (falling to ~36% and ~2% of 
control values respectively). 
3.3.1.2 Contralateral hippocampus 
The same recordings were carried out in contralateral slices, although from a 
separate batch of animals. These recordings showed that there were no significant 
differences between the spontaneous or evoked recordings within the CA1a or CA1c 
when comparing controls to TeNT slices. 
Having established that there are significant changes in the functional abilities in 
ipsilateral CA1c of TeNT injected animals, we next move on to looking at the boutons 
in the areas that were recorded from to gain a better insight into the effects of the 
TeNT, focusing on the cleavage of VAMP1 and VAMP2. We also looked at the 
boutons in CA3 to investigate the changes which occurred here. We did not have the 
electrophysiological data to go with this from the current experiments, but previous 
work has looked at the physiological effects of TeNT in the CA3 area (Jefferys & 
Empson, 1990; Empson & Jefferys, 1993; Whittington & Jefferys, 1994). 
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3.3.2 High magnification microscopy and analysis of VAMP1 immunopositive 
boutons in control and TeNT injected animals 
High magnification oil immersion microscopy allowed boutons in the different areas to 
be revealed. Bouton counts will be considered from the strata pyramidale and 
radiatum of the CA1a, CA1c and CA3. Analysis of the bouton counts within these 
different regions will compare the ipsilateral and contralateral sides, as well as control 
and TeNT treatments. Within each region this will consist of 4 tests and thus the 
significance criterion will be lowered to 0.0125 (Bonferroni correction for multiple 
comparisons). Comparisons of the bouton counts will then be made between the 
different regions, and here 3 tests are used so the significance criterion has been set 
at 0.0167 (Bonferroni correction for multiple comparisons). Unless stated, the test 
used will be a t-test. 
3.3.2.1 Str. pyramidale 
Within the CA1a str. pyramidale (Figure 3.17, panels A and B) there are no 
differences between the two sides of the hippocampus in control or TeNT slices. 
When comparing the ipsilateral control to the ipsilateral TeNT slices however, there 
are significantly fewer boutons in the TeNT condition (p=<0.001). This is likely to be 
due to spread of the toxin effect by 8-16 days that has spread from CA1c along 
towards the more medial area of CA1. There are no differences between the control 
and TeNT treatment in the contralateral CA1a, showing that this region is unaffected 
by the toxin. 
The str. pyramidale of CA1c (Figure 3.17, panels C and D) shows some differences 
to the CA1a. Here there are no differences between control and TeNT bouton counts 
within the ipsilateral hippocampus (p=0.014 which is non-significant after the lowered 
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significance criterion). The ipsilateral TeNT group only contained 3 slices. This was 
because the cell bodies within the str. pyramidale in the other images were not clear 
and therefore were not consistent and were excluded from the analysis. Of the 3 
slices that were included, there was a large variation, with bouton counts of 7, 8 and 
22. This would suggest that two slices showed significant cleavage of VAMP1 
positive boutons but that the other was not so affected by the toxin. There are fewer 
boutons in the ipsilateral TeNT slices compared with the contralateral TeNT 
treatment (p=0.012) which would suggest that there may indeed be cleavage in the 
ipsilateral TeNT slices. Further experiments to increase the number of slices in this 
treatment condition will validate this. Conversely, there are significantly fewer 
boutons in the contralateral control slices in comparison to the ipsilateral controls 
(p=0.006; Mann Whitney Rank Sum). 
The CA3 str. pyramidale (Figure 3.17, panels E and F) of control slices show a 
significant difference between the two sides, where there are fewer boutons in the 
contralateral side compared with the ipsilateral (p=0.011). This value is quite near to 
the significance criterion so should be analysed with caution but as will be mentioned 
in the next section, the same result is also seen in the CA3 of VAMP2 
immunopositive slices. There are no differences between the two hippocampal sides 
within the TeNT slices. Comparisons of control with TeNT slices show that there are 
significantly fewer boutons in the TeNT slices in both the ipsilateral and contralateral 
sides (p=0.003 (Mann Whitney Rank Sum) and p=0.009 respectively). This shows 
that the toxin is having a cleavage affect on the VAMP1 immunopositive boutons on 
both sides of the hippocampus, but with a greater effect on the ipsilateral side, which 
is to be expected. 
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3.3.2.2 Comparison of str. pyramidale in the different hippocampal regions 
Within this section, the CA1a, CA1c and CA3 will be compared to each other within 
one side of the brain and an individual treatment, for example the ipsilateral control 
slices. Three tests will be used for each of these conditions and thus the significance 
criterion has been set at 0.0167 (Bonferroni correction for multiple comparisons). 
There are no differences between the three regions in the ipsilateral control slices or 
within the contralateral control or contralateral TeNT slices. The ipsilateral TeNT 
bouton counts show that there are significantly fewer boutons in the CA1c compared 
with CA1a (p=0.009) but no differences comparing the other regions. Conclusions 
should be made cautiously because only 3 slices were included in the CA1c TeNT 
group, but the comparisons of the areas would suggest that in fact the CA1c does 
show a cleavage hence the significantly lower bouton counts compared with CA1a. 
The counts for CA3 lie between those of CA1a and CA1c which would identify why 
there are no differences between CA3 and either of the CA1 regions.
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Figure 3.17. VAMP1 immunopositive boutons in str. pyramidale of CA1a, CA1c and CA3. Panels A, C and E show high 
magnification images taken from the CA1a, CA1c and CA3 respectively, ipsilateral (black bars) and contralateral (grey bars) to 
the injection. Below, panels B, D and F show the bouton counts made within an area of interest (AOI; 15x60µm) placed within 
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20µm. The number of slices analysed is as follows, with ipsilateral then contralateral: CA1a Control 4, 9; CA1a TeNT 15, 14; 
CA1c Control 10, 16; CA1c TeNT 3, 9; CA3 Control 14, 25 and CA3 TeNT 15, 25. Abbreviations: SO, Str. Oriens; SP, Str. 
Pyramidale; SR, Str. Radiatum and SL, Str. Lucidum. 
- 118 - 
 
3.3.2.3 Str. radiatum 
The CA1a str. radiatum (Figure 3.18, panels A and B) shows significantly more 
boutons in the contralateral side compared with the ipsilateral side in both the control 
and TeNT slices (p=0.008 and p=0.004 respectively). There are no differences 
between the two treatments when compared within the individual sides of the brain 
which emphasises the differences between the counts in the individual sides but also 
shows that the toxin has no effect in the CA1a region of str. radiatum, unlike str. 
pyramidale. 
The CA1c region (Figure 3.18, panels C and D) also shows differences between the 
two sides, with the contralateral side again showing the greater bouton counts. This 
is present in both controls and TeNT slices (p=<0.001 and p=0.010 (Mann Whitney 
Rank Sum) respectively). There are significantly fewer boutons in the ipsilateral TeNT 
slices compared with ipsilateral control (p=0.001) but no differences in the 
contralateral side between the treatments. These data identify that the toxin is having 
a cleavage effect within the ipsilateral CA1c but not within the contralateral side and 
that there is a discrepancy between contralateral and ipsilateral boutons within 
control slices, as in the CA1a. 
There are no differences between the hippocampi on the two different sides of the 
brain in controls or TeNT slices within the CA3 (Figure 3.18, panels E and F). There 
are however significantly fewer boutons in TeNT slices compared with controls in 
both the ipsilateral and contralateral hippocampi (p=<0.001 and p=0.009 
respectively). This shows that the toxins most prominent effect is within the ipsilateral 
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hippocampus but its effects are also seen on the contralateral side, specifically in the 
CA3. 
3.3.2.4 Comparison of str. radiatum in the different hippocampal regions 
The bouton counts in the ipsilateral hippocampi show no differences between the 
three different regions, in control or TeNT slices. In the contralateral control however, 
there are significantly fewer boutons in the CA3 compared with both the CA1a and 
CA1c (p=0.004 and p=<0.001respectively). This is also seen in the TeNT slices 
(p=0.014 and p=0.004; CA1a vs CA3 and CA1c vs CA3 respectively). There are 
significantly more boutons in CA1c versus CA1a in the str. radiatum (p=0.007). This 
all suggests that the numbers of boutons with the str. radiatum is not consistent 
across the length of the hippocampus and should therefore be compared with 
caution. This difference is understandable considering that neurons within the 
different regions receive differing innervations.
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Figure 3.18. VAMP1 immunopositive boutons in str. radiatum of CA1a, CA1c and CA3. High magnification images (panels A, C 
and E) show boutons within the CA1a, CA1c and CA3. Control and TeNT slices are shown from ipsilateral (black bars) and 
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randomly placed in four positions throughout each image are shown in panels B, D and F. Data shown as mean ±SEM. * 
p<0.05, ** p<0.01 and *** p<0.001. Scale bar represents 20µm. The number of slices analysed is as follows, with ipsilateral 
then contralateral: CA1a Control 4, 6; CA1a TeNT 10, 6; CA1c Control 11, 8; CA1c TeNT 6, 4; CA3 Control 6, 12 and CA3 
TeNT 6, 12. 
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3.3.2.5 Summary of the effects of TeNT in hippocampal regions on VAMP1 
immunopositive bouton counts 
Overall, the bouton counts have shown that the toxin is able to cleave VAMP1 in the 
CA3 of both the ipsilateral and contralateral hippocampus in the strata pyramidale 
and radiatum, with the more prominent effects seen in the ipsilateral side. There is 
also evidence of cleavage in ipsilateral CA1a and CA1c of the str. pyramidale and 
CA1c of the str. radiatum. We have also seen differences between the counts in the 
sides of the brain which shall be considered in the discussion. 
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3.3.3 High magnification microscopy and analysis of VAMP2 immunopositive 
boutons in control and TeNT injected animals 
The previous section showed the changes in bouton counts within the different 
hippocampal regions for VAMP1 immunopositive boutons. In this section, the same 
comparisons will be made but for VAMP2 immunopositive boutons. 
3.3.3.1 Str. pyramidale 
As shown in low magnification microscopy (Section 3.3), the distribution of VAMP2 is 
somewhat different to VAMP1. This is further highlighted at high magnification, where 
VAMP1 immunopositive boutons encircle the cell bodies, but here VAMP2 
immunopositive boutons fill the area between the cell bodies rather than encircling 
them. The CA3 images show a bright area in the bottom section. This is where the 
mossy fibres are coming into the str. lucidum and show very high VAMP2 labelling. 
When the AOI is positioned, the str. lucidum area is avoided and the str. pyramidale 
layer focused upon. 
The CA1a str. pyramidale (Figure 3.19, panels A and B) shows no differences 
between the two sides of the brain in control slices but there are significantly more 
boutons in ipsilateral TeNT versus contralateral TeNT (p=0.004; Mann Whitney Rank 
Sum). This would seem like an unusual result but overall when coupled with results 
showing no difference between the control and TeNT slices in ipsilateral or 
contralateral slices it suggests that the TeNT has had no effect on the CA1a str. 
pyramidale and the difference in TeNT slices is due to hippocampal side differences. 
The toxin has cleaved VAMP2 immunopositive boutons in the CA1c (Figure 3.19, 
panels C and D). There are significantly fewer boutons in the TeNT slices compared 
with controls in both the ipsilateral and contralateral hippocampi (p=0.008 and 
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p=0.005 respectively). There are no differences between the two sides in control 
slices or TeNT slices. 
The CA3 region (Figure 3.19, panels E and F) shows significantly higher bouton 
counts in the ipsilateral control slices compared with contralateral controls (p=0.004), 
a result that mirrors that seen in the VAMP1 immunostained slices. There are no 
differences between the sides in the TeNT slices. Significant differences between 
controls and TeNT slices are seen in both the ipsilateral and contralateral hippocampi 
(p=<0.001 in both cases) and show that both sides are robustly affected by the toxin. 
3.3.3.2 Comparison of str. pyramidale in the different hippocampal regions 
Within ipsilateral control slices, there are no differences between the three regions. In 
the ipsilateral TeNT str. pyramidale, there are significantly fewer boutons in CA3 
versus CA1a (p=<0.001). This would be expected as the previous section showed 
that CA1a was unaffected by the toxin, and yet CA3 boutons were cleaved. In the 
contralateral hippocampus, the CA3 has significantly fewer boutons again in 
comparison to the CA1a, but here in control as well as TeNT slices (p=0.014 and 
p=<0.001 respectively). The results from the control slices should be approached 
with caution as it is quite close to the significance criterion and therefore no strong 
conclusions should be drawn from this. It is plausible that CA3 str. pyramidale may 
show fewer boutons than CA1a in the contralateral side, but without further tests in 
other batches of animals, this cannot be fully concluded. The difference in the 
contralateral TeNT slices however shows a clear difference and this further 
emphasises the effects of the toxin in the contralateral CA3 as well as the ipsilateral.
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Figure 3.19. VAMP2 immunopositive boutons in str. pyramidale of CA1a, CA1c and CA3. Panels A, C and E show high 
magnification images from CA1a, CA1c and CA3 of VAMP2 immunostained hippocampal slices. Control and TeNT slices are 
represented, along with both the ipsilateral (black bars) and contralateral (grey bars) sides. Panels, B, D and F show the 
associated bouton counts for the different treatments, areas and side of the brain taken within an area of interest (AOI; 
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represents 20µm. The number of slices analysed is as follows, with ipsilateral then contralateral: CA1a Control 4, 9; CA1a 
TeNT 9, 17; CA1c Control 6, 14; CA1c TeNT 3, 7; CA3 Control 14, 26 and CA3 TeNT 7, 23. Abbreviations: SO, Str. Oriens; 
SP, Str. Pyramidale; SR, Str. Radiatum and SL, Str. Lucidum.
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3.3.3.3 Str. radiatum 
Bouton counts within the str. radiatum of the control CA1a (Figure 3.20, panels A and 
B) show that there are significantly fewer VAMP2 immunopositive boutons in 
ipsilateral CA1a versus contralateral (p=0.009). There are no differences between the 
sides in TeNT slices and no differences between control and TeNT treatments in 
either side of the brain. Overall this suggests the toxin has no effect in CA1a but that 
contralateral str. radiatum has an increased number of boutons in control slices 
compared with the opposite side. 
The CA1c (Figure 3.20, panels C and D) also shows a higher number of boutons in 
the contralateral side, but here in both control and TeNT slices (p=0.002 and 
p=<0.001 respectively). The ipsilateral TeNT slices show fewer boutons than 
ipsilateral controls (p=0.003), indicating that the toxin affects the ipsilateral CA1c but 
not the contralateral. 
There are no differences between CA3 (Figure 3.20, panels E and F) in the two sides 
of the brain for control or TeNT slices. There are however significantly fewer boutons 
in the TeNT slices compared with controls in both the ipsilateral and contralateral 
sides (p=0.001 in both cases). 
3.3.3.4 Comparison of str. radiatum in the different hippocampal regions 
Comparisons between the different areas indicate no differences in the ipsilateral 
side of control or TeNT slices. In the contralateral side, there are significantly fewer 
boutons in the CA3 compared with the CA1a and CA1c in both the control (p=<0.001 
and p=0.004 (Mann Whitney Rank Sum) respectively) and TeNT slices (p=0.002 in 
both cases).
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Figure 3.20. VAMP2 immunopositive boutons in str. radiatum of CA1a, CA1c and CA3. High magnification images of the str. 
radiatum of the CA1a, CA1c and CA3 are shown in panels A, C and E respectively. The associated bouton counts collected 
from areas of interest (AOI; 10x10µm) within control and TeNT slices, from the ipsilateral (black bars) and contralateral (grey 
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of slices analysed is as follows, with ipsilateral then contralateral: CA1a Control 4, 4; CA1a TeNT 8, 7; CA1c Control 9, 9; 
CA1c TeNT 7, 4; CA3 Control 6, 12 and CA3 TeNT 5, 11. 
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3.3.3.5 Summary of the effects of TeNT in hippocampal regions on VAMP2 
immunopositive bouton counts 
Overall, the VAMP2 immunopositive bouton counts show that the CA3 is affected by 
the toxin in both the ipsilateral and contralateral sides of strata pyramidale and 
radiatum. The CA1c is also affected by the toxin in both these layers of the ipsilateral 
hippocampus, along with contralateral str. pyramidale. As in the VAMP1 
immunostained slices, there are differences between the bouton counts in the two 
sides of the brain in control sections, dependent on the area. 
3.3.4 Summary of the VAMP1 and VAMP2 immunopositive bouton analysis in the 
strata pyramidale and radiatum in control and TeNT injected rats 
The bouton counts from both the VAMP1 and VAMP2 immunostained slices have 
highlighted that there are differences between the sides of the brain. In the str. 
pyramidale, the ipsilateral side shows the most boutons within CA3, significantly 
higher than the contralateral side, in both VAMP1 and VAMP2. With one exception 
(VAMP1 CA1c), the CA1a and CA1c regions do not show differences between the 
two halves of the brain in control str. pyramidale. The str. radiatum however shows 
the contralateral side to have significantly higher counts than the ipsilateral side, but 
this time within the CA1a and CA1c, and no differences in the CA3. These results 
have highlighted that there are differences, not only between the sides of the brain, 
but also between the different regions within that side. These data will be further 
reviewed in relation to asymmetry in Chapter 5 (Discussion). 
The CA3 strata pyramidale and radiatum analysis shows that the TeNT cleavage 
occurs in both the ipsilateral and contralateral sides in VAMP1 and VAMP2 positive 
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sections. The only other region that shows cleavage in the contralateral side is the 
CA1c str. radiatum in VAMP2 positive sections. 
3.4 Summary of the effects of in vivo TeNT injections within the first 16 days 
of the epileptic syndrome 
This chapter has highlighted that intrahippocampal injection of TeNT causes a 
disruption of VAMP1 and VAMP2 positive boutons, which are differentially localised 
in inhibitory and excitatory neuronal populations respectively. Imaging and grey level 
analysis of slices at 2, 8 and 16 days has demonstrated the spatiotemporal 
progression of VAMP1 and VAMP2 cleavage following toxin injections. The 
electrophysiology and high magnification imaging of boutons at the later time points 
(8-16 days) have indicated that the toxin disrupts both inhibition and excitation, to 
differing levels, within the CA1c, closest to the injection. Immunohistochemistry has 
also clearly shown that VAMP1 and VAMP2 immunopositive boutons are cleaved in 
both the ipsilateral and contralateral hippocampi.  





4 INVESTIGATION OF THE EFFECTS OF FOCAL TETANUS 
TOXIN INJECTIONS ONTO ORGANOTYPIC HIPPOCAMPAL SLICE 
CULTURES
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4.1 Rationale for the use of organotypic hippocampal slice cultures to 
investigate the effects of TeNT 
The use of in vivo TeNT injections has many benefits for studying the effects of the 
toxin. However, there would be advantages to having an in vitro method for the toxin 
injections. This method could allow the study of changes across multiple time points 
as well as possibly providing a medium throughput method for the testing of 
antiepileptic and anticonvulsive drugs. The aim of this part of the project was to set 
up an in vitro method of TeNT injections and to establish whether the 
electrophysiological and immunohistochemical changes that are seen in the in vivo 
model are also seen in organotypic hippocampal slice cultures. 
4.2 Investigation into the effects of TeNT on organotypic hippocampal slice 
cultures using extracellular field recordings 
To investigate the physiological changes that may occur following treatment with the 
different toxin concentrations, extracellular recordings were carried out in organotypic 
hippocampal slice cultures. Recordings of the field potentials in the CA1 and CA3, in 
the str. pyramidale and str. radiatum, were undertaken at 2, 8 and/or 16 days post 
injection. Electrophysiological recordings from ex vivo slices that have been taken 
from TeNT injected animals are regularly undertaken and thus provide a good 
comparison for this new method of focal treatment in vitro. 
4.2.1 Multiple recordings from individual slices 
Organotypic hippocampal slice cultures allow repeated recordings from the same 
slice over many days. To test whether these repeated recording sessions damaged 
the slices, statistical analysis compared slices used on multiple occasions with those 
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that were used only once. T-tests or Mann Whitney Rank Sum tests were used. 
Overall, at all time points and within all areas and all treatments, there were no 
significant differences between the slices used multiple times and those used only 
once, showing no detriment to the responses recorded. However the power is very 
low for these calculations because sometimes there are only 2 or 3 slices in each 
group. For now all the slices have been grouped together within the respective time 
points, regardless of whether they were used multiple times or not. If further 
experiments are carried out in the future then this is an issue that needs to be 
considered further, particularly when larger numbers of slices are used in each group 
to see if there is a difference. The following sections use this pooled data. 
For the comparisons between the different treatment groups at individual time points, 
the significance criterion will be lowered to 0.0083 using the Bonferroni correction for 
multiple comparisons. This is because there will be 6 tests performed at each time 
point and thus lowering the significance criterion makes the chance of getting one or 
more false positives over these multiple tests 0.05. For statistical tests looking at the 
differences between the time points within individual treatments there will be 3 tests 
each and so the Bonferroni correction for multiple comparisons will be used to lower 
the significance criterion to 0.0167. 
In the next sections, the results from the CA1 and CA3 str. pyramidale and str. 
radiatum shall be considered separately, firstly looking at response sizes, then 
moving onto the additional effects of the toxin on slices. 
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4.2.2 CA1 str. pyramidale 
The most noticeable differences between the treatments in recordings from the CA1 
str. pyramidale is the lack of responses or very small responses seen in the 50ng/µl 
TeNT treated slices (Figure 4.1). At all three time points, these slices show 
significantly smaller maximal responses (Vmax) than control slices, p=<0.001, 
p=<0.001 (both Mann Whitney Rank Sum) and p=0.002 (t-test) for 2, 8 and 16 days 
post injection respectively (Figure 4.2). There are also significantly smaller responses 
in the 25ng/µl TeNT slices compared with controls at 8 and 16 days post injection 
(p=<0.001 and p=0.002; t-test and Mann Whitney Rank Sum respectively). At day 8 
the 5ng/µl slices also show significantly larger responses than 50ng/µl TeNT treated 
slices (p=0.004; Mann Whitney Rank Sum). 
The V50 values for the 50ng/µl TeNT slices are significantly smaller than controls at 
days 2 and 8 (p=<0.001 in both cases; Mann Whitney Rank Sum) (Figure 4.2). At 2 
days post injection there are also larger V50 values in controls compared with the 
25ng/µl TeNT slices (p=0.003; Mann Whitney Rank Sum) and at day 8 the 5ng/µl 
TeNT slices show larger V50 values than 50ng/µl TeNT slices (p=0.004; Mann 
Whitney Rank Sum). In these cases, a lower V50 shows that the tissue is more 
sensitive to stimulation. Considering that the Vmax for the higher doses of toxin 
slices are significantly lower than in controls, then coupling this with the lower V50s 
shows that the responses from the TeNT slices are significantly affected by the 
application of toxin and that synaptic transmission in the CA1 str. pyramidale is lost 
or significantly decreased. 
When comparing the size of the responses within individual treatments but between 
the time points, there are no significant differences between the maximal sizes of the 
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responses or the V50 values in any of the treatment groups. This shows that if the 
TeNT is having an effect on the responses (as has been shown when comparing the 
controls with 25 and 50ng/µl TeNT treatments) then the effect remains across all 
three time points.
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Figure 4.1.Field recordings from CA1 str. pyramidale of organotypic hippocampal slice 
cultures. Field recordings from control and 5, 25 and 50ng/µl TeNT treated slices 
from the CA1 str. pyramidale. These are representations of traces recorded at 2, 8 
and 16 days post injection following a stimulus of 50V directed at the CA3 str. 
radiatum. Population spikes are affected by toxin treatment in a concentration 
dependent manner. 








































Figure 4.2. Analysis of CA1 str. pyramidale responses. These graphs show the maximal response sizes (Vmax) and the voltage 
required to evoke half the maximal response (V50) in the CA1 str. pyramidale of organotypic hippocampal slice cultures. The 
slices had been treated focally with control or 5, 25, or 50ng/µl TeNT solution and recordings made at 2, 8 and 16 days post 
injection. The data points indicate the mean ± SEM. The number of recordings for each of the treatments at the time points of 
2, 8 and 16 days post injection respectively are: Controls 7, 11 and 7 slices; 5ng/µl 7, 5 and 6 slices; 25ng/µl 5, 7 and 6 slices, 
and 50ng/µl 7, 6 and 4 slices. 
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4.2.3 CA1 str. radiatum 
Similar to the str. pyramidale of the CA1, there are reductions in the maximal sizes of 
the responses in the CA1 str. radiatum of slices treated with the highest two 
concentrations of TeNT (Figure 4.3). At days 2, 8 and 16, the controls show 
significantly larger maximal responses than the 50ng/µl TeNT slices (p=<0.001, 
p=<0.001 and p=0.002; all Mann Whitney Rank Sum) (Figure 4.4). At days 8 and 16 
the control responses are also greater than the 25ng/µl TeNT slices (p=0.008 and 
p=0.003; both Mann Whitney Rank Sum). There are no differences between the 
lowest TeNT concentration and the higher concentrations at any of the three time 
points. 
The differences between the treatment groups are less apparent when comparing the 
V50 values. There are only differences between the highest concentration of TeNT 
and the control slices at 8 days post injection (p=0.003; Mann Whitney Rank Sum) 
(Figure 4.4).  
As seen in the str. pyramidale, there are no differences between the response sizes 
or the V50 values at the different time points within each treatment group. This again 
shows that if an effect is present, then it remains throughout all the time points 
studied.
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Figure 4.3. Field recordings from CA1 str. radiatum of organotypic hippocampal slice 
cultures. These traces show evoked responses within the CA1 str. radiatum following 
a stimulus of 50V in the CA3 str. radiatum. Slices had been treated focally with 
control or 5, 25 or 50ng/µl TeNT solutions and recordings were made at 2, 8 and 16 
days post injection. Concentration dependent effects are seen in toxin treated slices 
from the three different groups compared with controls. 












































Figure 4.4. Analysis of CA1 str. radiatum responses. These graphs show the maximal size of responses (Vmax) evoked within 
the CA1 str. radiatum and the stimulus size required to evoke half this maximal response (V50). Organotypic hippocampal 
slice cultures had been treated with control solution or TeNT solution at concentrations of 5, 25 or 50ng/µl and recordings 
made at 2, 8 and 16 days post injection. Data points indicate mean ± SEM. The number of recordings for each of the 
treatments at the time points of 2, 8 and 16 days post injection respectively are: Controls 11, 11 and 10 slices; 5ng/µl 5, 6 and 
6 slices; 25ng/µl 4, 6 and 8 slices, and 50ng/µl 11, 8 and 7 slices. 
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4.2.4 CA3 str. pyramidale 
As explained in the Materials and Methods section, the analysis for the CA3 
recordings differed from that of CA1 to take account of their different components. 
Within the CA3 str. pyramidale the peak positive amplitude was used. At all three 
time points control slices showed significantly larger maximal amplitudes than 
50ng/µl TeNT treated slices (p=<0.001 Mann Whitney Rank Sum, at all time points) 
(Figures 4.5 and 4.6). At days 8 and 16 the control responses were also significantly 
larger than 25ng/µl TeNT slices (p=0.008 and p=<0.001 respectively, both Mann 
Whitney Rank Sum) and at day 2 they were also larger than the slices treated with 
the lowest dose of TeNT, 5ng/µl (p=<0.001, Mann Whitney Rank Sum). The voltage 
required to evoke half the maximal amplitude (V50) showed minimal differences 
between the treatment groups. There was only a significantly greater V50 in the 
25ng/µl TeNT treatment group compared to controls at 16 days post injection 
(p=0.003). A comparison of the three time points within each individual treatment 
condition showed that there were no differences between the maximal amplitudes of 
the responses (Vmax) or the V50.
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Figure 4.5. Field recordings from CA3 str. pyramidale of organotypic hippocampal 
slice cultures. Evoked responses following a stimulus of 50V in the CA3 str. radiatum 
at 2, 8 and 16 days post injection in slice cultures treated with control or TeNT 
solution (5. 25 or 50ng/µl). As with the CA1, the TeNT treated slices show 
concentration dependent effects. 








































Figure 4.6. Analysis of CA3 str. pyramidale responses. These graphs show the comparisons of the maximal amplitudes of 
responses (Vmax) within the CA3 str. pyramidale and the stimulus required to evoke half the maximal response amplitude 
(V50). These measurements differ to those within the CA1 due to the disruption of measurements by the antidromic 
component of the response that is clearly present as well as the orthodromic. Organotypic hippocampal slice cultures had 
been treated with either control or TeNT (5, 25, or 50ng/µl) solutions and recordings made at 2, 8 and 16 days post injection. 
Data is plotted as mean ± SEM. The number of recordings for each of the treatments at the time points of 2, 8 and 16 days 
post injection respectively are: Controls 13, 12 and 11 slices; 5ng/µl 8, 8 and 5 slices; 25ng/µl 6, 7 and 8 slices, and 50ng/µl 
10, 8 and 8 slices.
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4.2.5 CA3 str. radiatum 
As mentioned in the previous section, the analysis within the CA3 str. radiatum also 
had to differ from that of the CA1. The analysis of the peak negativity within the CA3 
str. radiatum shows differences similar to that in the str. pyramidale. All three time 
points show larger maximal amplitudes of responses in control slices than 50ng/µl 
TeNT slices (p=<0.001, p=<0.001 and p=0.003 respectively as time increases, Mann 
Whitney Rank Sum) (Figures 4.7 and 4.8). At 2 days post injection there are also 
greater responses in controls compared with both 5 and 25ng/µl slices (p=0.002 and 
p=<0.001 respectively). Day 8 control also shows a greater response than the 
25ng/µl slices (p=<0.001). These results are interesting as it suggests that at the 
earliest time point all concentrations of TeNT affect the synaptic transmission within 
this region but there is a dose dependent effect on the time at which the responses 
remain affected. This demonstrates that only the higher concentration effects last into 
the later time points, or that there is some recovery of synaptic transmission in the 
lower concentration treated slices. 
The V50 analysis showed differences between control and 50ng/µl TeNT slices at 
days 8 and 16 (p=<0.001 and p=0.003 respectively, Mann Whitney Rank Sum) and 
between the 5 and 50ng/µl slices at day 16 (p=0.010, Mann Whitney Rank Sum). 
However these results show that the 50ng/µl V50 had the lowest V50 because it was 
zero at these time points. This shows that minimal or no synaptic transmission is 
detected at days 8 and 16 following treatment with the highest dose of the toxin in the 
majority of slices. 
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There are no differences within the individual treatments when comparing the 
different time points, in the analysis of Vmax or V50 which suggests that when 
changes occur, they continue or are similar to the other time points.
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Figure 4.7. Field recordings from CA3 str. radiatum of organotypic hippocampal slice 
cultures. These traces show the responses from slice cultures treated with control or 
5, 25, or 50ng/µl TeNT solutions. Recordings were made at 2, 8 and 16 days post 
injection. Traces shown indicate responses following a 50V stimulus to the CA3 str. 
radiatum. Dramatic decreases in responses are seen in slices that received the 
higher concentrations of TeNT. 







































Figure 4.8. Analysis of CA3 str. radiatum responses. The graphs show the maximal amplitude of responses from baseline to 
peak negativity (Vmax) and the stimulus required to evoke half this maximal amplitude response (V50) for organotypic 
hippocampal slice cultures at 2, 8 and 16 days post injection. These measurements are different to those from the CA1 due to 
the overlap of the antidromic and orthodromic components. Slices had been treated with control or TeNT (5, 25 or 50ng/µl) 
solutions. Data plotted indicates mean ± SEM. The number of recordings for each of the treatments at the time points of 2, 8 
and 16 days post injection respectively are: Controls 10, 10 and 9 slices; 5ng/µl 6, 8 and 8 slices; 25ng/µl 6, 7 and 7 slices, 
and 50ng/µl 8, 8 and 8 slices. 
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4.2.6 TeNT treatment results in epileptic activity in organotypic hippocampal slice 
cultures 
We have already shown that the synaptic transmission is affected by the toxin, 
particularly the highest dose, but that the effects vary within the region studied and 
the different time points. As well as these changes in evoked synaptic transmission, 
epileptic activity was also seen in these slice cultures. This occurred in many slices 
and examples of it could be seen in all regions of the hippocampus recorded from 
and in a variety of slices from the different treatment groups. However it presented 
itself in different forms even within slices from the same treatment groups. These 
consisted of evoked afterdischarges and/or spontaneous activity. Both these forms 
however showed two distinct types within them. 
4.2.6.1 Evoked afterdischarges 
The evoked afterdischarges could last less than 1 second or continue for up to 8 
seconds before returning to baseline. The characteristics of these two types of 
responses differed; one consisted of multiple spikes and the other represented 
seizure-like after-bursts. Examples of these responses can be seen in Figure 4.9 
panels A and B. 
The afterdischarges were dependent on a threshold stimulus. This threshold varied 
between slices and between the areas of the hippocampus but was always between 
20 and 45V for both the interictal-type and the seizure-like discharges. Table 4.1 
shows the percentages of slices that displayed afterdischarges. Whilst this table 
shows that control slices did show epileptic activity, it only occurred in a minority of 
recordings (5 from a total of 122 recordings across all three time points, counting 
each region of the hippocampus as a separate recording). It is also clear that the 
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majority of the epileptic activity was in slices treated with 25ng/µl TeNT (16 of 71 
recordings), although many afterdischarges were also seen in 5ng/µl TeNT slices (14 
of 78 recordings). The 50ng/µl slices showed minimal afterdischarges (3 of 93 
recordings) which can be attributed to the nearly complete disruption of evoked 
synaptic transmission suggested by the field recording analysis, particularly at the 
later time points. Whilst the time points and the four areas recorded from have been 
combined within Table 4.1, it overall suggests that the application of the toxin has 
effects on the slices, although to varying degrees, dependent on concentration. 
Table 4.2 indicates the spread of the effects of the toxin. Whilst there are some slices 
that only show afterdischarges (interictal-type and seizure-like pooled) within a single 
hippocampal region, it is clear that the 5 and 25ng/µl TeNT treatments cause 
epileptic activity in a widespread area, affecting both the CA1 and CA3 in the majority 
of slices affected. Interestingly, in all treatment conditions, the str. radiatum of the 
CA1 and CA3 is not affected alone. 
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Figure 4.9. Different forms of epileptic activity within slice cultures. These traces show 
the variations in epileptic activity seen in slice cultures. Seizure-like evoked afterdischarges 
(A) and multiple spike evoked afterdischarges (B) from 16 days post TeNT injection slices 
after a stimulus of 35V. A spontaneous discharge is shown in C from a 2 day post TeNT 
injected slice. 
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Afterdischarges Control (%) 5ng/µl TeNT (%) 25ng/µl TeNT (%) 50ng/µl TeNT (%) 
CA1 SP 8.00 22.22 50.00 11.76 
CA1 SR 3.13 17.65 16.67 0.00 
CA3 SP 5.56 23.81 23.81 3.85 
CA3 SR 0.00 9.10 10.00 0.00 
Mean 4.17 18.20 25.12 3.90 
Table 4.1. Evoked afterdischarges in organotypic hippocampal slice cultures. Table to show the percentage of recordings which 
showed afterdischarges in the different treatment groups and in the different areas across the hippocampus. This data consists of days 2, 
8 and 16 grouped together. If afterdischarges were seen then they always occurred in a number of frames and were dependent on 
reaching a threshold stimulus. This table includes both types of evoked afterdischarges. 
 




















Control 0 0 0 1 0 0 2 
5ng/µl TeNT 1 0 0 0 0 1 4 
25ng/µl TeNT 1 0 1 1 0 0 4 
50ng/µl TeNT 1 0 0 0 0 0 1 
Table 4.2. Localisation of evoked afterdischarges within organotypic hippocampal slice cultures. This table indicates the number 
of slices where evoked afterdischarges were observed in recordings from the different regions. Each slice is only included in one of the 
columns thus giving a representation of whether individual areas or multiple areas most commonly showed epileptic activity.
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4.2.6.2 Spontaneous activity 
The spontaneous activity also showed two forms. One consisted of very short lived 
bursts which lasted usually less than 1 second, and most commonly less than 0.3 
seconds (Figure 4.9 panel C). These were similar to interictal spontaneous activity 
recorded in ex vivo slices taken from adult rats that had received intrahippocampal 
TeNT injections at infancy (Lee et al., 1995; Smith et al., 1998). These could occur 
up to 5 times within 30 seconds (frame length), but more commonly 1-2 times. The 
other type showed more prolonged activity that was seen in clusters that ranged in 
duration from 2-14 seconds (Figure 4.10 panel A). These clusters were seen at a 
particularly high frequency in three of twenty six recordings that had been made in 
the CA3 str. pyramidale from slices treated with 50ng/µl TeNT. Here, robust 
spontaneous seizure-like activity was seen only at 2 days post injection (ten 
recordings within the CA3 str. pyramidale) (Figure 4.10). TTX was added to these 
TeNT slices to confirm that what was seen was biological activity and indeed it was. 
The responses were abolished during the TTX application and when washed out they 
returned, albeit with fewer clusters per frame (Figure 4.11). In the slice that shows the 
most robust seizure-like activity, the clusters occurred every 1-2 seconds. In the other 
two slices the clusters were observed 0-10 times within a 30 second frame. The 
amplitude of the individual deflections within the clusters most commonly ranged 
from 0.2-0.3mV. Recordings were also made from these 3 slices at 8 and 16 days 
post injection but the robust spontaneous seizure-like activity was not seen again, 
nor any evoked afterdischarges. 
Whilst this epileptic activity was seen in three slices treated with the 50ng/µl TeNT, 
only two other slices treated with this highest concentration showed any epileptic 
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activity. When it did occur in these two slices is was the spontaneous activity of the 
much shorter duration (less than 0.3 seconds) and none showed evoked 
afterdischarges. 
There is a greater occurrence of spontaneous activity within 25ng/µl TeNT slices and 
it varied between the clusters and short bursts (22 of 71 recordings). The repetitive 
and consistent type clusters that were seen in the three slices from 50ng/µl TeNT 
slices were not present in slices from any other treatment group. As with the 
afterdischarges, there was some activity in control treated slices but only in 4 of 122 
recordings across all the time points studied. The activity in two of these recordings 
consisted of the short burst, with durations and amplitudes that were similar to those 
in TeNT slices, although region and time matched equivalents from TeNT were not 
available at all concentrations for direct comparison. Within the other recordings, 
there were periods of spontaneous activity that ranged from 4-10 seconds and these 
consisted of larger overall amplitudes than see in TeNT slices. Only 8 of these long 
spontaneous bursts were seen within the 15 frames used for analysis. The 5ng/µl 
TeNT slices only showed spontaneous activity in 10 of 78 recordings, which suggests 
that the afterdischarges predominate slightly at this lower concentration. 
The spontaneous activity occurred in recordings regardless of the stimulus given, 
contrasting to that of afterdischarges. Table 4.3 shows the percentages of slices that 
displayed spontaneous activity. As with the afterdischarges, the 25ng/µl slices show 
the most spontaneous activity. Table 4.4 shows the localisations of the spontaneous 
activity. The most widespread activity is seen in the 25ng/µl TeNT treated slices, 
where the majority of slices show spontaneous activity in both the CA1 and CA3. The 
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spontaneous activity within slices treated with 50ng/µl TeNT is focussed mainly within 
the CA3 str. pyramidale. 
Overall, grouping all the treatments together showed that spontaneous activity was 
most commonly seen at 2 days point injection but evoked afterdischarges at 16 days 
post injection (data not shown). However, with such low incidences of this activity, 
statistical analysis has not been carried out.
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Figure 4.10. Seizure-like activity in organotypic hippocampal slice cultures. The top 
panel shows spontaneous seizure-like activity within the CA3 str. pyramidale of a 
slice culture injected with 50ng/µl and recording made at 2 days post injection. This 
was taken during 10 seconds following a stimulus of 50V to the CA3 str. radiatum. 
Panel B shows the corresponding portion from panel A expanded, and similarly for 
panel C. 
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Figure 4.11. Seizure-like activity abolished by TTX. These panels show the 
spontaneous seizure-like activity (A), followed by the addition of TTX to the ACSF (B) 
which abolished seizure-like activity. After washout (C) the seizure-like activity 
returned. These traces are from the same slice as shown in Figure 4.10 (50ng/µl at 2 
days post injection) but with a stimulation of 40V given every 30 seconds throughout 
the addition of TTX and washout. 
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Spontaneous Control (%) 5ng/µl TeNT (%) 25ng/µl TeNT (%) 50ng/µl TeNT (%) 
CA1 SP 0.00 5.56 41.67 11.76 
CA1 SR 3.13 17.65 33.33 0.00 
CA3 SP 2.78 9.52 28.57 11.54 
CA3 SR 6.901 18.18 25.00 4.17 
Mean 3.20 12.73 32.14 6.87 
Table 4.3. Spontaneous activity in organotypic hippocampal slice cultures. Table shows the percentage of recordings which showed 
spontaneous activity in the different treatment groups and in the different areas across the hippocampus. This data consists of days 2, 8 
and 16 grouped together. When spontaneous activity occurred, it appeared in many frames (each 30secs long) and was not dependent 
on the stimulus strength. This table includes spontaneous activity whether short bursts or clustered. 
 















Both CA3 strata 
pyramidale and 
radiatum 
Both CA1 and 
CA3 
Control 0 0 0 0 2 0 1 
5ng/µl TeNT 0 1 0 1 2 0 2 
25ng/µl TeNT 0 2 0 1 1 1 5 
50ng/µl TeNT 2 0 0 4 1 0 0 
Table 4.4. Localisation of spontaneous activity within organotypic hippocampal slice cultures. This table indicates the number of 
slices where spontaneous activity was observed in recordings from the different regions. Each slice is only included in one column which 
indicates whether individual areas or multiple areas are most commonly exhibiting epileptic activity.
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4.2.7 Summary of the effects of different concentrations of TeNT on field recordings 
up to 16 days 
The results from the field recordings show that treatment with the highest two 
concentrations of TeNT, 25 and 50ng/µl, cause decreases in the maximal sizes of 
responses in both the CA1 and CA3 strata pyramidale and radiatum in comparison to 
control treated slices. These effects are seen at all three time points for the 50ng/µl 
TeNT treated slices. The effects of the 25ng/µl TeNT are seen at the first two time 
points in the CA3 str. radiatum but not until the later two time points in all other 
regions. The effects of the lowest dose of toxin are only seen in the CA3 and at the 
earliest time point. This suggests that the higher concentration of the toxin has an 
earlier, longer lasting and more widespread effect. This has also been shown after in 
vivo intrahippocampal TeNT injections (Mellanby et al., 1977).  
It is interesting to see that epileptic activity is seen in a variety of forms in the different 
slices and is most prominent at the middle TeNT concentration. The robust seizure-
like activity however was only seen in the highest dose of toxin and at the earliest 
time point. 
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4.3 Investigation into the effects of TeNT on the distribution of VAMP1 and 
VAMP2 immunopositivity within organotypic hippocampal slice cultures. 
Having collected electrophysiological recordings from the hippocampal slice cultures 
treated with control or different concentrations of TeNT, we can now look at the 
effects that the toxin had on the VAMP1 and VAMP2. Considering that there are 
significant changes in synaptic transmission and observations of epileptic activity 
within the different areas following TeNT treatment that are concentration dependent, 
it questions whether effects on VAMP1 and VAMP2 may also be dependent on the 
concentration used. The results of the immunohistochemistry in Chapter 3 showed 
that VAMP1 and VAMP2 were both cleaved in ex vivo slices in a temporal and spatial 
manner. At 2 days post injection there were very focal effects that spread to include a 
wider area by day 8 and continued to be present at day 16, although with a different 
profile for the two different isoforms. In this section we consider the presence and 
extent of VAMP1 and VAMP2 cleavage in the organotypic hippocampal slice cultures 
following focal treatment with the toxin and control solutions. This will allow 
comparisons of the two models in relation to the immunohistochemistry. It will also 
allow any correlations with the electrophysiological responses to be made. 
The first part of the following section gives an overview of the immunostaining of 
VAMP1 at a low magnification. The later sections will look at higher magnification 
within the slices to give a more detailed representation of the effects of the toxin 
across the slice cultures and allow for quantitative analysis. These will then be 
repeated to consider the VAMP2 immunopositive slices. 
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4.3.1 Distribution of VAMP1 immunopositivity within control slices at low 
magnification 
The staining distribution across the hippocampal slice cultures in control treated 
slices shows a layer specific distribution, but less clear differentiation between layers 
than in the ex vivo slices (Figure 4.12, top row). The darkest area, showing a mostly 
immunonegative layer, is the granule cell layer of the dentate gyrus. Adjacent to this 
is the molecular layer which is also quite dark. The str. pyramidale is a darker region 
which runs through the strata radiatum and oriens, the brightest regions of the slice 
which show a large immunopositive population. The str. pyramidale is not always 
very clear throughout its length at low magnification. 
4.3.2 Distribution of VAMP1 immunopositivity within TeNT treated slices at low 
magnification 
The other images shown in Figure 4.12 are representations of the staining at each 
TeNT concentration. In some cases there are variations between the effects seen in 
slices from within the same group. This was also the case when using ex vivo slices. 
The 5ng/µl slices (Figure 4.12 row two) show overall immunostaining that is similar to 
that of the control slices. The granule cell layer remains the darkest area and 
generally the strata radiatum and oriens of the CA1 and CA3 are of similar 
intensities. The 25ng/µl TeNT slices (Figure 4.12 row three) however show some 
differences to the control slices, particularly at 2 days post injection. Here, much of 
the CA1 has darkened to a level that is of similar intensity to the molecular layers of 
the dentate gyrus, indicating a cleavage of the VAMP1 within the CA1. The brightest 
area is part of the CA3. At all three time points the differentiation between the granule 
cell layer of the dentate gyrus and the surrounding areas is less clear than in control 
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sections, suggesting that there may have been an overall decrease of the VAMP1 
immunopositivity following treatment with this concentration of toxin. 
The 50ng/µl TeNT treated slices (Figure 4.12 row four) show a darkening of much of 
the CA3 layer to intensities similar to the dentate gyrus at 2 days post injection in 3 of 
the 5 slices. The other two slices show immunostaining that at this magnification 
does not appear affected. At 8 days post injection all 5 slices show a darkening 
around the CA3 area. By day 16 the effects are smaller and localised just around the 
edge of the dentate gyrus into the CA3 but are still present.
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Figure 4.12. VAMP1 immunopositive organotypic hippocampal slice cultures. These 
VAMP1 immunopositive organotypic hippocampal slice cultures are from control and 
5, 25 and 50ng/µl TeNT slices at 2, 8 and 16 days post injection. Staining within 
control slices is consistent across the three time points but variations occur within 
toxin treated slices. The injection site is represented by an asterisk and applies to all 
images. Scale bar represents 400µm. 
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4.3.3 High magnification investigation of VAMP1 immunopositive boutons and the 
effects of different TeNT concentrations 
Having looked at the low magnification images of the VAMP1 immunopositive slices, 
we shall now look at high magnification images to consider the boutons present and 
whether the effects of the toxin can be seen at this level in the different areas and at 
the different time points. This will give a better representation of the effects of the 
toxin at different doses. As with the slices from those animals injected in vivo 
(Chapter 3), these data together with the electrophysiology allows consideration of 
the functional effects of the toxin when injected in hippocampal slice cultures. 
The analysis method for the bouton counts within slice cultures had to be adapted 
from that used in the ex vivo slices. The reasons for this have already been 
discussed in the Materials and Methods (Chapter 2). The analysis in this section 
uses the thresholding tool within ImagePro to specify only those bright objects that 
are considered to be boutons (see Materials and Methods, Chapter 2). There is a 
clear distinction between the appearance of boutons and background noise based on 
the clusters of pixels that are present. The area that is occupied by the VAMP1 or 2 
immunopositive boutons is calculated within the relevant area of interest (AOI): 
15x60µm within the str. pyramidale or six AOIs (10x10µm) placed randomly 
throughout the image in the str. radiatum. A value showing a larger area within the 
following sections shows a greater immunopositivity than images that show a very 
small area occupied by VAMP immunopositive boutons. 
In this section, all comparisons are made with a t-test unless stated and the 
significance criterion has been corrected for multiple comparisons using the 
Bonferroni correction. For comparisons made of the time points within individual 
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treatment groups the significance criterion has been lowered to 0.0167 (as 3 tests will 
be carried out). The criterion for comparing the treatments within a time point have 
been lowered to 0.0083 as 6 tests will be carried out. 
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4.3.3.1 CA1 str. pyramidale 
Figure 4.13 shows representations of the VAMP1 immunopositive boutons within the 
CA1 str. pyramidale and the corresponding bouton area for all slices. There were no 
significant differences between the values at the three time points within control or 
TeNT treated slices (graph in Figure 4.13). A comparison of the treatments within the 
individual time points highlights a significant decrease in the area covered by VAMP1 
immunopositive boutons in the 50ng/µl TeNT slices in comparison to controls and 
5ng/µl slices (p=0.005 and p=0.003 respectively) at 2 days post injection. At day 8, 
the area is significantly lower in 25ng/µl versus 5ng/µl slices (p=0.003) but there are 
no differences at the day 16 time point. 
4.3.3.2 CA1 str. radiatum 
Figure 4.14 shows images from the CA1 str. radiatum of VAMP1 immunopositive 
slices from all treatments. Comparisons of the different time points within the 
individual treatments show that there are only differences between the day 2 and 16 
time points within slices treated with 5ng/µl TeNT (p=0.015). Other than this, there 
are consistent areas covered by the boutons at the three time points within individual 
treatments. 
When comparing the different treatments, there are clear differences at all three time 
points. At day 2, both control and 5ng/µl slices show larger area values than the 
50ng/µl slices (p=<0.001 in both cases). The 5ng/µl also has a significantly larger 
area than the 25ng/µl slices (p=0.002). The control slices at day 8 continue to show a 
larger area than 50ng/µl slices (p=0.005) as well as those treated with 25ng/µl TeNT 
(p=0.002). At day 16, the 5ng/µl slices show a smaller area than the controls 
(p=0.008) suggesting a later occurring effect in this lowest toxin dose.







































Figure 4.13. VAMP1 immunopositive boutons in CA1 str. pyramidale. Examples of 
high magnification images at 2, 8 and 16 days post injection from the different 
treatment groups. The graph shows the area occupied by VAMP1 immunopositive 
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treatments. Data plotted as mean ± SEM and the number of slices in each condition 
was 4 or 5. ** indicates p=<0.01. Scale bar represents 20µm.







































Figure 4.14. VAMP1 immunopositive boutons in CA1 str. radiatum. High magnification 
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immunopositive boutons within six AOIs (10x10µm) positioned randomly across the 
image. Data includes each of the time points and the individual treatment groups. 
Data plotted as mean ± SEM and the number of slices for each group was 4 or 5 with 
the exception of control day 2 which was 3. ** shows p=<0.01 and *** indicates 
p=<0.001. Scale bar represents 20µm. 
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4.3.3.3 CA3 str. pyramidale 
High magnification images of the CA3 str. pyramidale VAMP1 positive boutons are 
shown in Figure 4.15. As was the general trend in the CA1, there are no differences 
between the three time points within each treatment group in the CA3 str. 
pyramidale. Although there are large differences between the controls and the higher 
two concentrations of TeNT slices at 2 and 8 days post injection, the differences are 
not significant. This is likely due to a large variation and a low sample number in the 
control group (n=3) for the day 2 data. At day 8 however, the 5ng/µl slices show a 
larger VAMP1 immunopositive area compared to both the 25 and 50ng/µl TeNT 
slices (p=0.001 and p=0.002 respectively). There are no differences at day 16. 
4.3.3.4 CA3 str. radiatum 
The bouton counts at the different time points with the CA3 str. radiatum show that 
within the controls and the three different TeNT concentrations there are no 
differences. Whilst there are no differences between the treatment groups at 2 and 
16 days post injection, the controls show a significantly larger area than the 25 and 
50ng/µl TeNT slices at day 8 (p=0.008 in both cases, Mann Whitney Rank Sum) 
(Figure 4.16). The lack of significant differences between the control and different 
TeNT concentrations at day 2 is likely due to the low sample number of the controls 
(n=3) as in the CA3 str. pyramidale.






































Figure 4.15. VAMP1 immunopositive boutons in CA3 str. pyramidale. High 
magnification images to show the boutons in each of the treatment conditions and at 
*** 
** 
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2, 8 and 16 days post injection. The area of VAMP1 immunopositive boutons within a 
15x60µm AOI are shown within the graph. Data plotted as mean ± SEM. The number 
of slices was 4 or 5 in each group, with the exception of control day 2 which was 3. ** 
shows p=<0.01 and *** indicates p=<0.001. Scale bar represents 20µm.






































Figure 4.16. VAMP1 immunopositive boutons in CA3 str. radiatum. High magnification 
images showing boutons at the different time points and within the different treatment 
** 
** 
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conditions. The associated graph shows the area occupied by VAMP1 
immunopositive boutons in six AOIs (10x10µm) positioned randomly across the 
image. Data plotted as mean ± SEM. The number of slices was 4 or 5 in each 
condition, with the exception of control day 2 which was 3. ** shows p=<0.01. Scale 
bar represents 20µm. 
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4.3.3.5 Summary of the effects of TeNT on the different areas of the slice culture in 
VAMP1 immunopositive slices 
Across all the areas of the hippocampus, the main effects of the toxin are focussed at 
8 days post injection. Interestingly, effects at day 2 were only seen in the CA1 (both 
strata pyramidale and radiatum). The 50ng/µl TeNT concentration shows the most 
effects, indicated by the smallest areas covered by VAMP1 immunopositive boutons, 
with the 25ng/µl closely behind. Very few differences are seen between controls and 
5ng/µl TeNT, and when this does occur (CA1 str. radiatum), it only occurs at the 
latest time point studied suggesting that the lower dose of toxin requires a longer 
incubation to cause a significant difference from controls. 
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4.3.4 Distribution of VAMP2 immunopositivity within control slices at low 
magnification 
The slice cultures showing VAMP2 immunopositivity shall now be investigated. It was 
shown in Chapter 3 that robust changes in VAMP2 immunopositivity occurred across 
the hippocampus of TeNT treated animals, with most changes seen at 8 and 16 days 
post injection. 
The lowest immunosignal within the control hippocampal slice cultures stained with 
the antibody against VAMP2 is from the granule cell layer of the dentate gyrus and 
the str. pyramidale of the CA3 and CA1 (Figure 4.17, top row). Whilst the granule cell 
layer is clearly visible, the str. pyramidale can be less clear in some slices at low 
magnification. This layer of the CA1 often spreads into a wider layer than the granule 
cell layer. The str. radiatum and str. oriens are bright areas, as are the molecular 
layers of the dentate gyrus. 
4.3.5 Distribution of VAMP2 immunopositivity within TeNT treated slices at low 
magnification.  
Looking at the 5ng/µl TeNT treated slices, it can be seen that the hilus and the str. 
lucidum become very bright, particularly at 2 and 8 days post injection (Figure 4.17 
row two). This was also seen in ex vivo slices from TeNT injected animals. These 
layers in the control slices are not seen as such a contrast to the surrounding layers. 
The day 2 slices of the 25ng/µl TeNT group (Figure 4.17 row three) show some 
variations. Three slices show staining that is comparable to control slices but the 
other 3 show a darkening within the CA3 area. The day 8 and 16 groups again show 
the brightening of the mossy layer and hilus, although this may stretch into the CA3 
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str. pyramidale as well. There is some darkening of the surrounding layers which was 
not seen in all the 5ng/µl slices even when a brightening of the str. lucidum was seen. 
The 50ng/µl TeNT treatment group (Figure 4.17 row four) shows that at 2 days post 
injection the bright mossy layer is not apparent but that overall the contrast between 
the different layers is not very clear at all, suggesting an overall decrease in VAMP2 
immunosignal. The day 8 and 16 slices again show the brightening of the mossy 
layer and also a decrease in the immunopositivity of the surrounding layers.
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Figure 4.17. Organotypic hippocampal slice cultures immunostained with antibody 
against VAMP2. Low magnification fluorescent images of VAMP2 immunostained 
organotypic hippocampal slice cultures treated with injection to the CA3 SR (asterisk) 
of control solution or 5, 25 or 50ng/µl of TeNT solution. Control slices show 
consistent staining across the three time points but variations are seen within the 
different TeNT concentrations. Scale bar represents 400µm. 
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4.3.6 High magnification investigation of VAMP2 immunopositive boutons and the 
effects of different TeNT concentrations 
As with the VAMP1 immunopositive slices, the area occupied by the VAMP2 
immunopositive boutons shall be used as a measure of the effects of the toxin within 
slices injected with different concentrations of TeNT and compared with those of 
control slices. 
4.3.6.1 CA1 str. pyramidale 
The CA1 str. pyramidale shows only minimal changes in these VAMP2 
immunopositive slices (Figure 4.18). There is a significantly lower VAMP2 
immunopositive area in day 8 compared to day 2 in 25ng/µl slices (p=0.010). All other 
treatment groups show no differences between the time points. At 2 days post 
injection, the 25ng/µl slices have a larger VAMP2 immunopositive area than slices 
treated with 5ng/µl TeNT (p=0.003). Other than this, there are no significant 
differences between the other treatment groups at any of the time points. 
4.3.6.2 CA1 str. radiatum 
Within the CA1 str. radiatum of VAMP2 immunostained hippocampal slice cultures 
(Figure 4.19) there are also no differences between the bouton counts of the different 
treatments at any of the time points studied. There are also no differences between 
the different time points when compared within the individual treatment groups. At 2 
and 8 days post injection, this is likely due to the large variation seen within a number 
of the treatment groups (shown by the large error bars in Figure 4.19).







































Figure 4.18. VAMP2 immunopositive boutons in CA1 str. pyramidale. High 
magnification images within the different treatments and time points. The associated 
** 
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graph shows the area occupied by VAMP2 immunopositive boutons within a 
15x60µm area of interest (AOI) placed within the str. pyramidale. Data plotted as 
mean ± SEM. The number of slices in each group is as follows, with days 2, 8 and 16 
listed respectively: Control 6, 4 and 8; 5ng/µl 3, 3, and 4; 25ng/µl 5, 4 and 7; and 
50ng/µl 7, 4 and 6. ** shows p=<0.01. Scale bar represents 20µm. 








































Figure 4.19. VAMP2 immunopositive boutons in CA1 str. radiatum. Images of boutons 
at high magnification from slices exposed to different treatments and at the three time 
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points studied. The graph below shows the area covered by VAMP2 immunopositive 
boutons within six AOIs (10x10µm) randomly positioned within the image. Data 
plotted as mean ± SEM. The number of slices in each group is as follows, with days 
2, 8 and 16 listed respectively: Control 6, 5 and 8; 5ng/µl 4, 3 and 4; 25ng/µl 5, 5, and 
7; and 50ng/µl 7, 4 and 6. ** shows p=<0.01 and *** indicates p=<0.001. Scale bar 
represents 20µm. 
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4.3.6.3 CA3 str. pyramidale 
The CA3 str. pyramidale shows no differences between the time points within 
individual treatments. However there are large differences between the area 
occupied by boutons in control slices and those of the different treatments (Figure 
4.20). At day 2, the area covered by VAMP2 immunopositive boutons in control slices 
is significantly larger than all of the 5, 25 and 50ng/µl TeNT slices (p=<0.001, 
p=0.001 and p=<0.001 respectively). By day 8 however the only difference occurs 
between control and 5ng/µl slices (p=0.004) and by day 16 there are no differences 
between the treatments, suggesting some recovery from the effects of the toxin. 
4.3.6.4 CA3 str. radiatum 
Comparisons of the time points within the individual treatment groups show that there 
are no differences in the area covered by boutons across the length of the study in 
CA3 str. radiatum of VAMP2 immunostained slices (Figure 4.21). At 2 days post 
injection, both the control and 25ng/µl slices show larger VAMP2 immunopositive 
areas than the 50ng/µl slices (p=0.001 and 0.003 respectively, Mann Whitney Rank 
Sum in both cases). No differences are seen at day 8 but at day 16 the difference 
between control and 50ng/µl slices occurs again, albeit to a lesser extent (p=0.008).





































Figure 4.20. VAMP2 immunopositive boutons inCA3 str. pyramidale. High 
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associated graph shows the differences between the area occupied by theVAMP2 
immunopositive boutons within a 15x60µm AOI from slices of different treatment 
groups. Data plotted as mean ± SEM. The number of slices in each group is as 
follows, with days 2, 8 and 16 listed respectively: Control 6, 3 and 8; 5ng/µl 4, 4, and 
4; 25ng/µl 5, 5, and 7; and 50ng/µl 6, 4 and 6. ** shows p=<0.01 and *** indicates 
p=<0.001. Scale bar represents 20µm. 







































Figure 4.21. VAMP2 immunopositive boutons in CA3 str. radiatum. VAMP2 




- 189 - 
 
different treatment groups. The graph below shows the area occupied by VAMP2 
immunopositive boutons within six AOIs (10x10µm) placed across the image and the 
differences between the treatment conditions. Data plotted as mean ± SEM. The 
number of slices in each group is as follows, with days 2, 8 and 16 listed respectively: 
Control 6, 5 and 8; 5ng/µl 3, 3, and 4; 25ng/µl 5, 5, and 7; and 50ng/µl 7, 4 and 6. ** 
shows p=<0.01 and *** indicates p=<0.001. Scale bar represents 20µm. 
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4.3.6.5 Summary of the effects of TeNT on the different areas of the slice culture in 
VAMP2 immunopositive slices 
In VAMP2 immunopositive slices, the changes in CA1 are minimal, which differs 
when comparing to the VAMP1 immunopositive slices. Interestingly, again in contrast 
to the VAMP1 sections, the main effects of the toxin on VAMP2 are focussed at day 
2 in the CA3. The 50ng/µl TeNT concentration shows effects that last into the latest 
time point in the CA3 str. radiatum, an effect not seen in slices treated with the lower 
two concentrations or in other regions of the hippocampus. 
4.4 Summary of the effects of TeNT on organotypic hippocampal slice 
cultures 
Overall, the experiments and results in this chapter have shown that the toxin has 
robust effects on synaptic transmission and results in epileptic activity in a number of 
slices, also indicating a concentration dependent effect. The toxin can also be 
associated with the cleavage of VAMP1 and VAMP2 within these slice cultures. The 
use of three concentrations of toxin has highlighted differences in the temporal 
effects as well as the toxins specificity for VAMP1 and VAMP2.  
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The effects of TeNT injection, both in vivo and in vitro, during the first 16 days of the 
epilepsy model have been shown within the last two chapters. In this chapter, the 
results shall be considered in relation to the current literature and the impact of the 
findings will be discussed. 
There is a large literature available that focuses on TeNT. This includes comparisons 
of its effects in the periphery and central nervous system (CNS), the mechanisms of 
entry into a variety of cells, its actions once within the cell, and the resulting effects 
that this can have on a system. Constant improvements to experimental methods are 
allowing more of an understanding of all of these issues, but there still remain a 
number of discrepancies and un-answered questions that revolve around this toxin 
and its effects. This is particularly relevant to the understanding of the epileptic 
syndrome induced by injections of minute amounts of toxin into regions of the brain. 
The data presented in this thesis goes some way to increasing the understanding of 
the early stage mechanisms in this chronic epileptic syndrome, however it also raises 
a number of further questions. 
5.1 Temporal and spatial cleavage of VAMP1 and VAMP2 by in vivo TeNT 
injection 
A prominent finding of this study is the evidence of TeNT cleaving both VAMP1 and 
VAMP2. The extent of the cleavage however differs between the two isoforms and is 
dependent on the time point studied, the region and position within the hippocampus 
and the side of the brain relative to injection. 
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5.1.1 Time course of TeNT effects 
5.1.1.1 Ipsilateral hippocampus 
A difference in the temporal cleavage of VAMP1 and VAMP2 compared with controls 
was observed in the ipsilateral hippocampus. This highlighted the minimal cleavage 
of VAMP2 at 2 days post injection, in contrast with robust changes occurring in the 
VAMP1 immunostained slices centred around the injection site, as shown by grey 
level analysis. Significant differences between control and TeNT slices in the 
ipsilateral hippocampus at 2 days post injection are only seen within the CA3 of 
VAMP1 immunostained slices. This indicates that whilst changes are seen in other 
areas, they either do not affect a large enough area or the focal and intense cleavage 
in a small area is not enough to cause a drastic decrease in the immunosignal that 
will affect the overall grey level distribution. Whether the initial cleavage of VAMP1 
before VAMP2 is due to the uptake of toxin into inhibitory neurons earlier than 
excitatory neurons is uncertain. Yeh et al. (2010) showed differential expression of 
SV2A and B within the two populations within the cortex (and spinal cord) but without 
confirmation within the hippocampus we cannot say whether SV2 isoform expression 
and the subsequent binding of TeNT differs in hippocampal neuronal populations. 
Jefferys (1989) showed that slices from animals injected 1-2 days previously had no 
changes in the electrophysiology. This is supported by minimal changes seen in 
VAMP expression at this early stage in our experiments, and suggests that the 
significant focal cleavage in CA3 of VAMP1 positive slices is not enough to cause 
epileptic activity. A small network of neurons may be affected by the toxin, but the 
chance of positioning electrodes in this area is minimal. A focal cleavage of VAMP1 
may be responsible for the start of the initial epileptogenesis. Here, the beginnings of 
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a disruption in the inhibition-excitation ratio may take place which over the coming 
days develops further to include both VAMP1 and VAMP2, ultimately resulting in 
seizures. Overall this suggests that a threshold level of cleavage of the VAMP1 
and/or VAMP2 may exist that must be surpassed before abnormal recordings are 
observed. 
Following the initial cleavage bias towards VAMP1 at day 2, the peak cleavage is 
also seen at an earlier time point in mid level VAMP1 immunopositive slices 
compared with VAMP2; day 8 versus day 16 respectively. By day 16, there is some 
recovery of VAMP1 immunosignal in mid level slices. In posterior sections however, 
the cleavage of both VAMP1 and VAMP2 does not occur until day 8 onwards and 
within the time scale of the study, no recovery is seen of either isoform. This 
suggests that whilst there may be some recovery of the VAMP1 around the injection 
site by 2 weeks, the direct and/or indirect effects of the toxin may be more focused in 
the posterior sections at this time point. Electrophysiological recordings within more 
posterior slices to investigate this in future experiments would provide further 
information, as well as a longer term immunohistochemical analysis to observe 
whether the cleavage spreads further into the ventral hippocampus. The delay of the 
cleavage of VAMP2 within mid level sections may signify that even though recovery 
occurs focally in VAMP1, the inhibition-excitation ratio is not restored because there 
is still an imbalance throughout the hippocampus. This may play an important role in 
the epileptic syndrome as the activation of interneurons may remain disrupted 
because of the cleavage of VAMP2 in excitatory neurons. This failure of activation of 
interneurons has been suggested previously, although it has not been correlated with 
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a direct effect of TeNT on excitatory neurons in these studies (Jordan & Jefferys, 
1992; Whittington & Jefferys, 1994; Jefferys & Whittington, 1996).  
The ipsilateral bouton analysis from days 8-16 show robust cleavage of VAMP1 and 
VAMP2 in the strata pyramidale and radiatum of CA3, consistent with the grey level 
analysis. The CA1c closest to the injection site, shows cleavage of both isoforms in 
the str. radiatum but only of the VAMP2 in the str. pyramidale. The lack of cleavage 
in the str. pyramidale of VAMP1 immunopositive slices is likely due to the low sample 
size that resulted from some difficult images that could not be analysed and the large 
variation within the slices that were analysed, where two showed robust cleavage 
whilst the other showed none. As shown in the grey level analysis, there is variation 
in the extent of the lesion across the time ranges of 8-16 days therefore a sample of 
three is not enough to draw strong conclusions. 
5.1.1.2 Contralateral hippocampus 
Within the contralateral side, the effects of the toxin occur later than in the ipsilateral 
side, and again the VAMP2 cleavage generally lags behind that of VAMP1. However 
some interesting differences between the ipsilateral and contralateral sides are seen 
within grey level and bouton analyses. In the grey level analysis of contralateral CA1 
of VAMP1 immunostained slices at day 8, there is significant cleavage in TeNT slices 
at both mid and posterior levels. This suggests transport of the toxin via commissural 
fibres from the ipsilateral CA3 or CA1 to the contralateral CA1. It is interesting that 
this effect occurs at the time when the peak effect is also seen in the ipsilateral side 
(day 8) indicating a wide spread of the toxin’s actions. By day 16 this effect is not still 
observable. Considering that there are commissural fibres from CA3 to contralateral 
CA3, as well as to contralateral CA1 (Amaral & Lavenex, 2007), it begs the question 
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of why contralateral cleavage is not seen in the grey level analysis of CA3. The 
bouton counts however shows opposite results to the grey level analysis. It indicates 
a significant cleavage of both VAMP1 and VAMP2 in the contralateral CA3 and yet 
the only significant cleavage in contralateral CA1 is of VAMP2 in the str. pyramidale 
of CA1c. 
High magnification imaging has the potential to reveal details and therefore is more 
likely to uncover subtle changes in VAMP1 and 2 expression. The layer specific 
staining of both the VAMP1 and 2 antibodies creates a mixture of brightnesses in the 
grey level analysis at low magnification. This affects the pixel distribution across the 8 
grey levels within individual regions. Layers unaffected by the toxin may dilute the 
effects in other layers. In the high magnification bouton counts however, an individual 
layer can be focussed upon and thus subtle changes are more noticeable. The 
bouton data is from a range of 8-16 days which encompasses the two different time 
points from the grey level analysis. Given that there are differences between 8 and 
16 days in the low magnification images, the bouton counts from a range of days 
may result in individual differences between the two extremes being lost as the 
expression of the VAMP isoforms changes across the 8 days included. Where the 
CA3 contralateral cleavage of either isoform was not detected using the grey level 
analysis, this may be because only a focal region was affected, and thus was not 
enough to cause a dramatic shift in the pixel distribution. 
5.1.2 Layer specificity of TeNT effects 
The low magnification images have shown that there are layers within the 
hippocampus that are more susceptible to the TeNT than others. This may be due to 
the neuronal populations present, but most likely due to the connections between 
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these layers and others, providing easy access or not for the toxin. The str. 
lacunosum moleculare for example shows a bright immunosignal in VAMP2 
immunopositive sections that remains unaffected by the toxin. However, apical 
dendrites of most CA1 and CA3 pyramidal neurons terminate in the str. lacunosum 
moleculare where they receive innervations from str. oriens lacunosum-moleculare 
(O-LM) interneurons (Leao et al., 2012). This would provide a route for the spread of 
the toxin by retrograde transport to O-LM interneurons which would likely affect the 
VAMP present in the axons of these interneurons. This would be dependent on the 
CA1 pyramidal cells containing the toxin however. The str. lacunosum moleculare 
shows minimal VAMP1 immunostaining, which considering it contains inhibitory 
synapses is surprising. The presence of VAMP2 however is prominent, suggesting 
that these interneurons may use VAMP2 instead. However the projection from the 
entorhinal cortex may account for the high VAMP2 presence (Amaral & Lavenex, 
2007; Spruston & McBain, 2007). The lack of cleavage in the str. lacunosum 
moleculare suggests that the toxin has not spread to include this population of 
neurons and is also unlikely to have travelled to the entorhinal cortex within the 
timeframe studied. Longer-term studies looking at 4, 6 and 8 weeks, following the 
progression of the epileptic syndrome from peak epileptic activity through to 
remission would identify whether the lesion of VAMP1 and VAMP2 spreads to 
include the str. lacunosum moleculare within the course of the model. The time point 
at which it may appear could have important implications for the spread of seizure 
activity to other regions of the brain. 
The clear difference between the populations of neurons in different layers of the 
hippocampus is particularly highlighted by the effects of the toxin on the outer 
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molecular layer of the dentate gyrus. Within VAMP1 immunopositive slices, the outer 
molecular layer appears very dark, showing a low immunosignal. This is in contrast to 
the inner molecular layer which has a bright immunosignal and within TeNT slices 
shows cleavage of VAMP1. In VAMP2 immunopositive slices however, both the inner 
and outer molecular layers have bright immunosignals in control slices and in TeNT 
slices both layers show a cleavage of VAMP2. This highlights that the neurons within 
different layers have separate VAMPs present and the cleavage of the relevant 
VAMP in these layers likely has an impact on the network. 
5.1.3 VAMP1 and VAMP2 expression in distinct populations – involvement in 
epileptic syndrome 
The above discussion has shown that there are differential effects of the toxin on the 
two VAMP isoforms, the position within the hippocampus and the side of the brain 
relative to the injection. All of these may have an involvement in the generation of the 
epileptic syndrome, as well as its continuation. Data from our laboratory 
(unpublished) has shown that VAMP1 and VAMP2 are differentially, but not 
exclusively, expressed in different populations of neurons within the hippocampus. 
VAMP1 is seen to co-localise with the marker for inhibitory neurons, whilst VAMP2 is 
mostly expressed in excitatory neurons. Bragina et al. (2010) showed that there were 
differential co-localisations between various synaptic proteins within the cortex so this 
phenomenon is not entirely unexpected. However, differences between the 
populations in the cortex are less distinct than in our observations of the 
hippocampus. Much of the literature has focused on the effects of the toxin on 
inhibition, but here we have shown that both inhibition and excitation are likely 
affected.  
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5.1.4 Specific observations following high magnification imaging of VAMP 
immunopositive boutons 
The counts of the boutons within the different regions of the ipsilateral and 
contralateral hippocampi in the different treatment conditions have highlighted 
aspects which are discussed in the following sub-section. 
5.1.4.1 Asymmetry of synaptic protein expression 
Asymmetry of the expression of VAMP1 and VAMP2 within the ipsilateral and 
contralateral hippocampi has been observed at high magnification. The extent of 
asymmetry varies between the region and the layer within that region. This occurs 
within control sections, therefore is not a result of TeNT treatment. It is also seen in 
some regions of TeNT treated slices however. Overall, the differences in the str. 
pyramidale appear to be focused in the CA3 whereas in the CA1 the differences are 
within the str. radiatum. It is also noteworthy that the side showing the higher bouton 
counts is opposite for the two layers: ipsilateral for str. pyramidale and contralateral 
for str. radiatum. Considering that both the VAMP1 and VAMP2 positive sections 
show these differences and that the differences vary in the dominant side between 
the layers, suggests that these are not due to an issue with the analysis or an 
anomaly. Asymmetry within the brain has been suggested previously in normal 
healthy rats, however no mention of VAMP1 or VAMP2 specifically has been found. 
Some groups have focused on the thickness of the hippocampus (Diamond et al., 
1982; Diamond et al., 1983) showing a right hippocampus bias in male rats, others 
have counted the neurons in the principal cell layers (Lister et al., 2006) showing 
significantly more neurons in the left hand CA1 and CA3 compared with the right. 
This was also shown in the CA3 of dog hippocampus (Ragbetli et al., 2010). Others 
have focussed on proteomics (Samara et al., 2011) and gene expression (Moskal et 
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al., 2006) and have shown a majority of a right hand bias. Overall these findings vary, 
with Diamond et al. (1982) showing that the differences were dependent on age, 
where a smaller difference occurred during sexual maturity which overall continued to 
decrease with age. If more cells reside in the pyramidal layers of the left 
(contralateral) hippocampus then that could explain the fewer boutons seen in the CA 
str. pyramidale regions because a greater amount of the area of interest would be 
occupied by the cell bodies. An increase in the pyramidal cell numbers in the CA3 
and CA1 would account for increases in the density of boutons within the str. 
radiatum, resulting in increased bouton counts in the contralateral versus ipsilateral 
hippocampus. 
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5.1.5 Correlation of bouton analysis and electrophysiological data 
The coupling of the electrophysiological and immunohistochemical techniques has 
allowed for a specific insight into the changes caused by TeNT injections at 8-16 
days post injection. 
5.1.5.1 Effects of TeNT on evoked neurotransmission in CA1 
The observed changes in evoked responses, such as abolition of IPSCs and a 
significant decrease in EPSCs, can be attributed to the significant cleavage of 
VAMP1 and VAMP2 proteins in the strata pyramidale and radiatum of CA1c. The 
stimulating electrode in these recordings was placed in the str. radiatum so the 
cleavage of the VAMP1 and VAMP2 in this layer will impact on the neurotransmitter 
release onto the dendrites of the pyramidal cell being recorded from. The cleavage of 
the VAMP1 in str. pyramidale of CA1c (in 2 of the 3 analysed slices) for example has 
important implications for the changes in the evoked IPSCs. This is the VAMP 
isoform localised in inhibitory neurons, thus synapses of basket cells and axo-axonic 
cells onto pyramidal neurons in the str. pyramidale will be affected, shown by the 
abolishment of evoked IPSCs.  
Electrophysiology in the CA1a of TeNT slices remained normal, and was associated 
with bouton counts comparable to control slices, except in the VAMP1 str. pyramidale 
where significantly fewer boutons were seen in TeNT slices. This may suggest that a 
spread of the toxin’s effect to include the CA1a in some slices had occurred. This 
scenario is likely as the boundary for the spread of the toxin is variable, particularly at 
8-16 days after injection. There is also variation in the position of the cells and their 
proximity to the injection site. 
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Interestingly, Vreugdenhil et al. (2002) showed that at 5 months after TeNT injection, 
population spike amplitude was still reduced in the CA1. They attribute this as an 
anti-epileptic mechanism which may be due to a reduced efficacy of excitatory 
synapses. A similar hypothesis was also presented by Hawkins & Mellanby (1987). It 
was suggested that its presence in the later stage of the model, after seizures have 
remitted, is likely to play a role in the learning impairments that still remain (Jefferys & 
Williams, 1987). However, considering that we have seen both VAMP isoforms 
cleaved at the early stages of the model indicates that the changes in excitation at 5 
months may not be anti-epileptic but rather a direct result of the protease action of 
the toxin within excitatory synapses as well as the inhibitory population. Experiments 
to investigate this later time point in the model coupling electrophysiological and 
immunohistochemical techniques are planned for the future. 
5.1.5.2 Effects of TeNT on spontaneous neurotransmission in CA1 
The reduction in the frequency, but preservation of the amplitude, of IPSCs and 
EPSCs in ipsilateral CA1c has been shown in previous studies using TeNT (Mellanby 
& Thompson, 1972; Duchen & Tonge, 1973). In these studies, as in ours, evoked 
responses have been abolished or drastically reduced. These differences between 
evoked and spontaneous release suggest one of two options: 1) that the cleavage of 
VAMP1 or VAMP2 is not complete in all neurons or within the local network or 2) that 
a protein other than VAMP1 or VAMP2 is responsible for the spontaneous release, 
possibly from a different pool of vesicles. The possibility that the cleavage within 
individual boutons is not complete does not seem to be appropriate given that 
evoked IPSCs at least are completely abolished. However, there is ongoing 
investigation as to whether spontaneous and evoked release is reliant on the same 
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or separate mechanisms (Chung et al., 2010; Ramirez et al., 2012). The cleavage 
within the local population however is not complete, shown by the remaining 
presence of some VAMP positive boutons in all images. These boutons may be 
enough to maintain spontaneous neurotransmission, but at a reduced frequency. 
There is also emerging evidence that SNAREs other than those forming the classic 
SNARE complex of VAMP2, syntaxin1 and SNAP25, may be involved in exocytosis 
(Fasshauer et al., 1999; Yang et al., 1999; Bragina et al., 2007; Benagiano et al., 
2011; Tsai et al., 2011; Raingo et al., 2012; Ramirez & Kavalali, 2012; Ramirez et al., 
2012). Whilst some disagree whether there are differences between the proteins 
contained in GABAergic and glutamatergic neurons (Verderio et al., 2004; Frassoni 
et al., 2005; Delgado-Martinez et al., 2007), the possibility of a variety of 
combinations being made between the different components of the SNARE 
complexes, and differences between those expressed in different neuronal 
populations, offers possibilities that there may be a compensation or additive 
mechanism when VAMP1 and 2 are cleaved by TeNT. The non-canonical SNAREs 
that may be candidates for evoked asynchronous or spontaneous neurotransmitter 
release include VAMP4 (Raingo et al., 2012), VAMP7 (Scheuber et al., 2006) and 
Vps10p-tail-interactor-1a (vti1a) (Ramirez et al., 2012). Whether these are 
responsible for some of the remaining spontaneous neurotransmission in our slices is 
uncertain at this stage. The use of the organotypic slice culture method would allow 
for slices to be obtained from VAMP4, VAMP7 or vti1a knockout mice that could then 
be treated with TeNT in the way described in this project. A further reduction in the 
frequency or a reduction in the amplitude of spontaneous release may identify a 
compensatory mechanism provided by these non-canonical SNAREs. 
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5.1.5.3 Effects of TeNT in CA3 
In the present study, patch clamp recordings were not carried out in the CA3 region 
but our bouton data can be related to sharp-electrode intracellular recordings from 
previous work. Empson & Jefferys (1993) showed that the contralateral CA3 
produced significantly more spontaneous epileptic bursts within ‘mirror’ foci than the 
ipsilateral side in experiments at 10-18 days post injection. Whilst we have shown 
that both VAMP isoforms are significantly cleaved by the toxin in CA3 of both 
hippocampi (in strata pyramidale and radiatum) within this time range, we have not 
seen a greater decrease in the contralateral bouton count compared with the 
ipsilateral side. Empson & Jefferys suggest that inhibitory neurons on the 
contralateral side may be functional, shown by the preservation of monosynaptic fast 
and slow IPSPs within CA3 during pharmacological block of EPSPs. This was not the 
case in the ipsilateral side. The depression of GABA release in the ipsilateral but not 
the contralateral side highlights the possible differences in mechanisms for epileptic 
foci on the two sides of the brain (Jefferys & Empson, 1990; Empson & Jefferys, 
1993). Considering that we have seen robust cleavage of VAMP1 and VAMP2 
immunopositive boutons in CA3 on both sides of the brain to similar levels also 
questions why there are different mechanisms in the separate hippocampi and would 
suggest that both inhibitory and excitatory neurons are directly affected by the toxin. 
The contralateral hippocampus receives both excitatory and inhibitory commissural 
inputs from the ipsilateral hippocampus and therefore both populations in the 
contralateral hippocampus have the possibility of being directly exposed to TeNT 
(Ribak et al., 1986). Differences in the time points included in each study or 
differences in the overall strengths of toxin and resulting epileptic syndromes may 
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play a role in the discrepancies between our study and that of Empson & Jefferys. 
Whole-cell patch clamp recordings within the CA3 of both hippocampi and the 
corresponding bouton analysis around recorded and filled cells after injection with our 
current toxin batch may highlight if there are variations in the effects between the two 
experiments. These results would also apply more directly to our current CA1 study 
by coupling electrophysiology and immunohistochemistry. 
Whittington & Jefferys (1994) also showed that whilst epileptic activity takes longer to 
occur in the contralateral CA3, and recovers faster, the peak time point for epileptic 
activity was at 2 weeks. The robust cleavage of VAMP1 and VAMP2 boutons at 8-16 
days corresponds with this electrophysiology, although analysis of later time points 
would indicate whether the peak effect on boutons has indeed occurred here or later. 
Empson & Jefferys (1993) suggest that extra CA3 pyramidal cell connections may be 
made, and that these may happen more efficiently in the side that has no direct 
contact with the toxin. However, the cleavage of the boutons that we have seen in 
the contralateral CA3 suggests that the toxin does in fact travel to the contralateral 
hippocampus and thus will be having a direct effect at synapses within the CA3. This 
is also contradictory to work by Mellanby (1989) who showed that up to 3 days post 
injection, no radiolabelled TeNT was detected in the hippocampus contralateral to 
injection, however later time points were not mentioned. It was also shown that by 9 
days post injection, only 1.5% of the radioactivity remained and this was focused 
around the injection site in the ipsilateral hippocampus. These results from Mellanby 
may be different to ours due to their injections being targeted to the ventral 
hippocampus, where commissural projections differ to the dorsal hippocampus 
(Amaral & Lavenex, 2007). The fact that we have seen significant cleavage in the 
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contralateral side indicates that the toxin must have travelled there, at least in the 
dorsal hippocampus. 
5.1.5.4 Potential changes in VAMP1 and VAMP2 expression as the epileptic 
syndrome progresses 
Considering that most animals injected with TeNT show remission from seizures at 
about 6-8 weeks (Mellanby et al., 1977; Brace et al., 1985; Empson & Jefferys, 1993) 
implies that a recovery from the effects of the initial cleavage would have occurred by 
this stage. What requires further investigation, is that the recovery from disinhibition 
in the ipsilateral CA3 (8 weeks) occurs before recovery from epileptic activity evoked 
in slices (16 weeks) (Whittington & Jefferys, 1994). It has been suggested previously 
that the continued presence of reduction in polysynaptic activation onto CA3 
pyramidal cells and dentate gyrus granule cells at 8 weeks following TeNT injection, 
at a time when monosynaptic IPSCs have recovered, may be due to a decrease in 
intrinsic excitability of the interneurons, or that excitatory connections on the 
interneurons are failing (Jordan & Jefferys, 1992; Whittington & Jefferys, 1994; 
Jefferys & Whittington, 1996). Having shown that the VAMP2, primarily located in 
excitatory terminals, in our slices is cleaved by the toxin, it suggests the latter; that 
the reduction in polysynaptic activation is likely due to a failure of the excitatory 
connections onto interneurons. Whether the recovery from cleavage of VAMP1 
coincides with the recovery from disinhibition (monosynaptic recovery), and recovery 
from epileptic activity occurs in line with normal VAMP2 expression being re-
established at a later time, would be a very interesting route to investigate. It would 
also be interesting to look at the expression of the VAMP isoforms at a time when the 
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animals have remitted from motor seizures (6-8 weeks), but a behavioural and 
electrophysiological impairment remains (Jefferys & Williams, 1987). 
Without further investigation into the expression of VAMP1 and VAMP2 at later time 
points (up to 16 weeks) in this model we cannot say how long the protease effect 
continues or remains. This is currently being addressed in our laboratory, however a 
recent study showed the presence of VAMP2 cleavage in protein extracts from 
mouse visual cortex up to 35 days after injection with TeNT (Mainardi et al., 2012). 
This would suggest that the effects of the toxin could continue into much later time 
points than the 16 days studied in this project, in our intrahippocampally injected 
slices. A really interesting study would use double-labelling of VAMP1 and VAMP2 to 
directly compare and contrast the cleavage of the two proteins within the same slice. 
This is likely to demonstrate key differences between the time scales of cleavage, 
particularly by extending the study to many weeks. 
Whittington & Jefferys (1994) also suggest that the pyramidal and granule cells could 
have a hypertrophy of excitatory synapses onto them which could overpower any 
inhibition. From the bouton counts that we have carried out from ex vivo slices 
prepared from chronically epileptic rats that have been used for whole-cell patch 
clamp recordings, we have not seen increases in the number of VAMP1 or VAMP2 
positive boutons in TeNT slices and therefore feel it unlikely that there is an increase 
in these excitatory connections. Immunohistochemistry using synaptophysin, a 
marker for synaptic boutons, (Muzerelle et al., 2003) would further confirm this. 
Comparing our results with that of Whittington & Jefferys must be done cautiously as 
we have not completed work to look at later time points in relation to the cleavage of 
VAMP1 and VAMP2 and so differences may be encountered at this later stage. 
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5.2 The use of organotypic hippocampal slice cultures as a model of TeNT-
induced epilepsy 
The addition of organotypic hippocampal slice cultures to this project has allowed a 
further insight into the functions of the toxin. As mentioned in the introduction, 
organotypic hippocampal slice cultures are being used more regularly for disease 
models. Whilst epilepsy has been studied in these slices following application of 
kainic acid to the culture medium (Bausch & McNamara, 2004; Reid et al., 2008) or 
perfusion with low Mg2+ solution (Gutierrez et al., 1999; Kovacs et al., 1999; Wahab 
et al., 2009), no focal application of a convulsant or otherwise has been made to slice 
cultures. The idea behind carrying out the experiments within our study was to see 
whether an in vitro model could be produced that would mimic the electrophysiology 
and immunohistochemistry results from ex vivo slices taken from previously injected 
rats. The results presented show that there are some differences between the two 
models, but it highlights that this technique could prove very useful in the future after 
further investigation has been carried out. There is the potential that the in vitro 
model could be used as a drug screen and could drastically decrease the number of 
animals used in drug application studies as only those that showed an effect in vitro 
would be initially tried in the whole animal. 
5.2.1 Effects of TeNT on field potentials within slice cultures 
The use of field recordings from the organotypic hippocampal slice cultures provided 
the first evidence of similarities between the effects of TeNT in slice cultures and ex 
vivo slices following in vivo injection. 
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5.2.1.1 Consistent results in control slices across the study 
Encouraging results from the field recordings of the organotypic hippocampal slice 
cultures show that there is no deterioration in the size of the responses within control 
slices across the three time points studied. This implies that the time spent in culture, 
up to 30 days, does not result in a decrease in the viability of slices. This has also 
been seen in preliminary recordings made at 32 days post injection (up to 46 days in 
culture; data not shown). This has important implications if the model were to be 
used to further assess the effects of the toxin at later time points than addressed in 
this study. This would be useful considering that the TeNT effects following in vivo 
injections result in a syndrome that lasts for weeks. 
5.2.1.2 Concentration dependent effects of TeNT 
The field recordings from the different areas of the slice cultures highlighted that the 
toxin was able to disrupt synaptic transmission, particularly at the highest two toxin 
concentrations. Within the region closest to the injection site, the CA3 str. radiatum, 
all three concentrations appeared to have an effect at the earliest time point of day 2. 
This was followed by a recovery of the 5ng/µl TeNT slices by day 8 and the 25ng/µl 
TeNT slices by day 16, suggesting a dose dependent continuation of the disruption 
or recovery at the lower doses. The region most distal to the injection site, the CA1, 
showed significant disruptions in synaptic transmission in both the strata pyramidale 
and radiatum in 25 and 50ng/µl TeNT slices, but not within the lowest dose, again 
suggesting a dose dependent effect of the toxin.  
The failure of the 5ng/µl TeNT injection to cause significant disruptions in synaptic 
transmission within the CA1, unlike the higher concentrations, offers evidence that 
the injection of the toxin does not spread across the slice but remains focal. If the 
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injection solution was to disperse across the majority of the surface of the slice then 
you would not expect to see this regional difference in responses. The effects of the 
higher concentrations of toxin on synaptic transmission within the CA1 are therefore 
likely to be due to the transport of the toxin to this region within neurons. The chance 
of this is higher due to the higher concentrations of toxin available. Alternatively, the 
higher concentrations may cause a block of synaptic transmission in a greater 
proportion of CA3 neurons which therefore has an indirect effect on the CA1. 
Considering that the stimulating electrode is within the CA3 for all recordings then 
this may apply. 
The use of three different concentrations of toxin in this study highlights another 
advantage offered by organotypic hippocampal slice cultures. It has allowed us to 
study the similarities and/or differences between the effects of the toxin at different 
concentrations. The use of concentrations that vary by a factor of ten could not be 
used in vivo for long term studies due to the toxin’s very poisonous nature, as shown 
by Bagetta et al. (1990) where high doses resulted in the death of most animals after 
only a few days. Each batch of toxin is different and the potency needs to be 
considered carefully for use in live animals. The use of multiple concentrations 
highlighted that the spatial spread as well as the time scale of the toxin’s effects is 
dependent on the concentration. These differences are likely to continue into time 
points later than 16 days and may play important roles as the epileptic-type 
syndrome progresses. 
Our concentration dependent results also highlight that differing results throughout 
the literature regarding TeNT use may be very dependent on the concentration and 
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toxicity of the particular batch of toxin used. Standardising this, however, would likely 
prove difficult. 
5.2.1.3 Epileptic activity 
The epileptic activity that has been seen within the slice cultures is interesting. The 
different types of activity, evoked afterdischarges and spontaneous activity, which are 
consistent with observations from ex vivo slices (Jefferys, 1989), albeit on a different 
time scale, offer encouraging evidence for the use of slice cultures as a tool to study 
TeNT induced epilepsy. Given that both types of activity exhibited two distinct forms 
highlights biological variation, not just between slices from different animals but also 
from slices within the same animal. Whether it is dependent on very subtle 
differences in the positioning of the injection and the neuronal network that is 
targeted initially is uncertain. This is something that could be investigated in the 
future, possibly through the use of tracers and targeting specific populations of 
neurons using genetically modified animals and injections at a higher magnification 
for greater accuracy. This has implications for epilepsy in general in that small 
differences in the position of the epileptic focus could result in different forms of 
seizure activity. Using these slice cultures to test drug applications and to see if the 
different forms of seizure activity are affected by the drugs in the same or different 
ways would provide important evidence to support this. 
We have shown that in organotypic hippocampal slice cultures the spontaneous 
activity occurs most commonly at 2 days post injection and the afterdischarges at day 
16, although the power was not enough to test whether differences were significant.  
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Future experiments to establish whether the afterdischarges begin at the highest 
dose at later time points should be carried out. This may give some indication of a 
recovery of the VAMPs, and may coincide with an increase in the synaptic responses 
following stimulation. Coupling electrophysiological and immunohistochemical 
analyses will help elucidate this. Another interesting future experiment would be to 
make multiple simultaneous recordings from the CA1 and CA3 to see whether the 
spontaneous activity or afterdischarges in the CA3 can spread to influence the CA1. 
Jefferys (1989) showed that spontaneous activity in the CA3 could trigger epileptic 
bursts in the CA1. If this also occurred in the slice cultures treated with TeNT then it 
would offer further evidence for the similarities between the two protocols. 
5.2.1.4 Epileptic activity in a minority of control treated slice cultures 
There was evidence of some epileptic activity within a small number of control slices. 
This may be due to the time spent in culture or a degeneration of part of the slice that 
led to these responses. Another possible explanation is the penicillin that is 
contained within the culture medium. However, because these responses are not 
consistent across all slices, it is unlikely that the penicillin plays a role. The final 
concentration of penicillin contained within our culture medium (100 U/ml) is also 
lower than concentrations that have been shown to cause epileptic activity (Lueders 
et al., 1980; Schwartzkroin & Prince, 1980). Within each well, 6-8 slices would have 
been exposed to the same culture medium and yet only a minority of control slices 
showed epileptic activity. The majority of this activity is focussed on TeNT treated 
slices and shows concentration dependent occurrences, thus we are confident that 
the epileptic activity in the majority of slices is a direct result of the toxin. 
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5.2.2 Time scale of TeNT effects relative to in vivo injections 
The effects of TeNT injections onto the slice cultures resulted in changes in 
responses from as early as 2 days post injection. These effects at 2 days post 
injection in the slice cultures may show an earlier onset of changes than TeNT 
injections in vivo, although reports from in vivo studies vary. Whilst slice recordings 
from adult rats injected in vivo have shown that there are no electrophysiological 
changes until the third day post injection onwards (Jefferys, 1989), electrodes 
implanted in the hippocampi of infant (Lee et al., 1995; Anderson et al., 1997) or 
adult (Anderson et al., 1997) rats has shown that there are variations. Electrographic 
seizures begin within 1-3 days in infant rats and between days 1-7 in adult rats. The 
onset of behavioural seizures also vary from the first 24 hours (Lee et al., 1995) to 
the third day post injection (Rashid et al., 1999) in infant rats and not until days 3-7 in 
adult rats (Jefferys & Whittington, 1996). Behavioural seizures do not always 
accompany electrographic seizures in either age group (Anderson et al., 1997). 
Changes in ex vivo slices may occur later than changes in vivo because an isolated 
slice from the animal only provides a small representation of the affected 
hippocampus. It may not contain large groups of neurons affected by the toxin at this 
early stage, thus detection is difficult (Jordan & Jefferys, 1992), whereas in vivo the 
intact connections would make the observations easier as the spread of the activity is 
uninterrupted. This may also be the reason that we see changes in the slice cultures 
earlier than in ex vivo slices, because the severed connections have reformed in slice 
cultures and there is a finite area that can be affected by the toxin. The lack of 
extrahippocampal inputs may also result in less dampening of seizure activity 
(Coulter et al., 2011). The other possibility is that our slice cultures are in fact a closer 
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model for infant TeNT induced epilepsy rather than adult. As mentioned in Chapter 4, 
the epileptic activity seen in the slice cultures is similar to that in adult slices, whether 
taken from animals injected during infancy and allowed to mature to adulthood (Lee 
et al., 1995; Smith et al., 1998) or from those injected as adults (Jefferys, 1989). This 
is something that needs to be investigated further, using adult slice cultures to 
compare with our current results, but also exploring these infant slice cultures in more 
detail, starting with intracellular recordings. Whole-cell patch clamp recordings from 
slice cultures would allow for comparisons of epileptic activity with slices from in vivo 
intrahippocampally injected adult animals. This would help to show whether the 
epileptic activity seen is similar in the two preparations or whether the young age of 
the animals used for culturing show differences because of a less mature network. 
As mentioned previously, at day 2 in the sections taken from in vivo injected animals 
there was a focal cleavage of VAMP1, particularly seen around the injection site, 
suggesting that this is not enough to cause an imbalance in the inhibition-excitation 
ratio. In our treated slice cultures however, we have seen robust effects of the toxin 
on both VAMP1 and VAMP2, starting as early as day 2. This may be due to the 
smaller network contained within a single slice of hippocampus, as well as the 
knowledge that the injection site is situated near to the recording, which cannot 
always be confirmed after in vivo injection. Therefore ex vivo slices may not show 
changes until the time of behavioural seizures because by that point a larger area is 
affected by the toxin and therefore recordings are more likely to be undertaken from 
a region affected. 
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5.2.3 Focal application of TeNT versus incubation in culture medium 
Focal injections of TeNT onto organotypic hippocampal slice cultures were meant to 
mimic in vivo injections in that a small area was initially exposed to the toxin. 
Previous work has only used TeNT application into culture medium (500ng/ml for 72 
hours) (Scheuber et al., 2006). Although seizure-like activity was not reported, 
incubation in the TeNT-containing medium was shown to abolish EPSCs in the CA1 
evoked by stimulation of Schaffer collaterals and within the CA3 where mossy fibre 
stimulation produced unreliable asynchronous responses (Scheuber et al., 2006). 
Scheuber et al. (2006) also showed spontaneous miniature EPSCs (mEPSCs) were 
significantly decreased in frequency. These results show that the TeNT is able to 
have its protease effect within slice cultures from mice when applied to the culture 
medium that will affect the whole slice. In relation to our focal experiments, the initial 
concentration of the toxin used by Scheuber et al. is 100 times lower than our highest 
concentration (500ng/ml versus 50ng/µl). 
The Scheuber et al. results differ slightly from the results of the patch clamp 
experiments in our ex vivo slices as their group have shown a total abolishment of 
EPSCs whereas we saw only a significant reduction, but a total abolishment of 
IPSCs. This is likely due to the different application of toxin: the entire slice culture in 
the Scheuber et al. study compared with a spread from a focal intrahippocampal 
injection. Our recordings were also made 7-15 days later so there may be some 
recovery of the responses by this time. The different concentrations of toxin are also 
likely to be important. The field recordings from our focally treated slice cultures offer 
similar results to that of Scheuber et al. in that population spike sizes were 
significantly reduced in toxin treated slices at the highest doses and these are 
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predominantly EPSPs. Future whole-cell patch clamp recordings from focally treated 
organotypic slice cultures will allow comparisons to be made between our results and 
those of Scheuber et al. It will also then allow comparisons to be made between the 
intracellular recordings within slice cultures and those from our slices from chronically 
epileptic rats. 
There is a possibility that following injection of TeNT onto slice cultures, there may be 
leakage of the toxin through the membrane into the culture medium. This would 
result in a greatly diluted concentration. The electrophysiological evidence already 
presented that shows regional and concentration dependent effects focussed around 
the injection site argues against this however. The immunohistochemical results 
showing a lack of homogeneous cleavage of VAMP1 and VAMP2, which would be 
expected to be seen if the entire slice was directly exposed to the toxin, also prove 
this leakage unlikely. Experiments that looked at the binding and internalisation of the 
toxin showed that incubation with radiolabelled toxin and warming of cells to 37°C 
resulted in nearly 70% of the radiolabelled toxin being resistant to digestion by 
incubation with pronase (a protease) within 10 minutes (Staub et al., 1986). This 
suggests that the binding and internalisation of the toxin occurs rapidly and as our 
slice cultures were incubated at this temperature then the likelihood of the binding 
and internalisation of the toxin occurring shortly after injection is high. 
5.2.4 Advantage of multiple recordings in slice cultures 
Most importantly, the results from the electrophysiology within the slice cultures 
shows that the TeNT is able to severely affect synaptic transmission and is able to 
cause epileptic activity in different forms. These results offer the great advantage of 
the ability to use the same slice at multiple occasions and follow the progression of 
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the changes induced by TeNT. This will be particularly important for detailed 
investigations of the actions of the toxin many weeks after injection. Recordings 
starting early in the model and repeated once every 1-2 weeks could really show the 
changes that occur across the course of the epileptic syndrome. This is something 
that is not possible in acute slices prepared from epileptic animals, but utilising both 
methods together will lead to deeper insights into the mechanisms and actions of 
TeNT.  
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5.2.5 Immunohistochemical analysis of VAMP immunopositive boutons in slice 
cultures 
To further understand the effects of the toxin on slice cultures, immunohistochemical 
analysis of VAMP1 and VAMP2 cleavage were also carried out in a similar way to 
that of ex vivo slices. This offered further data to compare with ex vivo slices and also 
to understand more of the effects of the toxin at different concentrations within a 
culture setting. 
5.2.5.1 Consistent measurements across the time course of the study 
As with the electrophysiology, there were no differences between the 
immunohistochemical results within control slice cultures at the three different time 
points studied, in VAMP1 or VAMP2, across any of the regions. Again this has 
encouraging implications for further use of this model to study later time points as the 
viability of the slices seem unaffected up to 4-5 weeks and therefore have potential 
uses for further days or weeks. 
5.2.5.2 Distribution of VAMP1 and VAMP2 immunopositivity in slice cultures 
Overall, the distribution of VAMP1 and VAMP2 was layer specific within slice 
cultures, particularly at high magnification, and showed immunopositive and negative 
layers comparable to those from the ex vivo slices and Raptis et al. (2005). The str. 
pyramidale of the CA1 in these slice cultures was not always particularly clear at low 
magnification (Muller et al., 1993). This is because the pyramidal cells of the CA1 
spread into a layer within the middle of the slice rather than remaining piled on top of 
each other as in the CA3 (Stoppini et al., 1991; Buchs et al., 1993). As this was 
consistent across slices, comparisons of the bouton quantification between the CA1 
str. pyramidale of different treatment conditions could still be carried out. 
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5.2.5.3 Differential cleavage of VAMP1 and VAMP2 by TeNT within slice cultures 
The analysis of the boutons within the VAMP1 and VAMP2 immunostained slices 
have shown some differences between the regions and time points most affected by 
the toxin. The most robust cleavage is seen within VAMP1 immunostained slices. 
Here, the highest two toxin concentrations consistently show the lowest area 
occupied by VAMP1 immunopositivity, although not always significantly lower than 
control slices. The differences between the treatments are focussed around days 2 
and 8, with minimal differences seen at day 16. This suggests a degree of recovery 
of the VAMP1 by this time point, consistent with the low magnification images. This 
matches the time scale of changes that appeared from the grey level analysis of the 
VAMP1 immunostaining in ex vivo slices from epileptic rats. The significant 
differences seen at day 2 only occur within the CA1 of 25 and 50ng/µl TeNT slices, 
and not within the CA3. Considering that the electrophysiology would suggest that 
the CA3 is affected by all concentrations of toxin, and the CA1 by only these highest 
two doses, it would have been expected that the CA3 would show significantly lower 
VAMP1 positive areas occupied by boutons at this earliest time point. The raw data 
shows that both the higher doses of toxin have very small VAMP1 positive areas 
within the CA3 compared with controls. However, the control data shows quite a 
large degree of variation in both the CA3 strata pyramidale and radiatum because 
only 3 slices could be included in the analysis, which is a particularly low number. 
Future experiments to increase the sample size for control CA3 will provide a more 
definitive answer as to the differences between control and the toxin doses. These 
results within the CA1 showing that only the two highest toxin concentrations cause a 
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significant decrease in the immunopositive bouton area, and not the 5ng/µl TeNT, are 
consistent with the electrophysiological data.  
The VAMP2 immunoprofile differs to that of VAMP1. The effects of the high toxin 
concentration on VAMP2 remain throughout the course of the study around the 
injection site however the cleavage of VAMP2 is minimal in distal regions  (CA1), 
even in slices that received the highest concentration of toxin. This region specific 
effect of the toxin in VAMP2 is interesting, especially considering that the effect of the 
toxin on VAMP1 is so widespread. It suggests that similar to the ex vivo slices; there 
is a lag in the spread of cleavage of VAMP2 compared with VAMP1. The recurrent 
excitatory connections that exist within the CA3 may also result in the cleavage of 
VAMP2 remaining focussed in a network local to the injection site. 
5.2.5.4 Comparison of ex vivo slices and slice culture bouton analysis 
The differences between the two populations of VAMP seen in slice cultures differ 
slightly to that from the ex vivo slices mentioned earlier. Without further investigation 
into later time points, it is difficult to say whether the VAMP2 is less affected in slice 
cultures, or whether the extent of the cleavage has not reached its peak within the 16 
days studied. It was shown in the ex vivo slices that the cleavage of VAMP2 lagged 
behind that of VAMP1. Considering that many similarities have been seen between 
the results using the two different protocols, particularly in the electrophysiology and 
the effects of the toxin on VAMP1, it would suggest that the VAMP2 may well be 
affected at a later time point and within the length of our current study we have not 
seen the full extent. However, the focal cleavage of VAMP2 within the CA3 of our 
slice cultures at the earliest time point is something that was not seen in the grey 
level analysis of ex vivo slices. Having said this, a very focal cleavage may not have 
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been enough to cause a change in the distribution of the entire area within that low 
magnification analysis. Without bouton counts within ex vivo slices from 2 days post 
injection, it is difficult to compare the results from the two protocols at this earliest 
time point to see whether an early cleavage of VAMP2 occurs in ex vivo slices. 
5.2.5.5 Comparison of electrophysiological and immunohistochemical data within 
slice cultures 
Interestingly, within the 5ng/µl TeNT slices the most epileptic activity (afterdischarges 
and spontaneous) is within the CA3 str. pyramidale, whereas for 25 and 50ng/µl 
TeNT slices the greatest amount of epileptic activity occurs within the CA1 str. 
pyramidale. This is likely to be because whilst synaptic transmission is severely 
affected by the toxin at the highest two concentrations in the CA1, it is to a lesser 
degree than in the CA3. As synaptic transmission is virtually abolished by these high 
concentrations of toxin within the CA3, then the establishment of afterdischarges or 
spontaneous activity is very unlikely to be seen. Therefore higher rates of epileptic 
activity are seen in the CA1 where the disruption of synaptic transmission is not as 
prominent, but is still affected. The lesser cleavage of VAMP2 within the slice cultures 
in CA1 may also play a role in the epileptic activity, indicating that excitatory 
transmission may predominate over inhibition. The changes in electrophysiology 
depend on the release of neurotransmitters from neurons and thus VAMP1 and 
VAMP2 are important, but because the stimulating electrode was in the CA3 str. 
radiatum even for CA1 recordings, the activation of CA1 which could depend on 
excitation of CA3 may be disrupted by the cleavage of VAMP1 and/or VAMP2 within 
the CA3. Simultaneous recordings within the CA1 and CA3 may uncover this. For the 
lowest TeNT concentration, the most epileptic activity occurs in the CA3 because this 
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is the area that is shown to have been affected by the toxin, but to a much lesser 
extent. The CA1 is unaffected by the toxin at this concentration and therefore 
epileptic activity is not seen. 
5.2.5.6 Both inhibition and excitation are affected by TeNT in slice cultures 
The electrophysiology showed significantly decreased synaptic transmission in the 
highest doses of toxin in all areas of the hippocampus and epileptic activity in a 
number of slices, suggesting that both excitation and inhibition are affected. If just 
inhibition was affected then it would be expected that the response to stimulation was 
increased, rather than decreased, as the inhibitory mechanisms would not be present 
to dampen any excitatory responses. This would also account for the epileptic activity 
as the network would have lost its inhibitory regulation. The dramatic and significant 
decreases in responses to stimulation at the higher doses of toxin show that the 
excitation is also affected by the toxin. Coupling the electrophysiological recordings 
and the cleavage of both VAMP1 and VAMP2 confirm this. 
5.2.6 Considerations for the use of slice cultures 
Whilst the use of organotypic hippocampal slice cultures offers a number of 
advantages, there are some areas that need consideration to be able to utilise them 
to their full potential. 
5.2.6.1 Choice of animal age  
As mentioned in Chapter 2, the age of the animals used for culturing impacts on slice 
viability (Gahwiler et al., 2001; Fuller & Dailey, 2007). Whilst the use of infant animals 
for our culturing study may not be ideal in an experiment that compares to results 
from adult animals injected intrahippocampally with TeNT, the methods for adult 
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cultures are relatively new and less established. Adult cultures are limited by the poor 
survival of slices or shorter term use, however the research is ongoing and advances 
are being made (Finley et al., 2004; Legradi et al., 2011; Kim et al., 2013). In the 
future, it may be possible to culture slices from adult animals that received in vivo 
intrahippocampal TeNT injections. That way, a more detailed and longer term study 
of the changes may be conducted using the slice culture method. This would allow 
for slices to be taken at different stages of the epileptic syndrome in vivo and then to 
record from the slices at multiple time points throughout their time in culture. Whether 
the features of the epileptic syndrome in vivo would continue in parallel in vitro would 
be very interesting to determine. It may be dependent on the time after injection that 
the slices were isolated. 
5.2.6.2 Difficulties with analysis of responses 
There are some difficulties with using field recordings in organotypic slices that are 
both very small and also have a degree of recurrent connectivity that is not present in 
acute ex vivo slices. This was shown to be an issue when recording from the CA3 
region, where the recording electrode was in such close proximity to the stimulus 
electrode. The CA3-CA3 recurrent connections occur at a higher frequency than 
CA1-CA1 connections in both acutely prepared (Deuchars & Thomson, 1996) and 
organotypic hippocampal slices (Debanne et al., 1995), adding another compounding 
factor. These issues meant that the recording of responses from the CA3, both within 
the strata pyramidale and radiatum resulted in responses that showed an antidromic 
component, and in the cases of controls and some TeNT slices, also an orthodromic 
component. Whilst the orthodromic component is reliant on synaptic transmission, 
the antidromic is not. Brace et al. (1985) showed the antidromic response remained 
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when orthodromic spikes were depressed in intrahippocampal TeNT injected 
animals. This also indicated that the changes in orthodromic responses were as a 
result of changes in synaptic transmission rather than neuronal loss because the 
antidromic response was still present and at sizes comparable to control animals. 
Therefore for the purposes of understanding the effects of the toxin within our slice 
cultures, it was important that if the two components could not easily be distinguished 
within the response then a method of analysis needed to be used that could take into 
account the different components. For this reason, the analysis of the field recordings 
for the CA3 regions were based on the amplitude of the responses (positive or 
negative for strata pyramidale and radiatum respectively) rather than the trough and 
slope measurements that were used within the CA1. Using the amplitudes from 
baseline was the best available measurement for the mainly synaptic or orthodromic 
component from evoked field potentials, because of the overlap with the antidromic 
spike. In future experiments, pharmacological tools (for example NBQX and 
bicuculline) could be used to isolate the antidromic responses by blocking all synaptic 
transmission to show that the responses that remained were truly antidromic. Within 
the 50ng/µl TeNT slices for example, the blocking of synaptic transmission using 
pharmacological means would be expected to show very little difference to the 
recordings made without this intervention, because of the effects of the toxin. 
5.2.6.3 Variation in recordings procedures 
There are differences between the protocols from different laboratories when carrying 
out electrophysiological recordings from hippocampal slice cultures. Some perfuse 
with culture medium (Wahab et al., 2009; Dyhrfjeld-Johnsen et al., 2010), others with 
ACSF (Kovacs et al., 1999; Ziobro et al., 2011; Berdichevsky et al., 2012). Similarly, 
- 225 - 
 
some use the submerged technique (Wahab et al., 2009; Berdichevsky et al., 2012) 
whereas others use interface chambers for recordings (Kovacs et al., 1999; 
Dyhrfjeld-Johnsen et al., 2010; Ziobro et al., 2011). Whether the conditions of the 
recordings and the perfusion solution used makes a difference in recordings is 
uncertain. We used the submerged technique as this was the only option available 
with a fitted incubator box to try and maintain the environment and relative sterility of 
the slices. In the future however, if access to an interface chamber with a fitted 
incubator box was available then it would be interesting to see if the recordings 
differed between the two techniques. This would be particularly relevant to the 
presence and type of epileptic activity seen. Considering that many of the recordings 
from acute ex vivo slices are made using the interface method, it would also be 
important to compare results from slice cultures using this technique to show whether 
the type of recording chamber effects the epileptic activity observed. 
5.2.6.4 Reorganisation of slices and its impact on the model 
One issue regarding slice cultures is that whilst they maintain the overall organisation 
of the normal hippocampus, there is some reorganisation within layers, particularly 
the CA1 (Stoppini et al., 1991; Buchs et al., 1993). The responses recorded from this 
layer can vary with only small movements of the electrode, whether within one plane 
or changing the depth (Muller et al., 1993). In a number of our slice cultures, typical 
str. radiatum responses were difficult to locate within the CA1. Small movements 
could change from a positive response to negative response (Muller et al., 1993) and 
sometimes a str. radiatum negative response could not be found. This is likely 
because of the reorganisation of the CA1 pyramidal layer (Buchs et al., 1993). Within 
control slices, some movement within the area was required to find the expected 
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population spikes and PSPs although often they were immediately identified. In TeNT 
slices however this was trickier as even when multiple sites within the area were 
tested, responses were often not found. To ensure that the lack of response was due 
to a disruption in synaptic transmission rather than an integral problem with the slice, 
multiple positions within the region were tried before carrying out the stimulus 
response curve. Only slices that appeared visually healthy were used for 
experiments to try and minimise the chance of a false negative recording. 
The development of slice cultures has been studied previously and has suggested 
that whilst there is a reorganisation within the cultures following the slicing procedure, 
the morphological and synaptic activity development has been preprogrammed by 5 
days of post natal life, at least in the CA1 pyramidal cells (De Simoni et al., 2003). 
After 1 week in culture, the development of slices begins to parallel that in vivo (De 
Simoni et al., 2003). By 21 days in vitro, similar dendritic morphologies in regards to 
spine density and dendritic trees were observed, as well as comparable synaptic 
currents. The development in culture is said to continue normally, despite there being 
no input from an external environment that an animal would normally be exposed to 
in its first weeks of life. The differences that occur within that first week after culturing 
are likely to be due to the manipulation of the slices during the culturing process. For 
example the slicing procedure will result in the severing of axons and therefore over 
the next week a degree of rearrangement will occur. These findings are very 
encouraging for the use of slice cultures as they offer a parallel to the in vivo situation 
and may be more representative than acute slices. Acute slices cannot recover from 
the slicing procedure in the same way as slice cultures and therefore slice cultures 
show a more physiological state and organisation because innervations have been 
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re-established. No manipulation of our slices was made until at least 10 days in 
culture to allow for the rearrangements to occur.  
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5.3 TeNT and its disruption of both inhibitory and excitatory 
neurotransmission 
As reviewed, the general consensus in the literature was that the TeNT effects are 
targeted to inhibitory neurons. However the results from the bouton analysis and the 
electrophysiology have shown this not to be the case in our study and that both 
inhibition and excitation are affected by TeNT injections. 
5.3.1 Selectivity of TeNT 
The key paper that introduced the idea that rat VAMP1 was insensitive to TeNT and 
VAMP2 was the sole target of the toxin was that of Schiavo et al. (1992). Here they 
stated that the cleavage site of the TeNT was between the peptide bonds at the 
Gln76-Phe77 position within VAMP2. These amino acids do not exist at these 
positions within VAMP1, therefore questioning how it is that we have seen cleavage 
of this isoform in our slices. It is unlikely that there is any overlap between the two 
antibodies that we have used, firstly because the two N-terminal sequences that are 
recognised by the antibodies are very different, and secondly, there were clear 
differences in the specificity of the individual antibodies for different layers within the 
hippocampus. 
What is interesting however is that the sequences for mouse and human VAMP1 
contain the Gln-Phe peptide bonds, although at amino acid positions 78-79 rather 
than 76-77 as in the rat VAMP2. Shone & Roberts (1994) showed that botulinum type 
B neurotoxin (BoNT B) was able to cleave human VAMP1, and actually at a faster 
rate than VAMP2. This was further shown by Yamamoto et al. (2012) where the light 
chain of BoNT B was able to cleave human VAMP1, VAMP2 and VAMP3 
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(cellubrevin). The Gln-Phe bond in VAMP3 is at positions 59-60. This suggests that 
the Gln-Phe peptide bond may be required for the action of this toxin, but its exact 
position within the sequence may not be important. Considering that the BoNT B and 
TeNT cleavage sites are thought to be at the same peptide bond, it is therefore 
indicative that the TeNT would also be able to cleave human VAMP1, and most likely 
mouse. 
The amino acid sequences surrounding the cleavage site are also thought to be 
important in the binding and cleavage properties of the toxin (Chen et al., 2008b). 
The recognition sequences, however, vary between the BoNT B and TeNT (Chen et 
al., 2008b). Interestingly the specific sequences that are required for VAMP2 
recognition by TeNT are also contained in the rat VAMP1 sequence, although at 
slightly different amino acid positions. This may play an important part in the VAMP1 
cleavage, even though the cleavage site is different from VAMP2.  
Overall, this all still raises questions as to why our data has shown a cleavage of rat 
VAMP1, considering that the Gln-Phe peptide bond is not present. Whether there is a 
difference in the methodology that could produce the discrepancy is uncertain. 
Schiavo et al. (1992) used highly purified synaptic vesicles from the cerebral cortex 
and Western blots whereas we have focused on whole tissue and looked at only one 
region of the brain. Shone & Roberts (1994) used peptides that were synthesised, 
and Yamamoto et al. (2012) used recombinant proteins and the light chains of the 
botulinum toxins. 
Our findings that the VAMP1 and VAMP2 are both cleaved by the toxin opens up 
further need for investigation into the cleavage site of TeNT in rat VAMP1. The data 
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we also have that the two isoforms are expressed in separate populations 
counteracts previous suggestions as well. Not only are both isoforms affected in our 
experiments, but if it was VAMP2 that was the primary target, then our data would 
suggest that these were mainly excitatory neurons. 
5.3.2 Differential effects on inhibitory and excitatory neurons 
The differing degrees of TeNT effect on inhibitory and excitatory populations, 
particularly suggested by the intracellular recordings in ex vivo slices, may be 
explained by the difference in population numbers within the hippocampus. Inhibitory 
neurons make up about 10% of the hippocampal neurons (Freund & Buzsaki, 1996). 
A widespread cleavage of VAMP1 (predominantly inhibitory) by day 8 could thus 
result in the majority of inhibitory neurons being affected by the toxin, supported by 
the complete abolishment of the evoked IPSCs within the CA1c of the ipsilateral 
hippocampus (8-16 days post injection). In contrast, the excitatory neurons, making 
up the majority of the hippocampus would require a much larger population to be 
affected to abolish all responses. The evoked responses fell to 22% of controls, 
suggesting that a considerable proportion of the population was affected, but not the 
entirety. This is also supported by the later effect of the toxin on VAMP2 shown in the 
grey level analysis. The significantly reduced responses in the slice cultures after 
treatment with the highest concentration of toxin also supports the idea that both 
inhibitory and excitatory neurotransmission are affected given that no prolonged field 
potentials or afterdischarges are seen. Taking into account the vast network of 
synapses within the hippocampus, particularly in vivo, it is likely that the toxin does 
not travel to, and thus does not have a direct effect on, all neurons. The indirect 
effects of the toxin are likely to affect a larger proportion of the hippocampal neurons. 
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A minority of other groups have also shown that excitation can be affected by the 
toxin, following different applications. This was shown by reduced excitability and 
smaller population spikes after intrahippocampal injection (Brace et al., 1985; 
Hawkins & Mellanby, 1987), reduced excitatory responses after intramuscular 
injection in cats (Kanda & Takano, 1983) and a decrease in the frequency of mini 
end-plate potentials seen in the neuromuscular junction after injections into the hind 
leg of mice (Duchen & Tonge, 1973). All this was early evidence that the TeNT was 
able to affect excitatory as well as inhibitory responses after injection in the periphery 
or directly into the brain. More recently, Scheuber et al. (2006) have shown that 
hippocampal slice cultures, pre-treated with TeNT for 72 hours, has effects on both 
evoked and spontaneous excitatory transmission. However the focus of many groups 
remained on inhibitory neurons due to the clinical effects of infection by TeNT: 
spastic paralysis, thought to be caused by blocking inhibitory neurotransmitter 
release onto motoneurons. 
Interestingly, differential TeNT effects on mEPSCs and mIPSCs have been shown 
between cortical neuronal cultures and spinal cord cultures (Yeh et al., 2010). In 
cortical neuronal cultures, there were greater decreases in excitation than inhibition 
following TeNT treatment, but the reverse occurs in spinal cord cultures. SV2, a 
protein considered to be involved in TeNT entry into neurons, has also been shown 
to have different isoforms present on different neuronal populations, although not 
exclusively. In both the cortical and spinal cord neurons, SV2A was mostly present in 
inhibitory neurons, whereas SV2B co-localised with excitatory neurons (Yeh et al., 
2010). However this did not explain the opposite effects of the toxin seen in the 
spinal cord versus cortical neurons. A differential expression of VAMP1 and VAMP2 
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in the different regions may offer an explanation if investigated. If SV2 is the 
mechanism of entry for the TeNT, then a differential presence of SV2A and SV2B in 
separate populations may also account for the temporal differences in cleavage of 
VAMP1 and VAMP2 if different rates of uptake exist. Investigation of the overlap of 
the VAMPs and SV2 proteins in the hippocampus would provide further insight. 
5.3.3 Inhibition and excitation affected at different time points 
Considering that we have seen both VAMP1 and VAMP2 affected in rat and mouse 
hippocampal slices, along with decreases in both evoked inhibition and excitation, 
albeit to varying degrees, further suggests that both populations are affected by 
injections of TeNT. Our grey level analysis of ex vivo slices and bouton analysis of 
slice cultures also signify an interesting differential cleavage of the two isoforms 
based on the time after injection. 
A number of very early papers looking at the effects of TeNT had shown that there 
was a differential effect of the toxin on excitatory and inhibitory neurons based on 
time (Albus & Habermann, 1983; Kanda & Takano, 1983; Bergey et al., 1987). The 
preparations vary in these papers, from injections peripherally that focus on 
motoneurons (Kanda & Takano, 1983), to spinal cord neuronal cultures (Bergey et 
al., 1987) and particles of forebrain cortex (Albus & Habermann, 1983). However, 
they all show that inhibitory neurons are affected at an earlier time point than 
excitatory neurons. This difference ranged from an hour (Albus & Habermann, 1983) 
to days (Kanda & Takano, 1983), although this is likely dependent on the 
preparation. It is possible, that other laboratories or experiments have not witnessed 
the effects on excitation as well as inhibition, because either their experiments did not 
last long enough, or because they did not look specifically for changes in excitation: 
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probably because of the general consensus that inhibitory neurons were the target of 
the toxin. This difference in the time scale of effects on the different populations is 
consistent with what we have shown in our grey level analysis. Here we saw that the 
peak effect of the toxin on inhibitory neurons (VAMP1) occurred earlier than in 
excitatory neurons (VAMP2). The slice cultures also showed that VAMP1 boutons 
were cleaved in a wider area than VAMP2 within the course of the study. Whether 
the VAMP2 cleavage would occur to a greater degree after 16 days is something that 
requires further investigation. The time scale of the current study did not allow us to 
see if the full recovery of one population occurred before the other. High 
magnification imaging of boutons from day 2 animals in ex vivo slices would also 
allow investigation to support focal effects of the toxin occurring earlier in inhibitory 
neurons. 
Differences in methodology may be responsible for some reports that excitatory 
responses are not affected by TeNT. For example, Shin et al. (2012) looked at the 
effects of TeNT on a nucleus from the spinal cord, and showed that both evoked and 
spontaneous inhibitory responses were affected by the TeNT but that glutamatergic 
responses were not. It may be that due to their methodology, where TeNT was 
applied to the slices directly for less than one hour during recordings, there was only 
a very short time for the TeNT to cleave either VAMP and thus the disruption of 
inhibition predominated. Differences in concentration may also be important. Jordan 
& Jefferys (1992) showed that EPSPs within CA3 remained intact when IPSPs were 
decreased at 8-18 days after injection of toxin, likely due to a very low concentration 
used (2-5ng). 
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It is likely that there will be variations between the different laboratories and 
experiments that use TeNT. Whether this is because of injections into different parts 
of the body or species, different sources or concentrations of toxin, these may 
influence the results. TeNT is one of the most poisonous substances but even so, 
there are likely to be differences between the effects of high and low doses. 
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5.4 Statistical analysis 
The different parts of this study contained many different variables. Multiple 
comparisons between these variables were required. Whilst the data from some 
sections of the project followed a normal distribution and groups showed equal 
variance allowing for two way ANOVAs to be used, data from other sections did not. 
In these cases t-tests (for those data that were normally distributed) or Mann Whitney 
Rank Sum tests (for those data that were not normally distributed) were required. 
Corrections for multiple comparisons were made where a cohort of data received 
more than one statistical test. The Bonferroni correction for multiple comparisons 
reduces the significance criterion to minimise the risk of obtaining one or more false 
positives. Multiple univariate tests rather than a single multivariate test were carried 
out on this data to include the numerous variables that were being tested. These 
univariate tests offered clarity within the large datasets, for example focussing on 
treatment and side of the brain within individual time points. This could then be 
followed by a comparison of time points within TeNT data, as control data was 
grouped to reduce the number of animals and therefore did not require the 
comparison of time points. 
5.5 Future directions 
A number of future avenues could be taken from the results presented within this 
thesis. As well as the extended investigations and studies already mentioned within 
this Chapter, there remain other directions to be explored. 
The slice cultures are now at a stage at which they can be used for longitudinal 
investigations of the full duration of the TeNT model. These studies would 
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complement parallel work in vivo and ex vivo. Co-cultures (Law et al., 2010) could be 
used as an additional tool to look at the spread of the toxin’s effects from one slice to 
another, using both immunohistochemical and electrophysiological analyses. Slice 
cultures also have the potential for screening of both anticonvulsant and 
antiepileptogenic drugs. This would reduce the numbers of animals used for drug 
screening studies. Comparison of the effects of carbamazepine and levetiracetam in 
slice cultures to those already established in vivo would provide a starting point 
(Doheny et al., 2002; Halliday et al., 2013). Using genetically modified mice would aid 
all these studies and would offer a further level of manipulation, particularly if using 
lines that are lethal in early life. 
The issue of species difference is currently being addressed in our laboratory by 
intrahippocampal TeNT injections into mouse brain in vivo. This will give a greater 
insight into the consistency of effects of the toxin in rats and mice, furthering what we 
have shown from current experiments which suggests a great deal of overlap 
between the effects of the toxin on the two species, even within animals from 
separate age groups. Further investigation is required, using both in vivo injections in 
mice and using infant rats for slice cultures. 
5.6 Implications for human epilepsy 
The results in the project have provided further evidence for the mechanisms of 
epilepsy in the TeNT-induced chronic model. This has implications for human 
epilepsy in that growing knowledge of the area of the hippocampus affected and the 
spread of foci to contralateral hippocampi and extrahippocampal regions in the brain 
can help understand the disease in greater details. The potential of the slice cultures 
- 237 - 
 
to act as drug screens for new antiepileptics is also very important for human 
sufferers. This TeNT model has the unique capability of modelling non-lesional 
epilepsy and thus is a key tool for research into this form of the disease. The 
complication of hippocampal sclerosis in other models therefore does not provide a 
sound model for patients who do not present with this pathology. Whilst there is still 
much to learn about TeNT-induced epilepsy, any insight into the changes that occur 
during epilepsy, including epileptogenesis and the propagation of seizures can only 
be of benefit to patients suffering from the disease.  
- 238 - 
 
5.7 Conclusions 
There has been a wealth of experiments following intrahippocampal injection of 
TeNT. What is new in our studies is that this electrophysiological activity has been 
directly collaborated with immunohistochemical investigation at the bouton level. We 
have also established that in vitro TeNT injections onto slice cultures offer a method 
to study the effects of the toxin that shows similarities to data already published. 
These results will deepen our understanding of published results. Overall, our data 
has shown: 
• Both VAMP1 and VAMP2 are cleaved by TeNT injections after in vivo 
intrahippocampal injection and within in vitro slice cultures, in rats and mice 
respectively. This counters previous reports that the toxin specifically targets 
VAMP2. The two isoforms have also been shown to co-localise in separate 
neuronal populations; VAMP1 mainly in inhibitory neurons and VAMP2 
predominantly in excitatory neurons. 
• Inhibition and excitation are disrupted by the toxin, albeit to different degrees, 
and with evoked and spontaneous activity differentially affected. The 
disruption can be related to the changes in VAMP1 and VAMP2 expression. 
• The VAMP1 cleavage occurs earlier and shows a more widespread effect, 
with the cleavage of VAMP2 delayed. Future studies into later time points, 
particularly many weeks post injection will clarify the importance of the 
difference in peak cleavage times of the two isoforms in relation to the 
development, continuation and recovery from the epileptic syndrome. 
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• Contrary to previous suggestions, the mirror foci seen in the contralateral 
hippocampus is likely to be the direct result of toxin cleavage of VAMPs rather 
than indirect mechanisms as previously suggested. 
• Focal application of TeNT onto organotypic slice cultures produces 
characteristics of the TeNT induced epilepsy model that are comparable to 
slices taken from animals injected in vivo. This technique offers a useful 
adjunct for future studies of the toxin. 
The use of both in vivo and in vitro TeNT treatments in this study has complemented 
each other. Whilst they both have advantages and disadvantages regarding their 
ease and flexibility of use, duration of use, suitability to relate to in vivo, cost and the 
reduction of animal usage, the combination of the two will help further the knowledge 
of the effects of TeNT and other substances, whilst improving insights into the 
mechanisms involved in epilepsy and other diseases.  
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7 APPENDIX 
7.1 Grey level data for the grouping of control slices 
7.1.1 VAMP1 control data 
Middle     Posterior 
Ipsilateral P value  Ipsilateral P value 
DG 0.067  DG 0.160 
CA2/3 0.067  CA2/3 0.933 
CA1 0.200  CA1 0.467 
     
Contralateral P value  Contralateral P value 
DG 0.200  DG 0.362 
CA2/3 0.067  CA2/3 0.468 
CA1 0.333  CA1 0.524 
The above data shows the p values after comparison of the control data from days 2, 
8 and 16. These are shown within each region of interest and within the mid and 
posterior levels of VAMP1 immunostained slices. One way ANOVAs were used to 
compare the three different time points. 
 
 
7.1.2 VAMP2 control data 
Middle     Posterior 
Ipsilateral P value  Ipsilateral P value 
DG 0.148  DG 0.487 
CA2/3 0.448  CA2/3 0.450 
CA1 0.206  CA1 0.329 
     
Contralateral P value  Contralateral P value 
DG 0.419  DG 0.426 
CA2/3 0.251  CA2/3 0.398 
CA1 0.342  CA1 0.698 
The above data shows the p values after comparison of the control data from days 2, 
8 and 16. These are shown within each region of interest and within the mid and 
posterior levels of VAMP2 immunostained slices. The tests were One way ANOVAs 
in all cases. 
  
- 253 - 
 
7.2 Conference abstracts 
7.2.1 British Neuroscience Association Meeting 2011 
Alteration of VAMP1 and VAMP2 synaptic protein expression and lack of 
inhibitory cell loss in tetanus toxin induced temporal lobe epilepsy 
Lucy Foss, Alex S. Ferecsko, Premysl Jiruska, John G.R. Jefferys, Attila Sik 
Intrahippocampal injection of tetanus toxin (TeTX) induces a chronic model of 
temporal lobe epilepsy. While the majority of rats lack obvious neuronal loss, it 
remains possible that a selective loss of inhibitory cells contributes to the epilepsy. 
We investigated the neuronal death and the spatiotemporal dynamics of VAMP1 and 
VAMP2 synaptic proteins, the substrates of TeTX. The chronic epileptic syndrome 
was induced by TeTX injection into the CA3 region of the hippocampus in vivo (under 
the UK Animals (Scientific Procedures) Act (1986)). TUNEL assay was used to reveal 
the spatial and temporal distribution of apoptotic and necrotic cells and 
immunofluorescent staining to identify TUNEL expression in parvalbumin (PV) and 
calretinin (CR)-expressing inhibitory neurons. Immunohistochemical labelling for 
VAMP1 and VAMP2 proteins was performed on control and TeTX injected rats post 
injection 2, 8 and 16 days.  Apoptotic and necrotic cells could be found in control and 
TeTX injected animals; some of the TeTx-injected rats at days 8 and 16 appeared to 
have more positive cells, but this difference between groups was only significant for 
pooled contralateral hippocampal regions on day 16, and no correlation was found 
between cell death and seizure severity or frequency. No co-localisation of TUNEL 
stained cells with either PV or CR labelled interneurons was observed. The labelling 
of VAMP1 and VAMP2 proteins showed the lowest intensity focally and increased 
with distance from the injection site. The extent of the regions lacking the VAMP1 
and VAMP2 labelling along the anterior-posterior dimension varied considerably 
between days 2 (320±80µm), 8 (1360±160µm) and 16 (1573±166µm). GABA, 
glutamate and neurofilament 68k expression were unaltered even in the focus of the 
injection. These data indicate that disruption of both VAMP1 and VAMP2 proteins 
rather than the lack of available neurotransmitter or inhibitory cell loss underlie the 
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7.2.2 Neuroscience 2011 
Differential distribution of hippocampal VAMP1 and VAMP2 isoforms and their 
cleavage by tetanus toxin. 
 
Lucy Foss, Alex S. Ferecsko, Premysl Jiruska, John G.R. Jefferys, Attila Sik 
 
Tetanus toxin (TeTx) is known to cleave vesicle associated membrane protein 
(VAMP). It is widely held that TeTx acts preferentially at inhibitory interneurons in 
brain and spinal cord. Two isoforms of the VAMP exist within the brain, VAMP1 and 
VAMP2, however previous reports do not agree on which isoform is the target of 
TeTx, whether it is both or just VAMP2. Here we tested the effects of the toxin on the 
VAMP proteins by incubating rat synaptosomes in TeTx, followed by denaturing and 
run on an SDS-PAGE gel followed by western blotting. Detection using enhanced 
chemiluminescence showed that the TeTx cleaved both the VAMP1 and VAMP2 
proteins. To test this on neurons in vitro, we carried out focal injections of TeTx onto 
the surface of the CA3 region of organotypic hippocampal slice cultures from mice 
followed by immunohistochemical staining for the VAMP2 protein. Results show that 
the VAMP2 protein is indeed cleaved by TeTx in this condition. To test the specificity 
in vivo, intrahippocampal injections of toxin were then made into the CA3 of rats and 
post mortem immunohistochemical staining carried out for both isoforms. The results 
show that both VAMP isoforms are cleaved in a spatiotemporal manner. To establish 
whether there was a differential expression of the two isoforms between inhibitory 
and excitatory neurons within the hippocampus we carried out co-localisation studies 
in paraformaldehyde perfused rat brains. VAMP1 and VAMP2 proteins were double 
labelled with antibodies against glutamic acid decarboxylase 65 (GAD65) and 
vesicular glutamate transporter 1 (VGLUT1), markers for inhibitory and excitatory 
neurons respectively. These results showed that VAMP1 is most commonly 
associated with inhibitory neurons and the VAMP2 with excitatory neurons. Overall 
these results show that the TeTx is responsible for the cleavage of both isoforms of 
the VAMP protein, contradicting what has previously been reported. They also show 
that the isoforms are differentially distributed within the hippocampus. The implication 
that both inhibitory and excitatory neurons are affected by the toxin poses interesting 
questions relating to the TeTx model of temporal lobe epilepsy, suggesting that it is 
not simply due to inhibitory dysfunction. 
